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GENERAL INTRODUCTION  
The growth of the global human population and a change in human dietary preferences 
towards more animal products, especially in Asian countries, has increased the demand for 
aquaculture products globally [1]. In addition, the limited supply of fish for human consumption 
from world capture fisheries contributed indirectly to the increased aquaculture production. It 
is estimated, that the production from world capture fisheries will stagnate on a level of around 
90 million metric tons per year [2]. In addition, only approximately 10.5% of marine fish stocks 
are currently considered to be underfished [2]. Thus, as global human population growth will 
continue, any further fish available for human consumption will have to come mainly from 
aquaculture production. A report from the World Bank estimates that in the year 2030 
aquaculture production will provide over 60% of the fish for human consumption [3].  
Intensively farmed fish species rely on compound aquafeeds with optimal physical and 
chemical qualities which are adapted to the fish to achieve a high product quality for human 
nutrition. Due to the increased demand for fish, compound aquafeed production increased 
rapidly from 7.6 million tons in 1995 [4] to 49.6 million tons in 2016 and is predicted to expand 
further by reaching 76.2 million tons in 2025 [5]. In the European Union, mainly carnivorous 
fish species like Atlantic salmon, rainbow trout and gilthead seabream are cultured [6]. These 
fish species require energy-dense feeds [7]. Most carnivorous fish species only have a poor 
capability to digest carbohydrates (reviewed in [8]). Thus, dietary lipids are utilized as the major 
energy contributors to avoid the oxidation of valuable and expensive protein for energy supply 
[9,10]. Traditionally, fish oil was used as the main lipid source in diets for fish species like 
Atlantic salmon and rainbow trout [11,12]. Besides being a source of energy, fish oil is rich in 
omega-3 (n-3) long chain polyunsaturated fatty acids (LC-PUFA) like eicosapentaenoic acid 
(20:5n-3, EPA) and docosahexaenoic acid (22:6n-3, DHA) [13]. In the past, the utilization of 
fish oil was economically reasonable, as it was inexpensive and readily available [11,14]. 
However, the current state is different: The worldwide production of fish oil peaked in 1987 and 
1990 with 1.6 million metric tons per year [7]. Since 2005, it declined steadily, and was less 
than 1 million metric tons in 2015 [15]. In addition, climate change impacts might promote a 
more frequent occurrence of El Niño [16]. This weather phenomenon has already caused a 
decrease in the population of small pelagic fish such as anchovies [17,18], the primary source 
for fish oil production [12,19]. In addition, already 75% of the fish oil produced worldwide is 
used for aquafeeds mainly for salmonids and marine finfish species (reviewed in [19]). The 
limited availability concomitant with the high demand excessively increased its price [11]. 
Aquafeeds for farmed fish make up approximately 50-80% of the total production costs in 
intensive aquaculture systems [7]. Depending on fish oil as a feed ingredient, its price increase 
became a bottleneck for the economic and sustainable growth of the industry [21].  
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Vegetable oils and fatty acids in fish nutrition 
A lot of research has been conducted so far to replace fish oil with vegetable oils in salmonid 
diets (reviewed in [22]). Vegetable oils are available on a large scale, cost effective and contain 
significant amounts of α-linolenic acid (18:3n-3, ALA) and linoleic acid (18:2n-6, LA) [13,23,24]. 
The content of these C18 fatty acids is important, since fish, like all vertebrates, lack the  
delta-12 and delta-15 desaturases that are needed to synthesize ALA and LA de novo from  
18:1n-9 [25]. Thus, fish rely on the dietary uptake of these fatty acids. Further physiologically 
essential fatty acids are the longer chained fatty acids arachidonic acid (20:4n-6, ARA), EPA 
and DHA [25,26]. Whether fish depend on the dietary supply or whether they are able to 
endogenously synthesize ARA, EPA and DHA from their PUFA precursors is species specific 
[27]. It depends on the presence and expression of various enzymes involved in the LC-PUFA 
biosynthesis like the delta-5- and delta-6-desaturase as well as the elongases [25,26]. In 
contrast to many marine fish species, many freshwater species are able to synthesize EPA 
and DHA from ALA. For example, salmonids like rainbow trout rely on their capability of 
endogenously synthesizing EPA and DHA as their natural prey is not rich in these fatty acids 
but contains high amounts of ALA and LA [25]. Thus, salmonids can be fed on plant-based 
diets without growth impairment as long as the requirement levels of ALA and LA are met [28–
31]. This fact has made vegetable oils the most implemented alternative to fish oil in salmonid 
diets with inclusion levels from 0% in 1990 to 19.2% in 2013 [12]. However, the fatty acid 
biosynthesis is not able to compensate for the lack of dietary EPA and DHA in plant-based 
diets, leading to significantly lower LC-PUFA tissue levels in comparison to fish fed dietary fish 
oil [28,30,32]. Thus, although dietary vegetable oils are able to satisfy the nutritional 
requirements for rainbow trout and can be considered economically and ecologically 
sustainable, the product quality of these fish is decreased for human consumption [33]. 
Fish in human nutrition 
Fish plays an important role in human nutrition. It provides about 17% of the worldwide 
available animal protein for human consumption [34]. In addition, fish is exceptionally rich in 
vitamin D [35] which is important for bone health [36]. Further, fish is a unique natural source 
of iodine and contains considerable amounts of selenium [35]. However, the main health-
beneficial effects are associated with the LC-PUFA content, specifically the content of EPA 
and DHA. EPA and DHA have been shown to be important for the infant neuronal and retinal 
development as well as the immune function [37,38]. Further, these fatty acids play a positive 
role in cardiovascular diseases, cancer and various mental illnesses (e.g. dementia) [38,39]. 
Similar to some fish species, humans are able to biosynthesize EPA and DHA from ALA. 
However, only 8% of ALA is converted to EPA and only 0.05-4% to DHA (reviewed in [40]). 
Moreover, high levels of n-6 fatty acids can additionally reduce the conversion efficiency by 
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40-50% (reviewed in [41]). The optimal n-6:n-3 ratio in human nutrition is approximately 1:1. 
However, in developed countries the dietary intake of n-6 fatty acids as well as the content of 
total fat and saturated fatty acids has increased, leading to a shift of the n-6:n-3 ratio toward 
20:1 which increases the risk of coronary heart disease and diabetes among other ailments 
(reviewed in [42]). Thus, to counteract the negative effects of an increased n-6:n-3 ratio on 
human health, the daily intake of up to 650 mg EPA and DHA via two servings of fish per week 
is recommended (reviewed in [43]). The LC-PUFA content in fish is dependent inter alia on the 
factors species, lipid content of flesh and dietary fatty acid composition [33,44–46]. Fish like 
Atlantic salmon and rainbow trout can be considered as rather oily and rich in EPA and DHA 
[33,47,48]. The main source of LC-PUFA in these fish is based on the supply via dietary fish 
oil and fishmeal [20,49]. The substitution of marine feed ingredients by terrestrial ingredients 
has caused a major effect in the product quality of fish for human nutrition. A study of farmed 
Atlantic salmon has shown a decrease of EPA and DHA levels from 2005 to 2015, which is 
due to the inclusion of dietary vegetable oils [33]. Thus, there is a major shortfall in EPA and 
DHA and the supply of these fatty acids by fish is far lower than the demand for the requirement 
for the global population.  
Strategies to ensure high quality fish for human consumption 
Significant effort has been put into finding alternatives to fish oil. For example, microalgae are 
the primary producers of LC-PUFA in the marine environment [23] and are already used as 
dietary supplements in human nutrition [34]. However, the production of fish oil alternatives 
has mainly been limited to DHA-producing, heterotrophic species (e.g. Schizochytrium) [50]. 
Their production is, so far, only possible in low volumes with high costs [23]. However, the 
genes of specific microalgae encoding for enzymes involved in the biosynthesis of EPA and 
DHA can be used in genetically modified (GM) oil crops. These genes have been inserted into 
plants such as camelina (Camelina sativa) and soy (Glycine max) generating seeds with up to 
20% of n-3 LC-PUFA [51,52]. For example, genetically modified camelina oil containing about 
6% EPA and DHA each has been shown to be a potent candidate to substitute dietary fish oil 
in Atlantic salmon. In this study, fish fed the diet containing camelina oil showed no difference 
in growth and health parameters compared to salmon fed other dietary treatments. Further,  
n-3 LC-PUFA tissue levels were higher compared to fish fed a diet based on an oil from a wild-
type of camelina [51]. However, genetically modified oilseed crops are currently not produced 
on a commercial scale and their utilization as feed ingredients in aquafeeds is still controversial 
[53,54]. Other strategies, like selective breeding for the heritable trait of n-3 LC-PUFA level in 
Atlantic salmon has been evaluated [55]. In addition, new feeding strategies like nutritional 
programming and circadian feeding schedules to promote the EPA and DHA contents were 
investigated [56,57]. For example, gilthead sea bream were fed diets based on canola oil and 
fish oil in daily alternation. These fish showed enhanced growth, feed intake and higher EPA 
4  General Introduction 
and DHA tissue levels compared to fish fed either of these diets continuously [57]. Another, 
commercially applied, feeding strategy is the use of finisher diets [58]. A fish oil based-diet is 
fed during the grow-out phase in order to restore the fatty acid contents in fish fed vegetable 
oil-based diets during the ongrowing phase to the desired n-3 LC-PUFA concentrations for 
human nutrition [30,58]. Although, the total amount of fish oil is reduced by this strategy, there 
is still a dependence on fish oil as a feed ingredient. 
This thesis will focus on the utilization of bioactive substances and a stearidonic acid-rich oil, 
respectively to substitute fish oil.  
Bioactive substances 
Isoflavones belong to the group of bioactive substances and naturally occur as glycosides in 
tropical legumes like soy and red clover (Trifolium pratense) [59,60]. In the intestine, isoflavone 
glycosides are hydrolyzed by various enzymes and are either absorbed or further metabolized. 
Daidzein, for example, can be metabolized to equol by the intestinal bacterial metabolism in 
animals and humans (reviewed in [61]). In general, bioactive substances have health-
beneficial effects beyond their basic nutritional value in human nutrition. For example, 
isoflavones have been associated with a reduced occurrence of breast and prostate cancer in 
humans of Asian countries due to their plant-based diet (reviewed in [62]). Besides their 
potential health benefits in humans, they might also be able to stimulate the endogenous 
biosynthesis of EPA and DHA and thereby increase the tissue levels of these fatty acids in 
rainbow trout. Genistein and daidzein have been shown to improve the lipid metabolism in 
obese-zucker rats and increase the expression of the transcription factor peroxisome 
proliferator-activated receptor alpha (PPARα) in murine cells [63]. PPARα is centrally involved 
in the peroxisomal β-oxidation [64] necessary to obtain DHA [20]. Further, soy isoflavones 
affected the lipid metabolism in rats (reviewed in [65]) and fish [66]. For example, genistein 
significantly increased the expression of genes involved in the biosynthesis pathway of n-3 LC-
PUFA in hepatocytes of Atlantic salmon [66]. Due to their structural similarity to estrogen, 
isoflavones belong to the group of phytoestrogens [60]. Thus, these substances and the 
metabolite equol are able to bind to estrogen-receptors and mimic estrogen [67–70]. Genes 
encoding proteins involved in the n-3 LC-PUFA synthesis pathway can be affected by estrogen 
[71–74]. This could be an important factor to increase tissue n-3 LC-PUFA levels in rainbow 
trout. 
Stearidonic acid-rich oils 
In contrast to common plants, Buglossoides arvensis, Echium plantagineum and Ribes nigrum 
naturally contain stearidonic acid (18:4n-3, SDA). The levels of SDA in the oils of these plants 
depend on the species and are in the range of 3% (Ribes nigrum) [75] to ~13% (Echium 
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plantagineum) and up to 18% (Buglossoides arvensis) [22]. These plants have a gene 
encoding for the delta-6-desaturase [23]. Thus, they are able to synthesize SDA from ALA and 
18:3n-6 from LA, respectively. In vertebrates, this step has been considered to be rate limiting 
in the LC-PUFA synthesis (reviewed in [45]). Thus, bypassing the initial synthesis step can 
increase the overall efficiency of the synthesis. This has already been shown in humans [76,77] 
and animals [78,79] leading to increased EPA levels. However, dietary Echium oil lead to 
controversial results in salmonids [80–82]. For example, rainbow trout fed a diet based on 
Echium oil showed similar LC-PUFA tissue levels as fish fed a diet based on linseed oil, as the 
substrate (ALA/SDA) availability might also be a limiting factor of the biosynthesis [80]. 
Ahiflower oil, an oil of the plant Buglossoides arvensis, is rich in SDA but has also significant 
amounts of ALA [83]. Thus, dietary Ahiflower oil might increase EPA and DHA tissue levels in 
rainbow trout by providing both SDA, to increase the efficiency of the biosynthesis, and ALA 
for further substrate availability.  
Aim of the thesis 
As mentioned in the beginning, a compound aquafeed has to ensure optimal physical and 
chemical quality adapted to the fish to achieve a high product quality for human nutrition. 
Although, these requirements might not have changed substantially over the last decades, it 
is more difficult than ever to meet them nowadays. Due to the limited availability of fish oil, the 
aquaculture production faces massive challenges in finding adequate alternatives to this feed 
ingredient. The approaches in this thesis aimed to enhance the levels of EPA and DHA in 
rainbow trout which were fed vegetable oil-based diets in order to increase the nutritional value 
of these fish for human consumption. The approaches are built on three hypotheses: 
(1) Isoflavones and their metabolites are able to stimulate the endogenous biosynthesis of 
LC-PUFA  
(2) Dietary Buglossoides arvensis (Ahiflower) oil enhances the efficiency of the LC-PUFA 
biosynthesis  
(3) Combining isoflavones and Ahiflower oil leads to an interaction that further increases 
the levels of LC-PUFA   
In total, four experiments were conducted to test these hypotheses. All experiments were 
performed with rainbow trout as this fish species is known for their ability to synthesize EPA 
and DHA endogenously.  
Chapter 1 examines the potential of the bioactive substances bioachanin A, daidzein, 
genistein and equol to stimulate the biosynthesis of EPA and DHA in rainbow trout and 
discusses the following research questions:  
6  General Introduction 
 Are they able to stimulate the biosynthesis of EPA and DHA and thereby increase the 
content of these fatty acids in tissues of rainbow trout fed with a vegetable oil-based 
diet? 
 Do these substances affect growth of fish and nutrient composition of whole body 
homogenates of rainbow trout? 
 Do they alter the expression and protein levels of genes encoding proteins involved in 
the fatty acid biosynthesis? 
Chapter 2 focuses on the dose-response of the most promising substances of chapter 1 
(genistein and equol) in order to increase the efficiency of the biosynthesis of EPA and DHA 
in rainbow trout and addresses the following research aims: 
 Do different dietary concentrations of genistein and equol affect growth of fish and 
nutrient composition of whole body homogenates of rainbow trout differently? 
 Are higher/lower dietary dosages of these substances more efficient in increasing 
tissue levels of EPA and DHA? 
 Do these substances and the dietary dosages, respectively, affect the fatty acid 
composition of tissues (liver, whole body homogenate and fillet) differently?  
Chapter 3 discusses the suitability of dietary Ahiflower oil to enhance EPA and DHA in rainbow 
trout tissues and examines the following scientific issues: 
 Do increased dietary ALA and SDA levels increase the efficiency of the EPA and DHA 
biosynthesis in rainbow trout? 
 Which concentration of Ahiflower oil can be used in rainbow trout diets without impairing 
growth performance and nutrient composition of fish?  
 Does the inclusion of Ahiflower oil modify the expression of genes involved in the 
biosynthesis of fatty acids differently in response to the dietary dosage? 
Chapter 4 is based on the observations of the chapters 1-3 and aims to evaluate the 
interactions of both dietary equol and Ahiflower oil to improve the nutritional quality of rainbow 
trout, focusing on the following questions: 
 Is the combination of dietary Ahiflower oil and different levels of equol able to further 
increase EPA and DHA levels in rainbow trout? 
 Do these dietary treatments have an effect on growth performance of fish? 
 Does the combination of dietary Ahiflower oil and equol alter the nutrient composition 
of whole body homogenates and fillets? 
- Which role does the concentration of equol combined with Ahiflower oil play on the 
hepatic mRNA steady state levels of the delta-6-desaturase? 
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Abstract 
Plant oil utilization in aquafeeds is still the most practical option, although it decreases the 
content of the nutritionally highly valuable omega-3 fatty acids eicosapentaenoic acid  
(20:5n-3, EPA) and docosahexaenoic acid (22:6n-3, DHA) in fish. Phytoestrogens and their 
metabolites are putatively able to affect genes encoding proteins centrally involved in the 
biosynthesis of EPA and DHA due to their estrogenic potential. Thus, the aim of the study was 
to screen the potential of the phytoestrogens to stimulate the biosynthesis of EPA and DHA in 
rainbow trout (Oncorhynchus mykiss). Additionally, the potential effects on growth 
performance, nutrient composition and hepatic lipid metabolism in rainbow trout were 
investigated. For that, a vegetable oil based diet served as a control diet (C) and was 
supplemented with 15 g/kg dry matter of biochanin A (BA), daidzein (DA), genistein (G) and 
equol (EQ), respectively. These five diets were fed to rainbow trout (initial body weight 83.3 ± 
0.4 g) for 52 days. Growth performance and nutrient composition of whole body homogenates 
were not affected by the dietary treatments. Furthermore, feeding EQ to rainbow trout 
significantly increased DHA levels by +8 % in whole body homogenates compared to samples 
of fish fed the diet C. A tendency towards increased DHA levels in whole body homogenates 
was found for fish fed the diet G. Fish fed diets BA and DA lacked these effects. Moreover, EQ 
and G fed fish showed significantly decreased hepatic mRNA steady state levels for fatty acyl 
desaturase 2a (delta-6) (fads2a(d6)). In contrast, carnitine palmitoyl transferases 1 (cpt1) 
hepatic mRNA steady state levels and hepatic Fads2a(d6) protein contents were not affected 
by the dietary treatment. In conclusion, when combined with dietary vegetable oils, equol and 
genistein seem to stimulate the biosynthesis of DHA and thereby increase tissue DHA levels 
in rainbow trout, however, only to a moderate extent.  
Keywords: Fish, bioactive, phytoestrogen, DHA, biosynthesis, vegetable oil  
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Introduction 
The amount of fish oil in feed formulas decreased steadily over the last decades due to 
increasing prices, resulting in the increased inclusion of plant oils [1,2]. Despite this fact, the 
share of aquaculture on global fish oil utilization increased, with most of it used for salmonid 
compound feeds [3]. On the one hand, this is due to the expanded production of these species 
in aquaculture [4]. On the other hand, producing alternatives high in eicosapentaenoic acid 
(20:5n-3, EPA) and docosahexaenoic acid (22:6n-3, DHA), such as single cell oils, is still not 
feasible on a commercial scale due to unreasonably high costs [5,6]. Furthermore, the industry 
is driven by consumer expectations of farmed fish being a rich source of EPA and DHA [3,5].  
In contrast to many other species, salmonids could be reared successfully on diets with up to 
100% fish oil replacement [7–11]. Particularly, rainbow trout (Oncorhynchus mykiss) can cope 
with plant oil based diets due to their ability to endogenously biosynthesize omega-3 (n-3) long-
chain polyunsaturated fatty acids (LC-PUFA) [12]. Thereby, dietary α-linolenic acid (18:3n-3, 
ALA), which is found in plant oils like linseed and rapeseed oil [13], is converted to the fatty 
acids EPA and DHA [14]. This, however, is insufficient to maintain the n-3 LC-PUFA levels of 
fish fed with fish oil [7,15,16]. Nonetheless, the use of plant oils as alternatives is the most 
practical and implemented option [17].  
Dietary application of phytochemicals seems to be a promising option to counteract the 
negative effect of plant oil inclusion on the n-3 LC-PUFA content in rainbow trout. 
Phytochemicals include isoflavones, for example biochanin A, genistein and daidzein [18]. 
Biochanin A is one of the major isoflavones in red clover (Trifolium pratense) [19] whereas 
genistein and daidzein are naturally present in soy (Glycine max) [18]. In contrast, equol is not 
plant-derived but is a metabolite from daidzein [20]. Equol can be synthesized from daidzein 
by the intestinal bacterial metabolism in animals and humans [21,22]. Isoflavones and their 
metabolites can act as antioxidants in humans [23] and showed anti-inflammatory properties 
in human endothelial cells [24]. 
Biochanin A, genistein, daidzein and equol belong to the group of phytoestrogens and their 
metabolites, respectively [20]. The estrogenic potency seems to be attributed to their structural 
similarity to estradiol [25]. This is of particular interest, since genes encoding proteins involved 
in the n-3 LC-PUFA biosynthesis were found to be responsive to estrogen [26–28]. For 
example, hepatic delta-6-desaturase  expression was upregulated in response to estradiol in 
rats [26,29]. The delta-6-desaturase is necessary inter alia for synthesizing DHA out of EPA 
[30]. Kitson et al. [26] suggest that the upregulation of the hepatic delta-6-desaturase 
expression increased DHA levels in rats. In addition, isoflavones can be potent ligands for the 
peroxisome proliferator-activated receptor α (PPARα) [31,32]. Carnitine palmitoyl transferase 
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(CPT) 1 is one of the target genes of PPARα and is centrally involved in the biosynthesis of 
fatty acids [33]. 
The objective of this study was to screen the potential of dietary isoflavones (Biochanin A, 
daidzein, genistein) and their metabolites (equol) to stimulate n-3 LC-PUFA biosynthesis and 
the potential effects on growth in rainbow trout. For this purpose, a feeding trial was conducted 
with rainbow trout. A vegetable oil based diet was supplemented with the different isoflavones 
and equol, respectively. Influences of the different dietary treatments on growth performance, 
fatty acid composition of liver, whole body and fillet, nutrient composition of whole body as well 
as hepatic fatty acyl desaturase 2a (delta-6) (fads2a(d6)) and cpt1 mRNA steady state levels 
and hepatic Fads2a(d6) protein levels were investigated.  
Materials and Methods 
Experimental setup  
The feeding trial was performed at the facilities of the Gesellschaft für Marine Aquakultur mbH 
(GMA, Büsum, Germany). A total of 300 monosex female rainbow trout juveniles 
(Forellenzucht Trostadt GbR, Reurieth, Germany) were acclimated to the experimental 
conditions in a recirculation aquaculture system (RAS, 20 m3, turnover rate 2.4 h-1, technical 
oxygen supply). The water purification system consisted of drum filter, biofilter, ultraviolet 
disinfection and protein skimmer with ozone. A light/dark (12 h/12 h) cycle was adapted. 
Following a 3-week adaptation period feeding a commercial diet, fish (83.3 ± 0.4 g) were 
randomly and equally stocked among 15 tanks (volume 150 L, 20 fish per tank, total initial 
biomass 1666.4 ± 7.2 g). Dietary treatments were randomly distributed in triplicate and were 
hand fed once per day for 52 days. To adjust daily feed supply of 2.0% of biomass, all tanks 
were bulk weighed every 14 days. Temperature (16.0 ± 0.6°C), oxygen (10.4 ± 0.2 mg/L O2) 
and pH (7.4) were monitored continuously. NH4+ (0.5 ± 0.4 mg/L), NO2- (0.5 ± 0.2 mg/L) 
(Microquant test kit for NH4+ and NO2; Merck KGaA, Darmstadt, Germany) and salinity  
(6.2 ± 0.2 ‰) were measured daily. The experiment was conducted according to the national 
regulations for animal welfare (TierSchVersV) and the EU Directive 2010/63/EU for animal 
experiments. Furthermore, it was approved by the Ministry of Energy, Agriculture, the 
Environment, Nature and Digitalization (MELUND, Kiel, Germany; approved on 11 July 2017, 
project number V241-37421/2017). 
Experimental diets  
All diets were formulated based on the same feed ingredient composition, only differing in the 
supplementation of the bioactive substances. A blend of palm fat, rapeseed, linseed and 
sunflower oil was used as dietary oil source (Table 1-1).   
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Table 1-1. Ingredients and nutrient composition (in g/kg dry matter (DM)) of the 
experimental diets C, BA, DA, EQ and G. 
Diet C BA DA EQ G 
Ingredients [g/kg DM]      
Fish meal a 150 150 150 150 150 
Blood meal b 50 50 50 50 50 
Feather meal c 55 55 55 55 55 
Pea protein isolate d 150 150 150 150 150 
Soy protein concentrate e 50 50 50 50 50 
Wheat gluten f 140 140 140 140 140 
Gelatin g 15 15 15 15 15 
Wheat starch f 210 210 210 210 210 
Oil sources 115 115 115 115 115 
Rapeseed oil h 36 36 36 36 36 
Linseed oil i 34 34 34 34 34 
Palm fat j 29 29 29 29 29 
Sunflower oil h 16 16 16 16 16 
Vitamin Mineral premix k 10 10 10 10 10 
Calcium hydrogen phosphate l 5.0 5.0 5.0 5.0 5.0 
α-Cellulose m 15 15 15 15 15 
Lysine n 4.0 4.0 4.0 4.0 4.0 
Methionine o 1.0 1.0 1.0 1.0 1.0 
Bentonite p 30 28.5 28.5 28.5 28.5 
Biochanin A q - 1.5 - - - 
Daidzein q - - 1.5 - - 
Equol q - - - 1.5 - 
Genistein q - - - - 1.5 
      
Nutrient composition [% DM]      
Dry matter [in % of diet] 89.1 88.2 88.8 89.3 89.0 
Crude protein 53.2 53.5 52.7 52.6 53.5 
Crude lipid 16.6 16.8 16.6 16.6 16.7 
Crude ash 6.0 5.8 5.8 5.8 5.9 
Total COH [in % DM] r 24.2 23.9 24.9 25.0 24.0 
Gross energy [MJ/kg DM] 23.4 23.4 23.3 23.3 23.3 
a Lean fish meal “low ash”, Bioceval GmbH & Co. KG, Cuxhaven, Germany; b Daka porcine bloodmeal, Daka 
Denmark A/S, Løsning, Denmark; c GePro Goldmehl, GePro Geflügel-Protein Vertriebsgesellschaft mbH & Co. KG, 
Diepholz, Germany; d Emsland-Stärke GmbH, Emlichheim, Germany; e Euroduna Food Ingredients GmbH, 
Barmstedt, Germany; f KRÖNER STÄRKE GmbH, Ibbenbüren, Germany; g Gustav Ehlert GmbH & Co. KG, Verl, 
Germany; h Food store, Büsum, Germany; i Makana Produktion und Vertrieb GmbH, Offenbach a.d. Queich, 
Germany; j DF 100 PT-PV; EFG Elbe Fetthandel GmbH, Geesthacht, Germany; k Emsland-Aller Aqua GmbH, 
Golßen, Germany; l JRS Pharma GmbH & Co. KG, Rosenberg, Germany; m Mikro-Technik GmbH & Co. KG, 
Bürgstadt am Main, Germany; n Biolys, Evonik Industries AG, Essen, Germany; o MetAmino, Evonik Industries AG, 
Essen, Germany; p Castiglioni Pes y Cía, Buenos Aires, Argentina; q Biochanin A: Cas No: 491-80-5, Daidzein: Cas 
No: 486-66-8, Equol: Cas No: 531-95-3, Genistein: Cas No: 446-72-0, Xi’an Natural Field Bio-Technique Co., LTD, 
Xi’an Shaanxi, China; r Total COH = 100 – (crude protein + crude lipid + crude ash).  
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These oil sources were included into the diets to meet the dietary ALA requirement (0.7-1.0% 
of dry diet) of rainbow trout [13]. Furthermore, only 15% of lean fish meal was used to obtain 
dietary EPA and DHA levels below the recommended levels for these fatty acids (0.4-0.5% of 
dry diet) for rainbow trout [13]. Each of the dietary treatments was supplemented with either 
1.5 g/kg of dry matter biochanin A (BA), daidzein (DA), equol (EQ) or genistein (G), 
respectively, in exchange for bentonite. A diet without the addition of bioactive compounds was 
designed as control diet (C), resulting in five experimental diets in total (C, BA, DA, EQ and 
G). All diets were isoenergetic and isonitrogenous. Dietary fatty acid composition is shown in 
Table 1-2. Amino acid content (not shown) of the diets was calculated based on the amino 
acid contents of the single ingredients. The experimental diets were designed following the 
amino acid requirements of rainbow trout [13]. Diets were produced with a pelleting machine 
(Type 14U175, Amandus Kahl, Hamburg) with 6 mm length and 4 mm in diameter. 
Table 1-2. Fatty acid composition (in % of fatty acid methyl ester (FAME)) of the 
experimental diets C, BA, DA, EQ and G. 
[% of FAME]  C BA DA EQ G 
14:0 0.7 0.7 0.7 0.7 0.7 
16:0 21.3 21.2 21.3 21.2 21.3 
18:0 3.6 3.6 3.6 3.6 3.6 
Total SFA 1 26.6 26.4 26.5 26.4 26.5 
16:1 0.5 0.6 0.5 0.6 0.6 
18:1 28.3 28.4 28.4 28.4 28.3 
Total MUFA 2 32.6 32.6 32.6 32.7 32.6 
n-6     
18:2n-6 22.4 22.5 22.5 22.5 22.5 
18:3n-6 0 0 0 0 0 
20:4n-6 0.1 0 0 0 0 
n-3     
18:3n-3 15.0 15.2 15.1 15.2 15.1 
18:4n-3 0.2 0.2 0.2 0.2 0.2 
20:5n-3 0.8 0.8 0.8 0.8 0.8 
22:6n-3 1.3 1.3 1.3 1.3 1.3 
Total PUFA 3 40.4 40.6 40.4 40.6 40.4 
ALA [% DM] 4 2.3 2.4 2.3 2.3 2.3 
∑EPA+DHA [% DM] 4 0.3 0.3 0.3 0.3 0.3 
1 Total SFA is the sum of saturated fatty acids; 2 Total MUFA is the sum of monounsaturated fatty acids;  
3 Total PUFA is the sum of polyunsaturated fatty acids; 4 Calculated from the percentage data and the lipid content 
in the diets (in % DM), assuming 93% of total lipid to be fatty acids. 
Sampling 
Eleven acclimatized residual fish (three whole body, eight fillet and liver) were anesthetized, 
killed by a blow on the head and sampled for determining the initial status. Fish were starved 
for 72 hours for gastric emptying at the beginning and the end of the 52 day-feeding trial and 
bulk weighed for determination of growth performance parameters: Feed conversion ratio 
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(FCR): feed intake [g]/weight gain [g]; specific growth rate (SGR, [% d-1]): [ln (final body weight) 
– ln (initial body weight)]/feeding day x 100; protein efficiency ratio (PER): weight gain 
[g]/protein intake [g]; protein retention efficiency (PRE): 100 x {[(final body protein x final body 
weight) – (initial body protein x initial body weight)]/protein intake}.  
After the bulk weighing, final samples were taken. Both samplings (initial and final) were 
conducted following the same procedure. Three fish per tank were sacrificed as a pool sample 
for fatty acid and nutrient composition of whole body homogenate and stored at -20°C. Five 
fish per tank were used for sampling fillet, liver and spleen. Liver and spleen weights were 
measured to calculate hepatosomatic and spleen somatic index (Hepatosomatic index (HSI): 
100 x (liver weight [g]/body weight [g]); Spleen somatic index (SSI): 100 x (spleen weight 
[g]/body weight [g]). One part of the liver was taken for measurement of Fads2a(d6) protein 
levels via ELISA and stored at -80°C. Another part of the liver was used for mRNA 
quantification via quantitative real-time reverse transcription polymerase chain reaction (qRT-
PCR), preserved in RNA later to prevent RNA degradation and stored at -20°C. Residual liver 
and fillet tissue was pooled for fatty acid analysis and stored at -80°C and -20°C, respectively. 
Length and weight of all sampled fish was measured to calculate Fulton condition factor (K: 
100 x (final body weight x final body length-3)). Whole body homogenate and fillet samples 
were freeze dried (alpha 1-4 LSC; Martin Christ Gefriertrocknungsanlagen GmbH, Osterode 
am Harz, Germany) and homogenized with a grinding mill (Grindomix, Retsch, Haan, 
Germany). 
Nutrient composition  
Proximate nutrient analysis of ingredients, diets and whole body homogenate was performed 
at the laboratory of the Gesellschaft für Marine Aquakultur mbH according to EU guideline (EC) 
152/2009 [34]. Dry matter was determined by drying samples (ED53 9010-0078; Binder 
GmbH, Tuttlingen, Germany) until constant mass. Same samples were incinerated in a muffle 
furnace (LE 6/11/P300; Nabertherm, Lilienthal, Germany) for crude ash analysis. Gross energy 
content was determined by bomb calorimetry (C 200; IKA-Werke GmbH & Co. KG, Staufen, 
Germany). Crude lipid content was analyzed according to the Soxhlet method 
(HYDROTHERM HT 6 and SOXTHERM 416; C. Gerhardt GmbH & Co. KG, Königswinter, 
Germany). Crude protein content was determined according to the methods of Kjeldahl 
(Scrubber K-415 and KjelFlex 360; BÜCHI Labortechnik GmbH, Essen, Germany and 877 
Titrino plus; Deutsche METROHM GmbH & Co. KG, Filderstadt, Germany).  
Fatty acid composition 
Fatty acid composition of diets, liver, fillet and whole body samples was analyzed by LUFA-
ITL GmbH, Kiel, Germany via gas chromatography (DGF, C-VI 10 a). Saponification with 
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methanolic NaOH and transmethylation of total lipids was used to prepare fatty acid methyl 
esters (FAME). For this, boron trifluoride and methanol were utilized (DGF, C-VI 11 a). GC via 
split-injection (column: CP-Sil 88 50 m x 0.25 mm x 0.2 µm or similar) separated FAME 
samples. FAME were detected by flame ionization detector (FID) using helium as a carrier gas 
and subsequently identified in comparison with certified fatty acid standard mixtures. Fatty acid 
composition was calculated as percent of FAME relative to total FAME. 
RNA isolation and qRT-PCR 
Total mRNA was extracted from liver samples of rainbow trout using the Innuprep RNA Mini 
Kit (Analytik Jena, Jena, Germany) according to the manufacturer’s instructions. Before the 
total RNA isolation, the samples were homogenized in a TissueLyser II (Qiagen, Hilden, 
Germany). NanoDrop measurements (NanoDrop2000c; ThermoScientific, Waltham, MA, 
USA) were used to determine RNA concentration. Quantification of mRNA steady state levels 
of genes encoding proteins related to lipid metabolism was measured via qRT-PCR. The 
SensiFast SYBR No-ROX One-Step Kit (Bioline, London, UK) and a Rotor-Gene 6000 real-
time PCR cycler (Corbett/Qiagen) were used for that. Primers and their respective annealing 
temperatures are shown in Table 1-3. Relative mRNA concentrations were calculated using a 
standard curve. The mRNA steady state levels of fads2a(d6) and cpt1a/c were normalized to 
the expression level of the housekeeping gene elongation factor 1 α (ef1α).  
Table 1-3. Primer sequences (forward and reverse) and the respective annealing 
temperatures for mRNA measurements via qRT-PCR of samples from rainbow trout 
liver. 
Genes Primer sequences FW Primer sequences Rv Annealing 
temp. (°C) 
Ref. 
 ef1α a ACAAGCCCCTYCGTCTGCC GCATCTCCACAGACTTSACCTCAG 61 [35] 
fads2a(d6) b GCTGGAGARGATGCCACGGA TGCCAGCTCTCCAATCAGCA 61 [35] 
cpt1a c TCGATTTTCAAGGGTCTTCG CACAACGATCAGCAAACTGG 55 [36] 
cpt1c c CGCTTCAAGAATGGGGTGAT CAACCACCTGCTGTTTCTCA 59 [36] 
a Elongation factor 1 α; b Fatty acyl desaturase 2a (delta-6); c Carnitine palmitoyl transferase 1. 
Enzyme-Linked Immunosorbent Assay (ELISA)  
Fads2a(d6) protein levels were determined using a Fish Fatty Acid Desaturase 2 ELISA Kit 
(MBS066226, MyBiosource Inc., San Diego, CA, USA; purchased from Biozol, Eching, 
Germany) following to the manufacturer’s protocol. Liver samples of rainbow trout were diluted 
in phosphate buffered saline in a TissueLyser II (Qiagen, Hilden, Germany). After the 
centrifugation, standards and diluted samples were applied to the Microelisa multiwall plate. 
Samples were incubated and treated with horseradish peroxidase (HRP) conjugate reagent 
followed by multiple washings. Color intensity was determined at 450 nm using a Labsystems 
iEMS MF multiplate reader (MTX Lab Systems, Bradenton, FL, USA purchased from Thermo 
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Fisher Scientific, Darmstadt, Germany). The Fads2a(d6) protein concentration in liver samples 
was calculated via standard curve. Values were normalized to the total protein concentration.  
Statistical analysis 
The statistical software R (2017) was used to evaluate the data, including the packages gdata, 
gplots, lsmeans, multcomp, nlme and piecewiseSEM. Prior to the data evaluation, appropriate 
statistical models were defined: (1) statistical linear model for data per tank (body weight, DFI, 
FCR, SGR, PER, PRE, nutrient and fatty acid composition); (2) mixed models [37,38] with tank 
as random factor if values per fish (HSI, SSI, K, mRNA steady state levels, Fads2a(d6) protein 
level) were considered. The data were assumed to be normally distributed and to be 
homoscedastic. These assumptions are based on a graphical residual analysis. The statistical 
model included the treatment (C, BA, DA, EQ, G). Based on the model, a Pseudo R2 was 
calculated [39] and multiple contrast tests (many-to-one) (e.g., see [40]) were conducted.  
Results 
Growth, performance and nutrient composition 
All groups tripled their initial body weight within the experimental period of 52 days  
(Table 1-4). Final body weights did not differ significantly between dietary treatments. In 
addition, DFI, PER, PRE, SSI and HSI were not significantly affected by the supplementation 
of bioactive substances. Fish fed with DA had significantly (p = 0.0497) lower K values 
compared to fish fed the control diet. Furthermore, the nutrient composition analysis of whole 
body homogenates showed no significant differences between fish fed the diets with bioactive 
substances and fish fed the control diet (Table 1-5). 
Tissue fatty acid composition  
Generally, the fatty acid composition of the sampled tissue was not modified to a great extent 
by the dietary treatments. However, fish fed EQ showed significantly (p = 0.037) increased 
DHA levels in their whole body homogenate samples compared to the samples of fish fed the 
diet C. Furthermore, fish fed the diet G tended (p = 0.059) to have higher DHA levels than the 
fish fed with C (Table 1-6). In fillet samples, elevated DHA levels were found for EQ and G fed 
fish (Table 1-7). In addition, fillets of EQ fed fish showed significantly lower 18:3n-6 and  
18:4n-3 levels compared to fish fed the control group (p = 0.017 and p = 0.049, respectively). 
Levels of SFA, MUFA and PUFA in whole body homogenate and fillet samples were not 
affected by the dietary treatments and remained in a similar range of concentrations as the 
initial samples (MUFA > PUFA > SFA). In contrast, livers of fish fed with EQ had significantly 
higher levels of the fatty acid 18:0 and total SFA (p < 0.0001 and p = 0.021, respectively)  
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(Table 1-8). Levels of MUFA and PUFA in livers, however, were not affected by the dietary 
treatments.  
Table 1-4. Growth performance, feed intake, feed efficiency and biometric parameters 
of rainbow trout fed with the experimental diets C, BA, DA, EQ and G for 52 days. 
  C BA DA EQ G  
IBW 1 83.4 ± 0.3 83.1 ± 0.3 83.2 ± 0.2 83.2 ± 0.0 83.6 ± 0.5 
FBW 2 255 ± 1.3 259 ± 3.4 259 ± 6.1 251 ± 6.3 257 ± 4.6 
FCR 3 0.98 ± 0.01 0.95 ± 0.02 0.95 ± 0.02 0.98 ± 0.02 0.98 ± 0.01 
SGR 4 2.15 ± 0.01 2.19 ± 0.03 2.19 ± 0.04 2.12 ± 0.05 2.16 ± 0.03 
DFI 5 2.10 ± 0.02 2.07 ± 0.03 2.08 ± 0.01 2.09 ± 0.01 2.11 ± 0.01 
PER 6 2.15 ± 0.02 2.24 ± 0.05 2.22 ± 0.05 2.17 ± 0.05 2.15 ± 0.03 
PRE 7 37.0 ± 0.9 38.0 ± 1.0 38.5 ± 0.4 37.8 ± 0.5 36.9 ± 0.2 
SSI 8 0.17 ± 0.08 0.15 ± 0.05 0.13 ± 0.05 0.15 ± 0.06 0.16 ± 0.05 
HSI 9 1.30 ± 0.16 1.29 ± 0.13 1.26 ± 0.14 1.29 ± 0.16 1.21 ± 0.19 
K 10 1.39 ± 0.08a 1.34 ± 0.08 1.32 ± 0.08b 1.38 ± 0.10 1.38 ± 0.08 
1 Average initial body weight [g]; 2 Average final body weight [g]; 3 Daily feed intake [% d-1]; 4 Feed conversion ratio 
= feed intake [g]/weight gain [g]; 5 Specific growth rate [% d-1] = [ln (final body weight) – ln (initial body 
weight)]/feeding day x 100; 6 Protein efficiency ratio = weight gain [g]/protein intake [g]; 7 Protein retention efficiency 
= 100 x {[(final body protein x final body weight) – (initial body protein x initial body weight)]/protein intake}; 8 
Hepatosomatic index = 100 x (liver weight [g]/body weight [g]); 9 Spleen somatic index = 100 x (spleen weight 
[g]/body weight [g]); 10 Fulton condition factor = 100 x (final body weight x final body length-3). Values (mean ± SD, 
IBW, FBW, FCR, SGR, DFI, PER, PRE: n = 3; HSI, SSI: n = 3 (5 fish/tank); K: n = 3 (8 fish/tank)) with different 
superscript letters within one row are significantly different (p < 0.05), values without superscript letters within one 
row are not significantly different (p ≥ 0.05) based on the statistical models described in Materials and Methods. 
Table 1-5. Nutrient composition of whole body homogenate (in % WW; gross energy in 
MJ/kg) of rainbow trout before the experiment (Initial) and after being fed the 
experimental diets C, BA, DA, EQ and G for 52 days. 
in % WW Initial C BA DA EQ G 
Moisture 72.6 67.8 ± 1.2 68.9 ± 0.3 68.3 ± 0.8 68.7 ± 0.3 68.0 ± 0.7 
Crude ash 2.7 2.0 ± 0.1 2.2 ± 0.3 2.3 ± 0.1 2.3 ± 0.2 2.2 ± 0.2 
Crude protein 16.2 16.9 ± 0.2 16.7 ± 0.1 17.0 ± 0.1 17.0 ± 0.2 16.8 ± 0.1 
Crude lipid 8.6 13.3 ± 1.2 12.0 ± 0.2 12.4 ± 0.8 12.0 ± 0.5 12.8 ± 0.8 
Gross energy [MJ/kg] 7.2 9.3 ± 0.5 8.8 ± 0.1 9.0 ± 0.3 8.9 ± 0.1 9.2 ± 0.3 
Values (mean ± SD, n = 3) without superscript letters within one row are not significantly different (p ≥ 0.05) based 
on the statistical models described in Methods. Initial data (n = 1, consisting of three fish) was not statistically 
analyzed. 
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Table 1-6. Fatty acid composition (in % of total fatty acid methyl ester (FAME)) of whole 
body homogenate of rainbow trout before the experiment (Initial) and after being fed the 
experimental diets C, BA, DA, EQ and G for 52 days. 
[% of FAME] Initial C BA DA EQ G 
14:0 1.4 1.2 ± 0.0 1.2 ± 0.0 1.2 ± 0.0 1.2 ± 0.0 1.2 ± 0.0 
16:0 9.3 15.2 ± 0.1 15.2 ± 0.2 15.5 ± 0.5 14.8 ± 0.3 14.8 ± 0.5 
18:0 2.7 3.9 ± 0.1 3.8 ± 0.2 3.9 ± 0.0 3.9 ± 0.1 3.8 ± 0.0 
Total SFA 1 14.2 20.7 ± 0.2 20.7 ± 0.3 21.1 ± 0.6 20.4 ± 0.3 20.2 ± 0.6 
16:1 1.9 4.6 ± 0.3 4.4 ± 0.2 4.5 ± 0.2 4.0 ± 0.2+ 4.4 ± 0.2 
18:1 43.3 37.3 ± 0.5 37.3 ± 0.1 37.0 ± 0.5 36.8 ± 0.5 37.4 ± 0.7 
Total MUFA 2 54.0 47.9 ± 0.7 47.6 ± 0.2 47.3 ± 0.5 47.1 ± 0.4 47.8 ± 0.9 
n-6       
18:2n-6 15.0 15.2 ± 0.4 15.5 ± 0.2 15.4 ± 0.1 15.6 ± 0.3 15.4 ± 0.3 
18:3n-6 0.6 0.5 ± 0.0 0.5 ± 0.0 0.5 ± 0.0 0.5 ± 0.0 0.6 ± 0.0 
20:4n-6 0.7 0.6 ± 0.0 0.6 ± 0.0 0.6 ± 0.0 0.6 ± 0.0 0.6 ± 0.0 
n-3       
18:3n-3 3.9 6.7 ± 0.3 6.6 ± 0.2 6.6 ± 0.0 6.7 ± 0.2 6.6 ± 0.3 
18:4n-3 1.1 1.1 ± 0.0 1.1 ± 0.0 1.2 ± 0.0 1.1 ± 0.1 1.2 ± 0.1  
20:5n-3 1.3 0.7 ± 0.0  0.7 ± 0.0 0.7 ± 0.0 0.7 ± 0.0 0.7 ± 0.0 
22:6n-3 6.2 3.9 ± 0.1a 3.9 ± 0.1 3.8 ± 0.1 4.2 ± 0.1b 4.2 ± 0.1(b) 
Total PUFA 3 31.3 31.3 ± 0.7 31.4 ± 0.2 31.1 ± 0.5 31.9 ± 0.4 31.7 ± 0.9 
1 Total SFA is the sum of saturated fatty acids; 2 Total MUFA is the sum of monounsaturated fatty acids; 3 Total 
PUFA is the sum of polyunsaturated fatty acids. Values (mean ± SD, n = 3, consisting of three fish each) with 
different superscript letters within one row are significantly different (p < 0.05), values without superscript letters 
within one row are not significantly different (p ≥ 0.05) based on the statistical models described in Materials and 
Methods. (b) Brackets indicate a tendency towards a statistical difference (p < 0.1). Initial data (n = 1, consisting of 
three fish) was not statistically analyzed. 
Hepatic fads2a(d6) mRNA steady state and Fads2a(d6) protein levels 
Fish fed the diet EQ showed significantly (p = 0.049) decreased and fish fed the diet G tended 
(p = 0.052) to have lower hepatic fads2a(d6) mRNA steady state levels compared to fish fed 
the control group. Cpt1a and cpt1c levels were similar between the dietary treatments  
(Fig 1-1). Furthermore, hepatic Fads2a(d6) protein levels of rainbow trout were not affected by 
the dietary treatment (Fig 1-2).  
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Table 1-7. Fatty acid composition (in % of total fatty acid methyl ester (FAME)) of fillet 
of rainbow trout before the experiment (Initial) and after being fed the experimental diets 
C, BA, DA, EQ and G for 52 days. 
[% of FAME] Initial C BA DA EQ G 
14:0 1.2 1.2 ± 0.0 1.2 ± 0.1 1.1 ± 0.0 1.2 ± 0.0 1.2 ± 0.0 
16:0 9.8 15.8 ± 0.2 15.6 ± 0.4 15.5 ± 0.0 15.8 ± 0.4 15.6 ± 0.0 
18:0 3.0 3.8 ± 0.1 3.7 ± 0.1 3.8 ± 0.0 3.9 ± 0.1 3.9 ± 0.0 
Total SFA 1 14.7 21.3 ± 0.1 21.1 ± 0.4 21.1 ± 0.3 21.4 ± 0.4 21.1 ± 0.1 
16:1 1.5 4.4 ± 0.1 4.4 ± 0.3 4.3 ± 0.3 4.5 ± 0.1 4.1 ± 0.0 
18:1 41.1 35.1 ± 0.3 35.1 ± 0.3 35.1 ± 0.4 34.4 ± 0.2+ 34.7 ± 0.1 
Total MUFA 2 50.7 45.0 ± 0.2 45.2 ± 0.0 45.0 ± 0.6 44.7 ± 0.3 44.3 ± 0.0 
n-6   
18:2n-6 14.2 15.0 ± 0.2 15.1 ± 0.1 15.1 ± 0.0 15.0 ± 0.2 15.3 ± 0.1 
18:3n-6 0.5 0.6 ± 0.0a 0.5 ± 0.0 0.5 ± 0.0 0.4 ± 0.0b 0.6 ± 0.1 
20:4n-6 0.2 0.7 ± 0.0 0.7 ± 0.0 0.7 ± 0.0 0.7 ± 0.0 0.7 ± 0.0 
n-3          
18:3n-3 3.4 6.5 ± 0.1 6.6 ± 0.1 6.6 ± 0.0 6.7 ± 0.0 6.6 ± 0.2 
18:4n-3 0.9 1.4 ± 0.0a 1.2 ± 0.0 1.2 ± 0.0 1.1 ± 0.1b 1.3 ± 0.2 
20:5n-3 1.6 0.9 ± 0.0 0.9 ± 0.0 0.9 ± 0.0 0.9 ± 0.0 0.9 ± 0.0 
22:6n-3 10.2 5.7 ± 0.1 5.6 ± 0.1 5.8 ± 0.2 5.9 ± 0.2 6.1 ± 0.2 
Total PUFA 3 34.4 33.4 ± 0.1 33.4 ± 0.3 33.4 ± 0.3 33.4 ± 0.5 34.1 ± 0.1 
1 Total SFA is the sum of saturated fatty acids; 2 Total MUFA is the sum of monounsaturated fatty acids; 3 Total 
PUFA is the sum of polyunsaturated fatty acids. Values (mean ± SD, n = 3, consisting of fillets from five fish each) 
with different superscript letters within one row are significantly different (p < 0.05), values without superscript letters 
within one row are not significantly different (p ≥ 0.05) based on the statistical models described in Materials and 
Methods. Initial data (n = 1, consisting of fillets from eight fish) was not statistically analyzed. 
Table 1-8. Fatty acid composition (in % of total fatty acid methyl ester (FAME)) of liver 
of rainbow trout before the experiment (Initial) and after being fed the experimental diets 
C, BA, DA, EQ and G for 52 days. 
[% of FAME] Initial C BA DA EQ G 
14:0 0.7 0.8 ± 0.1 0.9 ± 0.1 0.8 ± 0.0 0.7 ± 0.0 0.8 ± 0.1 
16:0 15.9 14.6 ± 0.8 14.8 ± 0.1 14.4 ± 0.3 14.7 ± 0.3 14.7 ± 0.8 
18:0 5.4 8.1 ± 0.2a 7.8 ± 0.1 7.7 ± 0.4 10.2 ± 0.0b 7.7 ± 0.7 
Total SFA 1 23.3 24.2 ± 1.0a 24.3 ± 0.1 23.4 ± 0.3 26.3 ± 0.2b 23.8 ± 1.0 
16:1 0.8 2.7 ± 0.1 3.4 ± 0.3 3.1 ± 0.4 2.1 ± 0.1 3.1 ± 1.0 
18:1 20.7 21.7 ± 2.6 23.0 ± 1.0 23.2 ± 2.6 16.3 ± 0.6 23.2 ± 6.2 
Total MUFA 2 25.5 30.2 ± 2.7 32.7 ± 1.4 32.3 ± 3.1 24.7 ± 0.4 31.8 ± 8.0 
n-6        
18:2n-6 7.2 5.6 ± 0.5 5.3 ± 0.0 5.8 ± 0.4 5.5 ± 0.6 6.1 ± 0.2 
18:3n-6 0.2 0.2 ± 0.0a 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0b 
20:4n-6 4.7 5.8 ± 0.4a 5.4 ± 0.1 5.7 ± 0.3 7.3 ± 0.4 3.5 ± 2.3b 
n-3     
18:3n-3 1.7 1.4 ± 0.2 1.1 ± 0.0 1.3 ± 0.2 1.5 ± 0.2 1.5 ± 0.1 
18:4n-3 0.5 0.3 ± 0.1 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.0 
20:5n-3 3.9 2.2 ± 0.1 2.1 ± 0.0 1.9 ± 0.2 2.3 ± 0.3 2.2 ± 0.4 
22:6n-3 29.5 25.2 ± 2.0 23.2 ± 1.2 23.7 ± 1.8 26.5 ± 0.9 23.8 ± 4.3 
Total PUFA 3 50.8 45.4 ± 1.7 42.7 ± 1.3 43.8 ± 2.8 48.7 ± 0.6 44.1 ± 6.8 
1 Total SFA is the sum of saturated fatty acids; 2 Total MUFA is the sum of monounsaturated fatty acids; 3 Total 
PUFA is the sum of polyunsaturated fatty acids. Values (mean ± SD, n = 3, consisting of livers from five fish each) 
with different superscript letters within one row are significantly different (p < 0.05), values without superscript letters 
within one row are not significantly different (p ≥ 0.05) based on the statistical models described in Materials and 
Methods. Initial data (n = 1, consisting of eight livers) was not statistically analyzed. 
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Fig. 1-1 Hepatic mRNA steady state levels. Rainbow trout were fed the experimental diets C, EQ and G 
for 52 days. Presented are boxplots of relative liver mRNA levels of fatty acyl desaturase 2a (delta-6) 
(fads2a(d6)) and carnitine palmitoyl transferase 1 (cpt1) a and c, respectively. Hepatic mRNA steady 
state levels were determined by qRT-PCR analysis and normalized to the housekeeping gene ef1α. 
Boxes represent values between the 25th and the 75th percentile; whiskers indicate 1.5 SD; medians 
are indicated by solid lines; outliers (above/below 1.5 SD) are indicated by solid circles. At the end of 
the experiment, 15 individuals per treatment were sampled in total (n = 15). Statistically significant 
differences between dietary treatments are represented by asterisks; p < 0.05 (*) based on the statistical 
models described in Materials and Methods. 
 
 
Fig. 1-2 Fatty acyl desaturase 2a (delta-6) (Fads2a(d6)) protein levels in liver samples. Rainbow trout 
were fed the experimental diets C, EQ and G for 52 days. Fads2a(d6) protein levels were determined 
by ELISA and were normalized to the total protein level (ng/mg protein). Bars represent the final 
expression values. At the end of the experiment, four individuals per treatment in total were sampled 
randomly (n = 4). Values were tested on significance based on the statistical models described in 
Material and Methods. No significant differences were found. 
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Discussion 
In the present study, fish responded well to their dietary treatments and tripled their initial body 
weight within 52 days of feeding. The FCR (< 1.0) and SGR values (> 2.1 %/d) can be 
considered as reasonable since other studies reported similar, lower (SGR) and higher (FCR) 
values for rainbow trout of the same size [16,37,38]. No significant effect on growth 
performance was found between fish of any of the treatments in the present study. For EQ and 
G fed fish, these findings are in line with results in literature. Jourdehi et al. [39] also found no 
effect on growth in female beluga sturgeon fed with equol. Furthermore, Torno et al. [38] 
reported no negative impact on growth performance of rainbow trout fed genistein. In contrast, 
Crespillo et al. [40] found a reduction of body weights in rats fed a diet containing daidzein. A 
possible explanation for the lack of effect of the bioactive substances could be their dietary 
dosage utilized in the present study. Phytoestrogens have been shown to affect components 
of the growth hormone (GH)/insulin-like growth factor (IGF) axis in livers of rainbow trout [41]. 
The negative impact of genistein on the GH/IGF axis was enhanced when genistein was 
administered at a higher concentration [41]. The dose of 1.5 g/kg DM dietary genistein seemed 
to have no effect on the growth performance of rainbow trout in the present study and could 
thus be considered as a low dietary concentration. With regard to the observed effects in the 
present study, this assumption might also be true for equol, daidzein and biochanin A. 
Moreover, the feed conversion ratios were not affected in response to dietary bioactive 
compounds. Similar results were reported by Torno et al. [38] who fed genistein at 3.0 g/kg  
DM to rainbow trout. According to this study, dietary genistein did not affect feed conversion 
negatively but induced a significant reduction in feed intake. The authors assume that the 
bitterness of phytochemicals partly contributed to the decrease in feed intake. In the present 
study, dietary bioactive substances did not alter feed intake when daily feeding levels were set 
at 2.1% of biomass per day. A direct comparison is difficult, because fish in the present study 
were fed on a fixed daily feeding level that was below the reported feed intakes in the study of 
Torno et al. [38]. Furthermore, the dietary genistein concentration of 3.0 g/kg DM was twice 
the amount of the concentration used in the present study (1.5 g/kg DM). Thus, it seems that 
supplementation of 1.5 g/kg DM of these bioactive substances does not affect the palatability 
of the diets and does not influence feed intake negatively. Furthermore, PER and PRE values 
of fish as well as the nutrient composition of whole body homogenate samples were not 
affected by dietary bioactive substances in the present study. This is contrasting previous 
results of Torno et al. [38] who described significantly increased PER values and protein 
productive values (PPV, equals PRE) for rainbow trout fed with 3.0 g/kg DM of genistein. This, 
again, strongly supports the assumption that phytoestrogens and their metabolites might 
exhibit dose-dependent effects. In addition, Schiller Vestergren et al. [42] assumed that 
differences in the response to bioactive compounds could be due to varying physiological 
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parameters (species, fish size, gender, age) and environmental conditions (temperature, feed 
composition). The observations in the present study indicate that dietary equol, genistein, 
daidzein and biochanin A at 1.5 g/kg DM can be fed to rainbow trout without detrimental effects 
on growth and performance. Furthermore, any interactions due to the inclusion of soy protein 
concentrate into the diets are expected to be negligible. The overall content of isoflavones in 
soy is low with most of them being present as glucosinolates [43]. Glycosidic bond isoflavones 
need to be hydrolized in the intestine before absorption [43], requiring additional time for this 
process in the intestine [44]. Thus, we assumed that these substances might be mostly 
excreted and the amount of isoflavones being bioavailable can be considered as low. 
The fatty acid composition of whole body homogenates and fillets was not affected to a great 
extent by the supplementation of bioactive substances in the present study. However, the DHA 
levels were increased in whole body homogenates and fillet samples of fish fed EQ and G in 
comparison to samples of fish fed the diet C. In contrast, EPA levels remained unaffected by 
the dietary treatments. For fish fed EQ, the increase in DHA could be possibly explained by its 
estrogenic potential [45]. In vertebrates, the synthesis of DHA occurs via the elongation 
(elongase 2) of 22:5n-3 to 24:5n-3 followed by a desaturation (delta-6-desaturation) to  
24:6n-3 and a final peroxisomal β-oxidation [46]. The genes encoding for  elongase 2 (elovl2) 
and the delta-6-desaturase (fads2) have been reported to be responsive to estrogen [26,28]. 
Estrogen application increased DHA in rats [26] and humans [47] by increasing the expression 
of fads2. Furthermore, equol showed a greater estrogenic potency than genistein, daidzein 
and biochanin A (equol > genistein > daidzein > biochanin A) in rainbow trout hepatocyte 
cultures [45]. In contrast to genistein and daidzein, equol is metabolically inert and can be 
readily absorbed [21]. This results inter alia in a higher bioavailability of equol in comparison 
to that of genistein [48]. Thus, the combination of the higher estrogenic potency and the 
increased bioavailability of equol putatively enhances the effect on the biosynthesis of DHA in 
comparison to the other bioactive substances in the present study. Simultaneously, the 
supplied amount of genistein, biochanin A and daidzein might be too low to develop estrogen- 
like effects. The significantly increased levels of the fatty acid 18:0 in the livers of fish fed EQ 
obtained in the present study support this hypothesis. For instance, an increase of 18:0 fatty 
acid has also been associated with increasing estrogen levels in rats [49]. Thus, it seems that 
dietary equol might have influenced the lipid metabolism via estrogen-like mechanisms. As the 
increase of both, DHA and 18:0 was only found for fish fed EQ it seems reasonable that other 
mechanisms led to the increased DHA levels in the G treatment. A factor possibly contributing 
to an increase in DHA are the antioxidant properties of genistein [23,50]. For example, 
genistein was found to protect cells from oxidative stress induced damage [51]. In the study of 
Hernandez-Montes et al. [51], genistein activated the transcription factor Nrf1 and thereby 
increased the activity and expression of its target gene glutathione peroxidase, an enzyme 
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involved in cellular defense mechanisms in endothelial cells. Thus, in the present study, 
genistein could have also increased the expression of glutathione peroxidase and thereby 
protected DHA from oxidation, leading to an indirect increase of DHA concentrations. However, 
bioactive substances could have further mechanisms of action to affect the DHA levels in fish. 
Trattner et al. [52] suggested that increased DHA levels in Atlantic salmon hepatocytes treated 
with the phytochemical sesamin might be a result of an increased peroxisomal β-oxidation. 
The peroxisomal β-oxidation is regulated inter alia by the transcription factor PPARα: PPARα 
binds to a peroxisome proliferator response element, thereby regulating the transcription of 
target genes centrally involved in the peroxisomal β-oxidation [53]. Ligands can bind to and 
activate PPARα. Genistein and daidzein have been found to be potent ligands for PPARα 
[31,32]. However, fish fed the diet G only tended to increase DHA levels in whole body 
homogenates and fish fed DA lacked an effect on tissue DHA in the present study. Thus, one 
could hypothesize that affecting the biosynthesis of DHA via PPARα is more complex and 
takes longer than directly influencing it via estrogen-like mechanisms. Furthermore, it could be 
possible that the dietary dosage of 1.5 g/kg DM of biochanin A and daidzein are too low to 
develop an effect either way.  
The increase in DHA levels in whole body homogenates was not shown to the same extent in 
fillet samples of fish fed EQ and G diets. This could be partly explained by the very slow 
synthesis of DHA from ALA in rainbow trout [12]. Thus, it could be possible that the 
experimental duration in the present study was too short. It remains elusive whether fish fed 
EQ and G diets could have further increased their DHA fillet levels if the experimental period 
was longer. However, the effect of dietary equol and genistein on DHA tissue levels was only 
moderate. Thus, further investigations are needed to evaluate if and to what economically 
reasonable extent these bioactive substances can be included into rainbow trout diets to result 
in similar EPA and DHA levels that would be expected from fish fed a diet based on fish oil.  
In the present study, hepatic mRNA steady state levels of fads2a(d6) were significantly lower 
in samples of fish fed EQ and tended to be lower in fish fed G compared to fish fed the diet C. 
Estrogen treatment enhanced the hepatic delta-6-desaturase expression and resulted in 
increased DHA levels in rats [26]. Thus, DHA concentrations in tissue samples were not well 
supported by the hepatic mRNA steady state levels. This effect has already been described in 
Atlantic salmon hepatocytes treated with the phytochemical sesamin [52]. In this study, DHA 
levels in hepatocytes were also significantly increased, although the gene expression of the 
gene encoding the delta-6-desaturase was down-regulated. A factor possibly contributing to 
the results in the present study could be the starvation time of fish before sampling. The half-
life of genistein in rainbow trout was reported to be 13 h [54]. The authors suggest that the 
half-life of genistein in trout is similar to the values obtained in humans. Assuming that this is 
also applicable to other phytoestrogens, equol could have a half time of less than 10 h in trout 
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as it was reported for humans [21]. Therefore, it could be possible that by the time of sampling 
most of the genistein and equol has already been excreted by the fish. In addition, Schiller 
Vestergren et al. [55] assume that mRNA turnover responds to dietary changes. Thus, mRNA 
levels might fluctuate constantly. Another factor leading to the decreased hepatic fads2a(d6) 
mRNA steady state levels in the EQ and G fed groups could be the influence of LC-PUFA on 
gene expression. A negative feedback loop from n-3 LC-PUFA on the delta-6-desaturase 
mRNA expression has been found in zebrafish [56]. In the present study, DHA levels in whole 
body homogenate and fillet samples were highest in fish fed diets with EQ and G, respectively. 
Therefore, one could hypothesize that by the time of sampling, the increased DHA tissue levels 
in fish fed the EQ and G led to a negative feedback on fads2a(d6) mRNA expression. 
Interestingly, the Fads2a(d6) protein levels did not show significant differences between the 
dietary treatments. This mismatch of fads2a(d6) mRNA steady state and Fads2a(d6) protein 
levels has also been reported by Torno et al. [57] in a study with rainbow trout fed the 
phytochemical resveratrol. However, we cannot exclude putative effects of the bioactive 
substances on the delta-6-desaturase activity, as this factor was not analyzed in the present 
study. Furthermore, cpt1a and cpt1c mRNA steady state levels in the present study were not 
affected by the dietary treatments. Cpt1 is involved in the mitochondrial β-oxidation. The 
isoforms Cpt1a and Cpt1c are necessary for the uptake of long-chain fatty acids into the 
mitochondria [33]. Our results are contrasting the findings of Kim et al. [31], who reported that 
genistein induced the expression of Cpt1 via activating PPARα. Furthermore, these authors 
suggested that this effect was non-estrogenic and dose-dependent. Again, it seems that the 
dietary dosage of bioactive substances is important and needs to be considered when applied 
in rainbow trout.  
Conclusion 
The present study indicates that dietary equol, genistein, daidzein and biochanin A can be fed 
to rainbow trout at 1.5 g/kg DM without detrimental effects on growth and performance 
parameters. Furthermore, 1.5 g/kg DM of dietary equol increased DHA levels putatively by 
influencing the biosynthesis via estrogen-like mechanisms. However, this was not resembled 
in hepatic fads2a(d6) mRNA steady state levels and protein contents. In contrast, genistein 
seems to affect the biosynthesis of DHA either indirectly due to its antioxidative characteristics 
or via PPARα-mediated pathways. Biochanin A and daidzein did not affect the tissue fatty acid 
composition of rainbow trout. However, the increase in DHA levels due to dietary equol and 
genistein were only moderate. The dietary dosage of these substances might be an important 
factor influencing the extent of the effect on the biosynthesis of DHA. Thus, future studies 
should investigate dose-dependent effects of these bioactive substances on growth 
performance and LC-PUFA synthesis in rainbow trout.  
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Abstract  
Phytoestrogens are putatively able to enhance the biosynthesis of eicosapentaenoic acid 
(EPA) and docosahexaenoic acid (DHA), but have also been shown to affect fish growth dose-
dependently. The aim of the present study was to identify a concentration for the phytoestrogen 
genistein and the phytoestrogen metabolite equol that further increases the endogenous 
biosynthesis of EPA and DHA without impairing fish growth. Juvenile rainbow trout (87.2 ± 0.3 
g) were fed seven diets on a fixed ratio for eight weeks. A vegetable oil based diet served as 
a control diet and was supplemented with equol (EQ) and genistein (G), respectively at 0.1, 
0.2 and 0.3% of feed dry matter (1, 2 and 3). Growth and nutrient composition of whole body 
homogenates were not affected by dietary treatments. EPA and DHA levels in liver, fillet and 
whole body samples were not significantly increased by EQ and G diets. Fish fed EQ diets 
showed dose-dependently increased liver weights and C18:0 liver levels, indicating estrogen-
like effects at increased dietary dosages. In conclusion, the utilization of equol and genistein 
in plant oil based diets in order to enhance the biosynthesis of EPA and DHA seems not 
reasonable in rainbow trout. 
Keywords: Rainbow trout; Phytochemicals; Biosynthesis; LC-PUFA; Aquafeed; Vegetable oils 
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Introduction 
Generally, vegetable oils are used to fill the shortfall of fish and invertebrate oils in aquafeeds 
[1]. As long as the requirement levels of essential fatty acids are met, the total substitution of 
fish oil by vegetable oils is possible without detrimental effects on growth and health in some 
fish species, mainly salmonids (reviewed in [2]). This is due the capability of these fish species 
to endogenously synthesize omega-3 (n-3) long-chain polyunsaturated fatty acids (LC-PUFA) 
from the precursor fatty acid α-linolenic acid (C18:3n-3, ALA) [3]. However, the efficiency of 
this biosynthesis pathway is limited and fish fed diets based on plant oils cannot maintain n-3 
LC-PUFA tissue levels of fish fed fish oil based diets [4–6]. Especially, the content of 
eicosapentaenoic acid (20:5n-3, EPA) and docosahexaenoic acid (22:6n-3, DHA) is reduced 
in fish fed a diet based on vegetable oils [4,7]. EPA and DHA are known for their health-
promoting effects in humans [8–10]. Thus, the product quality of fish fed diets with vegetable 
oils is reduced for human consumption. 
The utilization of dietary phytochemicals might be a promising strategy to increase EPA and 
DHA levels in rainbow trout fed with vegetable oils [11,12]. Recent investigations indicate that 
dietary genistein and equol at 0.15% of dry matter enhance tissue DHA levels in rainbow trout 
(Oncorhynchus mykiss) but only to a moderate extent [13]. Genistein and equol are 
phytochemicals, belonging to the group of phytoestrogens and their metabolites, respectively 
[14]. Genistein occurs naturally in soy (Glycine max) [15], whereas equol is a metabolite of the 
soy phytoestrogen daidzein [14]. Equol is not directly plant-derived but can be synthesized 
from its parent phytoestrogen daidzein by the intestinal bacteria in animals and humans 
[16,17]. Phytoestrogens such as genistein can bind to ligands that activate transcription factors 
(e. g. peroxisome proliferator-activated receptor α, PPARα) [18]. PPARα, in turn, regulates the 
transcription of target genes centrally involved in the peroxisomal β-oxidation [19] which is 
required for the synthesis of DHA. Furthermore, phytoestrogens have a similar structure as 
estradiol [20] and thus, show estrogenic properties in rainbow trout hepatocyte cultures [21]. 
The delta-6 desaturase is necessary for the synthesis of DHA out of EPA [22]. Estradiol 
application increases the expression of this desaturase in rats and thereby, increases DHA 
concentrations in livers and plasma of these animals [23]. Genistein and equol have been 
shown to exhibit antioxidant properties, estrogen-like effects and ligand-binding properties 
dependent on the dosage applied [24–26]. Therefore, a dose-dependent administration of 
genistein and equol might enhance the effect on the biosynthesis of DHA in rainbow trout found 
in our previous study [13]. However, when administered at higher dietary dosages the 
supplementation of phytochemicals is often associated with impaired fish growth [12,27,28] 
and reduced nutrient utilization [29].  
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The aim of the present study was to identify a concentration for genistein and equol that further 
increases the endogenous biosynthesis of EPA and DHA without impairing fish growth. Thus, 
a feeding trial was conducted with juvenile rainbow trout. A vegetable oil based diet was 
supplemented with equol and genistein at three differing dosages, respectively. Influences of 
the different dietary treatments on growth performance, fatty acid composition of liver, whole 
body and fillet, and nutrient composition of whole body were investigated.  
Material and methods 
Experimental setup  
All-female rainbow trout juveniles (87.2 ± 0.3 g initial body weight) used in this experiment were 
obtained from a local fish farm (Forellenzucht Trostadt GbR, Reurieth, Germany). The feeding 
trial was conducted at the facilities of the Gesellschaft für Marine Aquakultur (GMA, Büsum, 
Germany). Fish were acclimatized to the experimental conditions in the recirculating 
aquaculture system (20 m3, turnover rate 2.4 h-1, technical oxygen supply). During this time, 
experimental animals were fed a commercial fish feed. A light/dark cycle of 14 h/10 h was 
adapted. The water purification system included a drum filter, biofilter, ultraviolet disinfection 
and protein skimmer with ozone. Water parameters were in range for rainbow trout. Oxygen 
(12.0 ± 0.2 mg/L O2), temperature (14.8 ± 0.5°C) and pH (7.5) were monitored continuously 
via probes. NH4+ (0.3 ± 0.2 mg/L), NO2- (0.7 ± 0.3 mg/L) (Microquant test kits; Merck KGaA, 
Darmstadt, Germany) and salinity (4.2 ± 0.7 ‰) were measured daily. After two weeks 
acclimatization time, fish were weighed individually prior to the experimental start. A total of 
420 fish were randomly distributed among 21 tanks of the recirculating aquaculture system 
and each tank (150 L) was stocked with 20 fish (1743.9 ± 6.7 g total biomass). The dietary 
treatments were randomly distributed in triplicates and fish were hand-fed once per day for 
eight weeks. All fish in one tank were bulk-weighed every 14 days to adjust daily feed supply 
at a daily feed intake level of 1.6% of biomass. The experiment was approved by the Ministry 
of Energy, Agriculture, the Environment, Nature and Digitalization (MELUND, Kiel, Germany; 
approved on 18 October 2017, project number V241-37421/2017) and carried out according 
to the national regulations for animal welfare (TierSchVersV) and the EU Directive 2010/63/EU 
for animal experiments.  
Experimental diets 
All seven diets were formulated based on the same feed ingredient composition (Table 2-1). 
The oil blend used as a dietary oil source consisted of palm fat, linseed, rapeseed and 
sunflower oil. This oil blend was designed to be above the dietary ALA requirement levels 
(requirement 0.7 - 1.0% of dry diet; see Table 2-2) of rainbow trout [30] as the aim of the study 
was to increase the biosynthesis of EPA and DHA. Further, dietary EPA and DHA levels were 
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restrictively supplied by only 15% of lean fish meal inclusion (recommendation 0.4 - 0.5% EPA 
+ DHA of dry diet [30]).  
Table 2-1. Ingredients and nutrient composition (in % of dry matter (DM)) of the 
experimental diets C, EQ1, EQ2, EQ3, G1, G2 and G3. 
Diet C EQ1 EQ2 EQ3 G1 G2 G3 
Ingredients [% DM]        
Fish meal a 15.0 15.0 15.0 15.0 15.0 15.0 15.0 
Blood meal b 5.0 5.0 5.0 5.0 5.0 5.0 5.0 
Feather meal c 5.5 5.5 5.5 5.5 5.5 5.5 5.5 
Pea protein isolate d 12.0 12.0 12.0 12.0 12.0 12.0 12.0 
Soy protein concentrate e 5.0 5.0 5.0 5.0 5.0 5.0 5.0 
Wheat gluten f 14.0 14.0 14.0 14.0 14.0 14.0 14.0 
Gelatin g 1.5 1.5 1.5 1.5 1.5 1.5 1.5 
Wheat starch f 22.0 22.0 22.0 22.0 22.0 22.0 22.0 
Oil sources 11.5 11.5 11.5 11.5 11.5 11.5 11.5 
Rapeseed oil h 3.3 3.3 3.3 3.3 3.3 3.3 3.3 
Linseed oil i 4.2 4.2 4.2 4.2 4.2 4.2 4.2 
Palm fat j 2.2 2.2 2.2 2.2 2.2 2.2 2.2 
Sunflower oil h 1.8 1.8 1.8 1.8 1.8 1.8 1.8 
Vitamin Mineral premix k 1.0 1.0 1.0 1.0 1.0 1.0 1.0 
Calcium hydrogen phosphate l 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
α-Cellulose m 2.8 2.8 2.8 2.8 2.8 2.8 2.8 
Lysine n 0.7 0.7 0.7 0.7 0.7 0.7 0.7 
Methionine o 0.1 0.1 0.1 0.1 0.1 0.1 0.1 
Bentonite p 3.4 3.3 3.2 3.1 3.3 3.2 3.1 
Genistein q - - - - 0.1 0.2 0.3 
S-Equol q - 0.1 0.2 0.3 - - - 
        
Nutrient composition [% DM]        
Dry matter [in % of diet] 86.8 84.6 88.1 86.9 87.6 88.4 87.7 
Crude protein 52.1 52.0 51.3 51.8 52.7 51.4 51.5 
Crude lipid 16.2 16.0 16.1 16.1 15.6 15.9 16.0 
Crude ash 6.2 6.1 6.0 5.9 5.1 5.0 4.7 
Total COH [in % DM] r 25.5 25.9 26.7 26.2 26.7 27.6 27.8 
Gross energy [MJ/kg DM] 23.0 23.1 23.3 23.3 23.4 23.0 23.1 
a Lean fish meal “low ash”, Bioceval GmbH & Co. KG, Cuxhaven, Germany; b Daka porcine bloodmeal, Daka 
Denmark A/S, Løsning, Denmark; c GePro Goldmehl, GePro Geflügel-Protein Vertriebsgesellschaft mbH & Co. KG, 
Diepholz, Germany; d Emsland-Stärke GmbH, Emlichheim, Germany; e Euroduna Food Ingredients GmbH, 
Barmstedt, Germany; f KRÖNER STÄRKE GmbH, Ibbenbüren, Germany; g Gustav Ehlert GmbH & Co. KG, Verl, 
Germany; h Food store, Büsum, Germany; i Makana Produktion und Vertrieb GmbH, Offenbach a.d. Queich, 
Germany; j DF 100 PT-PV; EFG Elbe Fetthandel GmbH, Geesthacht, Germany; k Emsland-Aller Aqua GmbH, 
Golßen, Germany; l JRS Pharma GmbH & Co. KG, Rosenberg, Germany; m Mikro-Technik GmbH & Co. KG, 
Bürgstadt am Main, Germany; n Biolys, Evonik Industries AG, Essen, Germany; o MetAmino, Evonik Industries AG, 
Essen, Germany; p Castiglioni Pes y Cía, Buenos Aires, Argentina; q Genistein: Cas No: 446-72-0, Equol: Cas No: 
531-95-3, Xi’an Natural Field Bio-Technique Co., LTD, Xi’an Shaanxi, China; r Total COH = 100 – (crude protein + 
crude lipid + crude ash).  
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Three diets each were supplemented with equol and genistein, respectively with 0.1, 0.2 and 
0.3% dry matter (DM) in substitution for the filler ingredient bentonite (EQ1, EQ2, EQ3, G1, G2 
and G3). One diet without supplementation served as a control diet (C). The dietary fatty acid 
composition is shown in Table 2-2. The experimental diets were formulated according to the 
amino acid requirements of rainbow trout [30] based on the amino acid contents of the single 
ingredients. All diets were isoenergetic and isonitrogenous. A pelleting machine (Type 14U175, 
Amandus Kahl, Hamburg) was used to produce the pellets (4 mm diameter, 6 mm length). 
Table 2-2. Fatty acid composition (in % of FAME*) of the experimental diets C, EQ1, EQ2, 
EQ3, G1, G2 and G3. 
  C EQ1 EQ2 EQ3 G1 G2 G3 
14:0 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
16:0 18.8 18.5 18.5 18.4 18.5 18.5 18.5 
18:0 3.5 3.5 3.5 3.5 3.5 3.6 3.5 
Total SFA  23.6 23.3 23.3 23.2 23.3 23.5 23.6 
16:1 0.3 0.3 0.3 0.3 0.3 0.4 0.3 
18:1 29.3 29.1 29.3 29.1 29.1 29.1 29.0 
Total MUFA  32.1 32.2 32.2 32.1 32.2 32.3 32.1 
n-6               
18:2n-6 24.7 24.7 24.8 24.7 24.7 24.8 24.7 
18:3n-6 tr † tr tr tr tr tr tr 
20:4n-6 tr tr tr tr tr tr tr 
n-3               
18:3n-3 16.7 17.2 17.1 17.2 17.1 17.0 17.1 
18:4n-3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 
20:5n-3 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
22:6n-3 1.1 1.0 1.0 1.0 1.0 1.1 1.0 
Total PUFA  43.5 43.9 43.9 43.9 43.9 43.9 43.9 
ALA [% DM] 1 2.5 2.6 2.6 2.6 2.5 2.5 2.5 
EPA+DHA [% DM] 1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 
1 calculated from the percentage data and the lipid content in the diets (in % DM), assuming 93% of total lipid to be 
fatty acids; † tr = traces (values < 0.1); * FAME = Fatty acid methyl ester. 
Sampling 
For the determination of growth performance parameters, fish were bulk-weighed at the 
beginning and the end of the 56 days feeding trial after 72 hours starvation. Feed conversion 
ratio (FCR), specific growth rate (SGR), protein efficiency ratio (PER) and protein retention 
efficiency (PRE) were calculated following the equations in Table 2-3. After the final bulk-
weighing and prior to the final sampling, fish were fed the experimental diets again for two 
days. This was done to maximize the quality of the samples, as physiological parameters might 
be very sensitive to an extended starvation time. The initial and the final sampling were 
conducted following the same procedure: Fish were starved for 24 hours before the sampling 
and were anesthetized and killed by a sharp blow on the head. After two weeks of 
acclimatization and before the experiment, residual fish were used to determine the initial 
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status. Five fish per tank (eight fish for initial sampling) were sacrificed for individual samples 
of liver, spleen and fillet. Liver and spleen samples were weighed to calculate the hepato- and 
spleen somatic index (HSI and SSI). Livers and fillets were pool-sampled for analysis of fatty 
acid composition and stored at -80°C and -20°C, respectively. Further, three fish per tank 
(initial: three fish) were killed, chopped and pool-sampled for nutrient composition and fatty 
acid composition of whole body homogenate. Samples were frozenand stored at -20°C. 
Afterwards, for the analyses, whole body homogenate and fillet samples were freeze-dried 
(alpha 1-4 LSC; Martin Christ Gefriertrocknungsanlagen GmbH, Osterode am Harz, Germany) 
to constant mass, followed byhomogenization with a cutting mill (Grindomix, Retsch, Haan, 
Germany). Length and weight was taken from all sampled fish to calculate Fulton condition 
factor (K, Table 2-3).  
Nutrient composition 
The analysis of the nutrient composition was performed at the laboratory of the Gesellschaft 
für Marine Aquakultur according to EU guideline (EC) 152/2009 [31]. Samples of diets and 
whole body homogenates were analyzed including content of DM, crude ash, crude protein, 
crude lipid and gross energy content. For determination of DM, samples were dried in a drying 
oven (ED53 9010-0078; Binder GmbH, Tuttlingen, Germany) at 103°C until constant mass 
(around 4.5 hours) followed by incineration in a muffle furnace (LE 6/11/P300; Nabertherm, 
Lilienthal, Germany) at 560°C for four hours to determine crude ash. Crude protein content 
was determined according to the method of Kjeldahl with a nitrogen to protein coefficient of 
6.25 (KjelDigester K-449, Scrubber K-415, KjelFlex 360; BÜCHI Labortechnik GmbH, Essen, 
Germany and 877 Titrino plus; Deutsche METROHM GmbH & Co. KG, Filderstadt, Germany). 
Crude lipid content was analyzed according to the Soxhlet method using hydrolysis and 
extraction (HYDROTHERM HT 6 and SOXTHERM® 416, Multistat/SX PC; C. Gerhardt GmbH 
& Co. KG, Königswinter, Germany). The content of gross energy was analyzed using bomb 
calorimetry (C 200; IKA®-Werke GmbH & Co. KG, Staufen, Germany).  
Fatty acid composition 
Fatty acid composition of diets, liver, whole body homogenates and fillet samples was analyzed 
by LUFA-ITL GmbH, Kiel, Germany via gas chromatography (DGF, C-VI 10 a). Preparation of 
fatty acid methyl ester (FAME) was conducted by saponification with methanolic NaOH and 
transmethylation of total lipids. For that, boron trifluoride and methanol were utilized (DGF, C-
VI 11 a). Afterwards, FAME samples were separated by split-injection (column: CP-Sil 88 50 
m x0.25 mm x0.2 µm or similar) via gas chromatography. In addition, FAME were detected 
with a flame ionization detector (FID). For that, helium was used as a carrier gas. Further, 
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FAME were identified by comparison with certified standard mixtures. The distribution of fatty 
acids was calculated as percent of FAME in relation to total FAME.  
Statistical analysis 
All statistical data evaluations were performed using the statistical software R (2017), including 
the packages gdata, gplots, nlme, piecewiseSEM and multcomp. The data were considered 
as normally distributed based on a graphical residual analysis. Homoscedasticity or 
heteroscedasticity, respectively, was taken into account. The data evaluation started with the 
definition of appropriate statistical models: (1) statistical models based on general least 
squares [32] for FBW, FCR, SGR, PRE, PER, nutrient and fatty acid composition; (2) mixed 
models [33,34] with tank as random factor if values per fish (HSI, SSI, K) were considered. 
The statistical model included the additive (C, EQ, G) and the additive level (0, 1, 2, 3). Based 
on the model, a Pseudo-R2 was calculated [35] and multiple contrast tests (e.g., see [36]) were 
conducted in order to compare different additive levels within one additive type and to the 
control group and further, the same additive levels across the additive type.   
Results 
Growth performance and nutrient composition 
All fish more than doubled their weight during the eight weeks and showed no significant 
differences for values of final body weights and weight gain (%) (Table 2-3). Furthermore, FCR, 
SGR, PER and PRE values were not affected by the dietary treatments. However, the 
supplementation of dietary equol at 0.2 and 0.3% significantly increased HSI dose-dependently 
with fish fed EQ3 having the highest levels: C = EQ1 < EQ2 < EQ3. In addition, fish fed EQ2 
and EQ3 had significantly higher HSI values than fish fed G2 and G3, respectively. In contrast, 
SSI values of EQ3 fed fish were significantly decreased compared to G3 fed fish. K values also 
differed significantly with fish of EQ2 having higher levels than fish of the dietary group G2. 
The nutrient composition of whole body homogenate samples was not affected by the dietary 
treatments (Table 2-4). 
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Fatty acid composition 
Generally, the fatty acid composition of sampled tissue was affected to a greater extend by the 
supplementation of dietary equol than by genistein. In whole body homogenates, fish fed the 
diets EQ3 and G3 showed the highest (non significant) EPA and DHA levels of all dietary 
treatments (Table 2-5).  
In fillet samples, 18:0 levels were significantly higher for G1 fed fish compared to fish fed the 
control diet C (Table 2-6). In addition, fillets of fish fed diets containing equol had significantly 
increased levels of this fatty acid compared to fish fed the control diet. Furthermore, EPA fillet 
levels in EQ2 fed fish were significantly lower than in C and EQ1 fed fish. In contrast, DHA fillet 
levels were not altered by the dietary treatments. 
Similar to the fillet samples, increased levels of 18:0 were found in the livers of fish fed diets 
with equol (C < EQ1 = EQ2 < EQ3) (Table 2-7). There was also a tendency (p=0.052-0.069) 
towards lower C18:1 levels in livers of fish fed with equol treatments when compared to fish 
fed the control diet. EPA levels were significantly higher in EQ1 fed fish compared to G1 fed 
fish. DHA levels did not differ significantly among treatments.   
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Discussion 
Effects of dietary equol and genistein on growth and EPA and DHA levels 
In the present study, all fish more than doubled their initial body weight and showed similar 
final body weights among dietary treatments. This is in line with recent studies of Torno et al. 
[37] who fed genistein to rainbow trout at 0.3% without detrimental effects on growth 
performance of fish. Furthermore, own investigations revealed no negative effects of 0.15% 
dietary equol supplementation on growth of rainbow trout [13]. Thus, it seems that these 
findings can be confirmed in the present study and that dietary equol and genistein do not 
impair growth of rainbow trout when the dietary doses of 0.1 - 0.3% are fed with fixed feeding 
ratios of 1.6% of biomass/day. In accordance, FCR and SGR values did not differ significantly 
between the dietary treatments. The FCR and SGR values were in an acceptable range as 
other studies reported similar or higher (FCR) and lower (SGR) values for rainbow trout of the 
same size [6,37,38]. Moreover, the nutrient composition of whole body homogenates was not 
significantly altered by the dietary treatments. This is in accordance with findings of D’Souza 
et al. [39] who fed diets containing genistein to rainbow trout. Thus, it seems that dietary 
genistein and equol at 0.1 - 0.3% did not negatively affect the nutrient utilization. Furthermore, 
PER and PRE values were not affected in the present study. This is contrasting results of 
Torno et al. [37] who found increased PER and PPV (equals PRE) values for rainbow trout fed 
0.3% of genistein. The discrepancies between the two studies might be related to differing 
daily feed intakes as the feed intake in the study of Torno et al. [37] was higher compared to 
the one in the present study (2.2% and 1.6% of biomass/day, respectively). By increasing the 
feeding level, the total amount of ingested bioactive substances increases and thus, the effects 
of these substances on protein retention could possibly be enhanced. Therefore, when 
comparing results of different studies using bioactive substances, it must be considered both, 
the dietary dosage and the feeding level. However, it seems that dietary genistein and equol 
can be included into rainbow trout feeds at levels of 0.1 - 0.3% without impairing growth 
performance and nutrient utilization when fed a fixed feeding ratio of 1.6% of biomass/day. 
The evaluation of dietary equol and genistein at differing concentrations revealed no significant 
enhancement of EPA and DHA tissue contents in rainbow trout. EPA in fillet was significantly 
decreased in fish fed EQ2 and lower in fish fed EQ3 in comparison to fish fed the control diet. 
The application of the phytoestrogen sesamin also decreased EPA levels in Atlantic salmon 
hepatocytes, putatively due to an increased biosynthesis of DHA [40]. Bou et al. [41] showed 
that low dietary levels of DHA increase the conversion of EPA to DHA in Atlantic salmon. In 
contrast to these findings, DHA levels in fillet and liver samples of fish fed EQ2 and EQ3 were 
not increased in the present study. However, DHA levels were slightly increased (non 
significant) in whole body homogenates of these fish. A factor contributing to this result could 
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be the very slow synthesis efficiency of DHA in rainbow trout [3]. In addition to that, 
phytochemicals can affect the biosynthesis of DHA via different mechanisms, for example by 
increasing the expression of genes encoding proteins or by increasing the levels of proteins 
centrally involved in the biosynthesis [12,28,40]. These pathways putatively require additional 
time to further increase DHA tissue levels of fish. However, no significant effects of dietary 
application of equol and genistein on DHA tissue levels within the experimental duration were 
found in the present study. Thus, an extension of the experimental duration would have shown 
most likely only a marginal, if any, increase of DHA levels in fillets of fish. 
Nevertheless, results of the present study are not in line with our initial hypothesis that higher 
dietary levels of bioactive substances might increase the effect on the biosynthesis of DHA. 
Own investigations revealed that 0.15% of dietary equol significantly increased and genistein 
tended to increase DHA levels of whole body homogenates in rainbow trout [13]. The 
difference between the dietary EPA and DHA concentration of the previous and the present 
study (EPA + DHA: 2.1% and 1.6% of FAME, respectively) could have partly contributed to 
these results. Low dietary long-chain polyunsaturated fatty acids levels increase the 
biosynthesis of EPA and DHA in rainbow trout [5,42]. However, it might be possible that the 
lower dietary EPA and DHA levels in the present study already challenged our rainbow trout. 
Thus, it seems that genistein and equol increase the efficiency of the EPA and DHA 
biosynthesis in rainbow trout only if the dietary levels of these fatty acids are higher than in the 
present study.  
Effects of dietary equol on liver metabolism 
In contrast to growth performance and the tissue contents of EPA and DHA, there was a dose-
dependent effect of dietary equol on livers of rainbow trout. Liver weights and thus, HSI levels 
of rainbow trout were significantly increased and showed the highest values in fish fed the EQ3 
diet. Similar results were found in livers of rainbow trout fed diets containing equol at levels of 
0.2% and 0.3% of DM in our previous study [11]. These findings might be attributable to the 
estrogenic properties of equol due to its structural similarity to estradiol [20]. A dose-dependent 
increase of liver to body weight ratios due to estradiol application in rainbow trout is associated 
with the presence of vitellogenin [43]. Equol induces hepatic vitellogenin synthesis in Siberian 
sturgeon when administered via injection [44]. As vitellogenin synthesis can be induced 
already in immature fish [45], it is possible that dietary equol induced vitellogenin synthesis in 
the present study and thereby increased liver weights of rainbow trout. In addition to these 
results, there was a dose-dependent effect on C18:0 levels in liver samples and increased 
levels of this C18:0 in fillet samples of fish fed the EQ diets. The synthesis of C18:0 from C16:0 
requires an elongation step mediated by the enzyme elongase 6 [46]. Elongase 6 is increased 
in ovariectomized rats treated with estradiol [47]. Further, overexpression of elongase 6 
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increases C18:0 in INS-1 cells (rat insulinoma cell line) [46] and in goat mammary cells [48]. 
Thus, it might be plausive to speculate that the estrogenic potential of equol is primarily 
responsible for the increase of C18:0 in fish fed EQ diets by increasing the expression of 
elongase 6. Furthermore, these effects seem to be more pronounced in response to increased 
dietary dosages of equol. Whether the increase in liver weight induced by dietary equol impairs 
health of rainbow trout needs further investigation (e.g. liver histology). 
Overall, mainly the livers of rainbow trout seem to be affected by the dietary equol 
supplementation. Pelissero et al. [49] assume that dietary phytoestrogens possibly reach the 
liver, similar to estradiol, via the entero-hepatic circulation. The liver has the highest ER 
amounts among all tissues in rainbow trout [50]. In addition, equol can bind to estrogen 
receptors [51]. Furthermore, the fact that females have up to three times higher amounts of 
estrogen receptors than male rainbow trout [52] could have added to the effect of equol on the 
liver. Thus, equol might affect the liver via estrogen-like mechanisms. However, future studies 
should investigate whether (European) consumers accept phytoestrogens in rainbow trout 
diets that exhibit estrogen-like effects.  
A factor contributing to the lack of activity of dietary genistein could be its lower estrogenic 
potency in rainbow trout hepatocyte cultures [21] and a lower bioavailability in comparison to 
equol [53]. 
Conclusion 
In conclusion, present data indicate that dietary genistein and equol can be included into 
rainbow trout feeds at levels of 0.1 - 0.3% of dry matter of the diet without impairing growth 
performance and nutrient utilization when fish are fed 1.6% of biomass per day. Nevertheless, 
dietary equol putatively exhibited estrogen-like activity in livers of rainbow trout. Dietary equol 
and genistein were not able to increase the efficiency of the biosynthesis and the tissue levels 
of EPA and DHA in the present study. Therefore, the utilization of equol and genistein in plant 
oil based diets in order to enhance the biosynthesis of EPA and DHA seems not reasonable 
in rainbow trout. 
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Abstract 
The utilization of vegetable oils in salmonid diets substantially decreased the body-content of 
omega-3 long-chain polyunsaturated fatty acids (n-3 LC-PUFA) and thus, the product quality 
for human consumption. Therefore, new ingredients for aquaculture feeds are needed that 
maximize the deposition of the health promoting n-3 LC-PUFA. This study investigated 
Buglossoides arvensis (Ahiflower) oil, a plant oil rich in alpha-linolenic acid (18:3n-3, ALA) and 
stearidonic acid (18:4n-3, SDA), as a source of n-3 fatty acids in rainbow trout (Oncorhynchus 
mykiss) nutrition. Rainbow trout (87.4 ± 0.6 g) were fed for 56 days. The oils of the control diet 
(FV) were substituted by Ahiflower oil at 33, 66 and 100% (A33, A66, A100). Dietary Ahiflower 
oil increased the final body weights of fish. mRNA steady state levels of fatty acyl desaturase 
2a (delta-6) (fads2a(d6)) and 2b (delta-5) (fads2b(d5)) as well as carnitine palmitoyl 
transferase 1 a (cpt1a) were not altered by dietary treatments. In contrast, cpt1c mRNA steady 
state levels were significantly downregulated in samples of fish fed A66 and A100. Significantly 
higher eicosapentaenoic acid (20:5n-3, EPA) and docosahexaenoic acid (22:6n-3, DHA) levels 
were found in the liver and significantly higher EPA levels in the fillet of rainbow trout of A66 
and A100 compared to FV. The content of DHA in fillets of fish fed Ahiflower oil was not 
significantly different to fish fed FV. Thus, high dietary amounts of Ahiflower oil can 
compensate for reduced dietary EPA and DHA levels. 
 
Keywords: Rainbow trout, Ahiflower oil, Stearidonic acid, Oil replacement, Fatty acid 
metabolism, long-chain polyunsaturated fatty acids (LC-PUFA) 
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Introduction 
Fish plays a crucial role in human nutrition. Besides its highly valuable protein, minerals and 
vitamins [1], fish provides important omega-3 (n-3) fatty acids such as eicosapentaenoic acid 
(20:5n-3, EPA) and docosahexaenoic acid (22:6n-3, DHA) [1,2]. These fatty acids are known 
for a variety of beneficial effects in humans such as supporting optimal cell and tissue function 
as well as promoting health [3–5]. Western diets are rich in omega-6 (n-6) fatty acids and low 
in n-3 fatty acids [6]. High dietary intake of n-6 fatty acids can cause an imbalance in n-3:n-6 
ratio in humans. This imbalance has been shown to increase the production of proinflammatory 
eicosanoids synthesized from arachidonic acid (20:4n-6) [7,8]. To achieve a balanced n-3:n-6 
ratio, several health advisory organizations recommend the daily consumption of up to 650 mg 
EPA and DHA via two servings of fish per week [4]. 
Farmed rainbow trout (Oncorhynchus mykiss) receive n-3 long-chain polyunsaturated fatty 
acids (LC-PUFA) mainly via feeds traditionally based on fish oil as lipid source [9,10]. During 
the past few decades, dietary fish oil has been partially replaced by vegetable oils in fish diets 
[11,12]. However, vegetable oils are generally richer in n-6 PUFA than fish oil and devoid of  
n-3 LC-PUFA [13], leading to an unfavorable modification of the fatty acid composition of 
farmed fish [14–17]. This results in a reduced quality of rainbow trout for human consumption. 
Thus, new ingredients for aquaculture feeds that ensure the nutritional benefits of fish for 
humans are needed.  
Rainbow trout are able to compensate lower dietary EPA and DHA levels via the endogenous 
fatty acid biosynthesis but only to a limited extend [18]. The n-3 LC-PUFA biosynthesis of fatty 
acid mainly takes place in the liver of fish [19]. Biosynthesis of n-3 LC-PUFA is initiated by the 
conversion of the precursor fatty acid alpha-linolenic acid (18:3n-3, ALA) to stearidonic acid 
(18:4n-3, SDA) catalyzed by the enzyme delta-6-desaturase. Furthermore, it requires a chain 
elongation step followed by delta-5-desaturation to form EPA. Synthesizing DHA from EPA 
involves, inter alia, a second delta-6-desaturation [20]. However, the efficiency of the 
endogenous n-3 LC-PUFA biosynthesis is limited [18]. Thus, bypassing the initial step (ALA to 
SDA) by providing dietary SDA may enhance the biosynthesis of EPA and DHA. Studies of 
humans [21,22], mice [23] and dogs [24] revealed that SDA is converted into EPA up to fourfold 
more efficiently than ALA, indicating SDA as a superior substrate for n-3 LC-PUFA synthesis. 
When applied in Atlantic salmon feed, dietary SDA affected tissue n-3 LC-PUFA contents 
positively. In Atlantic salmon parr, increased dietary SDA led to significantly higher amounts of 
SDA, EPA and DHA in red and white muscle tissues in comparison to feeding canola oil [25]. 
Similar results were obtained by feeding a plant oil rich in SDA (Echium oil) to seawater Atlantic 
salmon. In comparison to canola oil, feeding Echium oil resulted in higher contents of SDA and 
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EPA in whole body tissue [26]. In the same species, Echium oil upregulated delta-5-desaturase 
gene expression in the liver [27].  
The plant oil with the naturally highest SDA levels known is Ahiflower oil [28]. It is extracted 
from the seeds of Buglossoides arvensis. Further, it is characterized by a favorable n-3:n-6 
ratio due to low levels of linoleic acid (18:2n-6) and high amounts of ALA (Table 3-1). Moreover, 
it has a relatively neutral flavor which is described as “earthy […and] slightly nutty” [29]. This 
could be an advantage over plant oils with intensive flavoring like linseed oil, impairing feed 
intake in rainbow trout negatively when applied in higher dosages [30]. Thus, Ahiflower oil 
seems to be a promising candidate for fish oil replacement. Previously, this oil has been 
investigated in mice and humans. In mice, Ahiflower oil increased EPA and DHA levels in liver 
in comparison to controls fed flaxseed oil that is rich in ALA [28]. Lefort et al. [31] observed a 
dose-dependent increase of ALA and EPA levels in plasma of humans following dietary 
Ahiflower oil administration. 
Table 3-1. Fatty acid composition (in mole%) of oil ingredients utilized in the 
experimental diets FV, A33, A66 and A100. 
Fatty acid Fish oil Linseed 
oil 
Palm oil Rapeseed 
oil 
Sunflower 
oil 
Ahiflower 
oil 
Total SFA  16.5 10.4 81.8 7.1 10.7 7.0 
Total MUFA  52.5 20.6 15.1 64.1 28.1 11.6 
n-6       
18:2n-6 13.8 15.7 3.0 19.3 60.5 12.0 
18:3n-6 0.1 tr§ tr tr tr 5.3 
n-3       
18:3n-3 6.1 52.9 tr 8.6 0.1 45.1 
18:4n-3 0.8 tr tr tr tr 18.4 
20:5n-3 2.7 tr tr tr tr tr 
22:6n-3 3.6 tr tr tr tr tr 
Total PUFA  30.2 68.6 3.0 27.9 60.6 80.8 
§ tr = traces (values < 0.1) 
To our knowledge, at the time of writing, there are no studies investigating Ahiflower oil in fish 
nutrition. Furthermore, new ingredients for aquafeeds are needed that maximize the quality of 
fish as a product for human consumption. Therefore, we aimed to evaluate the potential of 
Ahiflower oil as a source of n-3 fatty acids in rainbow trout nutrition, its effects on liver gene 
expression, and product quality for human nutrition. We were specifically interested to 
determine if high dietary levels of ALA and SDA would promote higher concentrations of EPA 
and DHA in tissues of rainbow trout. Thus, we substituted Ahiflower oil in a stepwise manner 
(0%, 33%, 66% and 100%) for an oil blend to determine an optimal dietary inclusion level for 
rainbow trout. EPA levels were significantly increased in the fillets of fish fed 66% and 100% 
of Ahiflower oil whereas DHA levels remained unaffected. Thus, high inclusion levels of dietary 
Ahiflower oil can compensate for reduced dietary levels of EPA and DHA, making Ahiflower oil 
a promising option to substitute fish oil in rainbow trout diets. 
60  Chapter 3 
Materials and Methods 
Experimental setup 
The feeding trial was performed in a recirculating aquaculture system (RAS) at the Gesellschaft 
für Marine Aquakultur mbH (GMA, Büsum, Germany). Monosex female rainbow trout used in 
this experiment were obtained from a local fish farm (Forellenzucht Trostadt GbR, Germany). 
Before starting the experiment, fish were acclimatized to the experimental conditions and fed 
on a commercial fish feed (AllerGold, 3mm, AllerAqua) for two weeks. A total of 240 juvenile 
rainbow trout (87.4 ± 0.6 g initial body weight) were randomly distributed among twelve tanks 
of the RAS (20 m3, turnover rate 2.4 h-1, technical oxygen supply via oxygen cone). The water 
purification system comprised of a drum filter (mesh size 20µm), biofilter, ultraviolet (UV) 
disinfection and protein skimmer with ozone. Temperature (14.8 ± 0.5°C), oxygen (12.0 ± 0.2 
mg/L O2) and pH (7.5) were continuously monitored via probes. NH4+ (0.32 ± 0.25 mg/L), NO2- 
(0.69 ± 0.27 mg/L) (Microquant test kit for NH4+ and NO2; Merck KGaA, Darmstadt, Germany) 
and salinity (4.2 ± 0.7 ‰) were measured daily. Each tank with a volume of 150 L was stocked 
with 20 fish (1747 ± 12 g). Fish were individually weighed (± 0.1 g) at the start of the 
experiment. A light/dark (14 h/10 h) cycle was adapted. Each diet was randomly distributed in 
triplicate and was hand fed once per day for 56 days. Each tank was bulk weighed every 14 
days to adjust daily feed intake at a daily feed intake (DFI) level of 1.6% of biomass. The 
experiment was carried out according to the EU Directive 2010/63/EU for animal experiments 
and the national regulations for animal welfare (TierSchVersV). Furthermore, it was approved 
by the Ministry of Energy, Agriculture, the Environment, Nature and Digitalization (MELUND, 
Kiel, Germany; approved on 18 October 2017, project number V241-37421/2017). 
Experimental diets 
Fish were fed four diets in total. All diets were formulated based on the same feed ingredient 
composition, differing only in their oil sources (Table 3-2). A diet based on fish oil and a blend 
of vegetable oils (FV) served as a reference diet. For the experimental diets, Ahiflower oil was 
substituted for FV at levels of 33%, 66% and 100% (A33, A66 and A100). All diets were 
isonitrogenous and isoenergetic. Fatty acid composition of oil ingredients and final diets is 
shown in Table 3-1 and Table 3-3, respectively. Dietary content of EPA and DHA decreased 
with an increasing level of Ahiflower oil. Dietary content of amino acids was calculated based 
on the amino acid contents of single ingredients. The experimental diets were formulated 
according to the amino acid requirements of rainbow trout [13]. Pellets were produced with a 
pelleting machine (Type 14U175, Amandus Kahl, Hamburg) with 4 mm diameter and 6 mm 
length. 
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Table 3-2. Ingredients and nutrient composition (in % of dry matter (DM)) of the 
experimental diets FV, A33, A66 and A100. 
Diet FV A33 A66 A100 
Ingredients [in % DM]     
Fish meal a 15.0 15.0 15.0 15.0 
Blood meal b 5.0 5.0 5.0 5.0 
Feather meal c 5.5 5.5 5.5 5.5 
Pea protein isolate d 12.0 12.0 12.0 12.0 
Soy protein concentrate e 5.0 5.0 5.0 5.0 
Wheat gluten f 14.0 14.0 14.0 14.0 
Wheat starch f 22.0 22.0 22.0 22.0 
Oil sources 11.5 11.5 11.5 11.5 
Fish oil g 5.0 3.4 1.7 - 
Rapeseed oil h 0.2 0.2 0.1 - 
Linseed oil i 4.0 2.7 1.4 - 
Palm fat j 0.5 0.3 0.2 - 
Sunflower oil h 1.8 1.2 0.6 - 
Ahiflower oil k - 3.8 7.6 11.5 
Gelatin l 1.5 1.5 1.5 1.5 
Vitamin Mineral premix m 1.0 1.0 1.0 1.0 
Calcium hydrogen phosphate n 0.5 0.5 0.5 0.5 
α-Cellulose o 2.8 2.8 2.8 2.8 
Lysine p 0.7 0.7 0.7 0.7 
Methionine q 0.1 0.1 0.1 0.1 
Bentonite r 3.4 3.4 3.4 3.4 
     
Nutrient composition [% DM]     
Dry matter [in % of diet] 86.3 86.5 87.2 90.1 
Crude protein 52.0 51.7 51.7 50.8 
Crude lipid 16.1 15.9 16.0 15.8 
Crude ash 6.2 6.2 6.2 6.1 
Total COH [in % DM] s 25.7 26.2 26.1 27.3 
Gross energy [MJ/kg DM] 23.1 23.1 23.1 22.8 
a Lean fish meal “low ash”, Bioceval GmbH & Co. KG, Cuxhaven, Germany; b Daka porcine bloodmeal, Daka 
Denmark A/S, Løsning, Denmark; c GePro Goldmehl, GePro Geflügel-Protein Vertriebsgesellschaft mbH & Co. KG, 
Diepholz, Germany; d Emsland-Stärke GmbH, Emlichheim, Germany; e Euroduna Food Ingredients GmbH, 
Barmstedt, Germany; f KRÖNER STÄRKE GmbH, Ibbenbüren, Germany; g Bioceval GmbH & Co. KG, Cuxhaven, 
Germany; h Food store, Büsum, Germany; i Makana Produktion und Vertrieb GmbH, Offenbach a.d. Queich, 
Germany; j DF 100 PT-PV; EFG Elbe Fetthandel GmbH, Geesthacht, Germany; k Nature’s Crops International, 
Kensington, Canada; l Gustav Ehlert GmbH & Co. KG, Verl, Germany; m Emsland-Aller Aqua GmbH, Golßen, 
Germany; n JRS Pharma GmbH & Co. KG, Rosenberg, Germany; o Mikro-Technik GmbH & Co. KG, Bürgstadt am 
Main, Germany; p Biolys, Evonik Industries AG, Essen, Germany; q MetAmino, Evonik Industries AG, Essen, 
Germany; r Castiglioni Pes y Cía, Buenos Aires, Argentina; s Total COH = 100 – (crude protein + crude lipid + crude 
ash)  
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Table 3-3. Fatty acid composition (in mole%) of the experimental diets FV, A33, A66 and 
A100. 
Fatty acid FV A33 A66 A100 
14:0 1.2 1.0 0.6 0.4 
16:0 13.1 11.8 10.4 9.0 
18:0 3.4 23.0 2.7 2.2 
Total SFA  18.5 16.4 14.1 11.7 
16:1 1.3 1.0 0.7 0.3 
18:1 27.8 22.6 17.6 12.3 
Total MUFA  33.9 27.3 21.6 15.2 
n-6     
18:2n-6 24.9 22.5 20.2 17.8 
18:3n-6 0.0 1.4 2.6 4.0 
20:4n-6 0.2 0.1 0.1 0.2 
n-3     
18:3n-3 17.2 23.0 29.0 35.0 
18:4n-3 0.3 4.7 9.1 13.7 
20:5n-3 1.3 1.0 0.7 0.6 
22:6n-3 2.0 1.7 1.3 1.0 
Total PUFA  47.0 55.4 63.5 72.3 
n-3:n-6 1 0.8 1.3 1.8 2.3 
1 n-3:n-6 is the ratio of ∑n-3 and ∑n-6 of n-3 and n-6 fatty acids, respectively, shown in this table. 
Sample collection 
Fish were bulk weighed at the beginning and the end of the 56-day-feeding trial after 72-h 
starvation to determine growth and performance parameters (Fig. 3-1). Specific growth rate 
(SGR), feed conversion ratio (FCR), protein efficiency ratio (PER) and protein retention 
efficiency (PRE) were calculated following the equations in Table 3-5. After the final bulk 
weighing, fish were fed the experimental diets again for two days prior to final sampling, as 
physiological parameters might be very sensitive to an extended starvation time.  
 
Fig. 3-1Timeline of the experimental period and sample collection. *Initial samples were taken from 
fish continuously fed the commercial diet of the adaptation period. 
Both samplings (initial and final) were performed following the same procedure: Fish were 
deprived of feed 24 h before the sampling and were anesthetized and killed by a blow on the 
head. For the determination of the initial status, acclimated residual fish were used. Three fish 
per tank (pool sample) were sacrificed for nutrient composition of whole body homogenate and 
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stored at -20°C. Furthermore, five fish per tank (initial sampling: eight fish) were used for 
individual samples of liver, spleen, and fillet. Weight of liver and spleen was measured to 
calculate hepatosomatic and spleen somatic index (HSI and SSI). One part of the liver was 
used for mRNA quantification via quantitative real-time reverse transcription polymerase chain 
reaction (qRT-PCR). For that, samples were placed immediately into RNA later to prevent RNA 
degradation and stored on ice during sampling of each tank. In addition, these samples were 
incubated at 4°C overnight, followed by a storage at -20°C. Residual liver and fillet tissue was 
pool sampled for fatty acid analysis and stored at -80°C and -20°C, respectively. Length and 
weight were measured for all sampled fish to calculate the Fulton condition factor (K,  
Table 3-5). Fillet and whole body homogenate samples were freeze dried (alpha 1-4 LSC; 
Martin Christ Gefriertrocknungsanlagen GmbH, Osterode am Harz, Germany) and 
homogenized using a cutting mill (Grindomix, Retsch, Haan, Germany). 
Nutrient composition 
Proximate nutrient analysis of diets and whole body homogenate included dry matter (DM), 
crude protein, crude lipid and crude ash. It was performed at the laboratory of the Gesellschaft 
für Marine Aquakultur according to EU guideline (EC) 152/2009 [32]. Dry matter was 
determined by drying the samples at 103°C in a drying oven (ED53 9010-0078; Binder GmbH, 
Tuttlingen, Germany) until constant mass. Afterwards, same samples were incinerated for ‘ 
4 h at 560°C in a muffle furnace (LE 6/11/P300; Nabertherm, Lilienthal, Germany) to determine 
crude ash. Crude protein content was analyzed according to the methods of Kjeldahl via 
digestion (KjelDigester K-449 and Scrubber K-415; BÜCHI Labortechnik GmbH, Essen, 
Germany), distillation (KjelFlex 360; BÜCHI Labortechnik GmbH) and titration (877 Titrino plus; 
Deutsche METROHM GmbH & Co. KG, Filderstadt, Germany) using a nitrogen to protein 
coefficient of 6.25. Crude lipid content was determined according to the Soxhlet method using 
hydrolysis with hydrochloric acid (HYDROTHERM HT 6; C. Gerhardt GmbH & Co. KG, 
Königswinter, Germany) and extraction with petroleum ether (SOXTHERM 416, Multistat/SX 
PC; C. Gerhardt GmbH & Co. KG, Königswinter, Germany). Gross energy content was 
determined by bomb calorimetry (C 200; IKA-Werke GmbH & Co. KG, Staufen, Germany), 
calibrated with benzoic acid.   
Fatty acid composition 
Fatty acid composition was analyzed by LUFA-ITL GmbH, Kiel, Germany. Fatty acid 
composition of oils, diets, liver, and fillet samples was determined by gas chromatography (GC) 
(DGF, C-VI 10 a). Fatty acid methyl ester (FAME) were prepared by saponification with 
methanolic NaOH and transmethylation of total lipids using boron trifluoride and methanol 
(DGF, C-VI 11 a). Further, FAME samples were separated by GC via split-injection (column: 
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CP-Sil 88 50 m x 0.25 mm x 0.2 µm or similar) and detected with flame ionization detector 
(FID). Helium was used as carrier gas. FAME were identified by comparison with a certified 
standard mix (18919-1AMP Supelco, F.A.M.E. Mix, Sigma-Aldrich). The resulting FAME 
values were converted to moles and reported as mole% of total fatty acids. 
RNA isolation and qRT-PCR 
Approximately 15 mg of RNA later stabilized liver tissue of rainbow trout was homogenized in 
a TissueLyser II (Qiagen, Hilden, Germany) prior to total RNA isolation. Total RNA was 
extracted from liver samples using the Innuprep RNA Mini Kit (Analytik Jena, Jena, Germany) 
according to the manufacturer’s protocol. RNA concentration and purity were determined by 
measuring the absorbance at ratios of A260/280 and 260/230 via NanoDrop measurements 
(NanoDrop2000c; ThermoScientific, Waltham, MA, USA). mRNA steady state levels of 
selected target genes were quantified via qRT-PCR measurements using the SensiFast SYBR 
No-ROX One-Step Kit (Bioline, London, UK) and a Rotor-Gene 6000 real-time PCR cycler 
(Corbett/Qiagen). Eigtheen microliters of a 1000-fold-diluted RNA sample were added to 27 µl 
Master Mix. The 27 µl Master Mix consisted of 2.48 µl DEPC treated water, 0.40 µl reverse 
transcriptase, 0.90 µl RNase inhibitor, 22.5 µl 2x SensiFAST-Mix and 0.36 µl of each primer. 
The analysis was done in duplicate using 20 µl of this mixture each. The cycling conditions 
were as follows: at 49°C for 30 min, at 95°C for 10 min, 40 cycles of 95°C for 15 s, annealing 
temperature of the primer pair for 30 s and 72°C for 30 s, followed by a melt curve analysis 
from 60 to 99°C of 1°C increments. Primer sequences and the respective annealing 
temperatures are shown in Table 3-4.  
Table 3-4. Primer sequences (forward and reverse) and the respective annealing 
temperatures for mRNA measurements via qRT-PCR of samples from rainbow trout 
liver. 
Gene Primer Sequence 5’→ 3’ Annealing 
Temperature (°C) 
ef1α a,* F ACAAGCCCCTYCGTCTGCC 61 
ef1α a,* R GCATCTCCACAGACTTSACCTCAG 61 
fads2b(d5) b,§ F GGACATTTCCTGGATGTTTTTGAT 57 
fads2b(d5) b,§ R TCTGACAAGGATTAAAACAATTATA 57 
fads2a(d6) c,* F GCTGGAGARGATGCCACGGA 61 
fads2a(d6) c,* R TGCCAGCTCTCCAATCAGCA 61 
cpt1a d,# F TCGATTTTCAAGGGTCTTCG 55 
cpt1a d,# R CACAACGATCAGCAAACTGG 55 
cpt1c d,# F CGCTTCAAGAATGGGGTGAT 59 
cpt1c d,# R CAACCACCTGCTGTTTCTCA 59 
a ef1α: Elongation factor 1 α; b fads2b(d5): fatty acyl desaturase 2b (delta-5) c fads2a(d6): fatty acyl desaturase 2a 
(delta-6); d cpt1: Carnitine palmitoyl transferase 1; * Geay et al. [70]; § Gregory [71]; # Kolditz et al. [72]. 
A standard curve was used to calculate relative mRNA concentrations. The mRNA steady state 
levels of genes encoding proteins related to lipid metabolism were normalized to the 
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expression level of the housekeeping gene elongation factor 1 alpha (ef1α). Ef1α was 
previously used and suggested as a gene reference in salmonids [33]. 
Statistical analysis 
The statistical software R (2017) was used to evaluate the data, including the packages gdata, 
gplots, nlme, piecewiseSEM and multcomp. The data evaluation started with the definition of 
appropriate statistical models: (1) statistical models based on general least squares [34] for 
final body weight, DFI, FCR, SGR, PER, PRE, nutrient and fatty acid composition and (2) 
mixed models [35,36] with tank as random factor if values per fish (HSI, SSI, K, fads2a(d6), 
fads2b(d5), cpt1a, cpt1c) were considered. The data were considered as normally distributed 
by a graphical residual analysis. Homoscedasticity or heteroscedasticity, respectively, was 
taken into account. Based on the model, a Pseudo R2 was calculated [37] and multiple contrast 
tests (e.g., see [38]) were conducted to compare the dietary treatments. Furthermore, 
regression analysis was performed by fitting a linear model to fillet and diet fatty acid 
composition to show a potential relationship. 
Results 
Dietary Ahiflower oil increases final body weight  
All groups more than doubled their initial body weight within the experimental period  
(Table 3-5). The final body weight was higher in all groups fed Ahiflower oil and significantly 
higher in A100 (p < 0.05) compared to FV. Furthermore, this group exhibited the lowest FCR 
and highest SGR values among treatments (p > 0.05). SSI was dose-dependently increased 
with significantly higher (p < 0.05) values in A66 and A100. DFI, PER, PRE, HSI and K were 
not significantly affected by the different dietary treatments.  
Nutrient composition of whole body homogenates is not affected by dietary treatment 
The analysis of nutrient composition of whole body homogenates showed no significant 
differences between groups in terms of crude ash, crude protein, crude lipid and gross energy 
(Table 3-6).  
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Table 3-5. Growth performance, feed intake, feed efficiency and biometric parameters 
of rainbow trout fed with the experimental diets FV, A33, A66 and A100 for 56 days. 
 FV A33 A66 A100 
Initial weight 1 87.1 ± 0.2 87.4 ± 0.9 87.7 ± 0.6 87.1 ± 0.2 
Final weight 2 210.3 ± 4.0a 216.4 ± 1.0ab 213.2 ± 2.0ab 218.5 ± 2.2b 
DFI 3 1.60 ± 0.01 1.60 ± 0.01 1.59 ± 0.01 1.59 ± 0.01 
FCR 4 1.02 ± 0.03 0.99 ± 0.01 1.00 ± 0.01 0.97 ± 0.02 
SGR 5 1.57 ± 0.03 1.62 ± 0.01 1.59 ± 0.03 1.64 ± 0.02 
PER 6 2.20 ± 0.06 2.27 ± 0.03 2.21 ± 0.03 2.26 ± 0.04 
PRE 7 39.1 ± 0.7 44.4 ± 4.7 37.8 ± 0.9 38.5 ± 2.1 
HSI 8 1.56 ± 0.21 1.52 ± 0.22 1.52 ± 0.17 1.53 ± 0.18 
SSI 9 0.12 ± 0.03a 0.17 ± 0.09ab 0.18 ± 0.05b 0.21 ± 0.07b 
K 10 1.38 ± 0.13 1.35 ± 0.09 1.39 ± 0.09 1.39 ± 0.11 
1 Average initial body weight [g]; 2 Average final body weight [g]; 3 Daily feed intake [% d-1]; 4 Feed conversion ratio 
= feed intake [g]/weight gain [g]; 5 Specific growth rate [% d-1] = [ln (final body weight) – ln (initial body 
weight)]/feeding day x 100; 6 Protein efficiency ratio = weight gain [g]/protein intake [g]; 7 Protein retention efficiency 
= 100 x {[(final body protein x final body weight) – (initial body protein x initial body weight)]/protein intake}; 8 
Hepatosomatic index = 100 x (liver weight [g]/body weight [g]); 9 Spleen somatic index = 100 x (spleen weight 
[g]/body weight [g]); 10 Fulton condition factor = 100 x (final body weight x final body length3). Values (mean ± SD, 
Initial weight, Final weight, DFI, FCR, SGR, PER, PRE: n = 3; HSI, SSI: n = 3 (5 fish/tank); K: n = 3 (8 fish/tank)) 
with different superscript letters within one row are significantly different (p < 0.05), values without superscript letters 
within one row are not significantly different (p ≥ 0.05) based on the statistical models described in Materials and 
Methods. 
Table 3-6. Nutrient composition of whole body homogenate (in % OM; gross energy in 
MJ/kg OM) of rainbow trout before the experiment (Initial) and after being fed the 
experimental diets FV, A33, A66 and A100 (mean ± SD, n = 3) for 56 days. 
[in % OM] Initial FV A33 A66 A100 
Dry matter 27.1 30.8 ± 0.3 31.5 ± 2.1 30.6 ± 0.4 30.0 ± 0.4 
Crude ash 2.8 2.1 ± 0.0 2.1 ± 0.0 2.1 ± 0.2 2.2 ± 0.2 
Crude protein 16.4 17.2 ± 0.1 18.1 ± 1.1 16.8 ± 0.3 16.8 ± 0.5 
Crude lipid 7.9 11.4 ± 0.2 11.3 ± 1.0 11.7 ± 0.4 11.0 ± 0.5 
Gross energy [MJ/kg] 6.9 8.6 ± 0.1 8.7 ± 0.6 8.6 ± 0.2 8.3 ± 0.3 
Values (mean ± SD, n = 3) without superscript letters within one row are not significantly different (p ≥ 0.05) based 
on the statistical models described in Methods. 
Dietary Ahiflower oil substitution dose-dependently alters fatty acid composition of 
fillet 
Fatty acid composition of fillets dose-dependently altered due to the substitution of Ahiflower 
oil for FV (Table 3-7). Contents of fatty acids (in mole%) in the experimental groups A66 and 
A100 differed from FV to a greater extent than values of A33. A100 resulted in the highest  
(p < 0.05) fillet PUFA content of all treatments. A100 exhibited significantly (p < 0.05) higher 
levels of ALA and SDA (two- and sixfold, respectively) compared to FV. Consequently, the  
n-3:n-6 ratio increased significantly (p < 0.05) in a stepwise manner from FV to A100. In 
addition, EPA levels of fish fed with the diets A66 and A100 were identical and significantly  
(p < 0.05) higher than in fillets of fish fed with the diet FV. In contrast, increasing dietary 
Ahiflower oil levels led to lower (p > 0.05) DHA and significantly (p < 0.05) lower 
monounsaturated fatty acids and linoleic acid (18:2n-6) contents. Simultaneously, content of 
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γ-linolenic acid (18:3n-6) increased significantly from FV to A100. A66 and A100 also showed 
significantly lower saturated fatty acids levels than FV.  
Table 3-7. Fatty acid composition (in mole%) of fillet of rainbow trout fed the 
experimental diets FV, A33, A66 and A100 for 56 days.  
Fatty acid Initial FV A33 A66 A100 
14:0 1.5 1.7 ± 0.1a 1.6 ± 0.1a 1.4 ± 0.1b 1.3 ± 0.0b 
16:0 11.3 15.8 ± 0.3a 15.9 ± 0.1a 15.1 ± 0.3ab 15.0 ± 0.2b 
18:0 2.9 3.7 ± 0.1 3.7 ± 0.1 3.6 ± 0.2 3.7 ± 0.0 
Total SFA  16.3 21.8 ± 0.4a 21.8 ± 0.2a 20.5 ± 0.4b 20.2 ± 0.2b 
16:1 1.7 4.3 ± 0.1 4.2 ± 0.2 3.8 ± 0.2 3.7 ± 0.1 
18:1 39.6 33.6 ± 0.6a 30.5 ± 0.7b 28.8 ± 0.3b 26.0 ± 0.7c 
Total MUFA  48.7 43.2 ± 0.8a 39.4 ± 0.7b 36.9 ± 0.6c 33.8 ± 0.9d 
n-6              
18:2n-6 14.3 15.6 ± 0.1a 14.8 ± 0.2b 13.8 ± 0.2c 12.4 ± 0.2d 
18:3n-6 0.3 0.4 ± 0.0a 0.8 ± 0.0b 1.3 ± 0.0c 1.8 ± 0.0d 
20:4n-6 0.8 0.5 ± 0.0a 0.4 ± 0.1ab 0.4 ± 0.0ab 0.3 ± 0.0b 
n-3              
18:3n-3 4.2 7.5 ± 0.1a 10.3 ± 0.3b 12.9 ± 0.3c 15.4 ± 0.4d 
18:4n-3 0.7 1.1 ± 0.0a 2.9 ± 0.3b 4.7 ± 0.0c 6.7 ± 0.3d 
20:5n-3 1.5 1.1 ± 0.1a 1.2 ± 0.1ab 1.4 ± 0.0b 1.4 ± 0.0b 
22:6n-3 10.5 5.8 ± 0.5 5.5 ± 0.1 5.2 ± 0.2 5.0 ± 0.2 
Total PUFA  34.6 34.3 ± 0.6a 38.2 ± 0.7b 42.0 ± 0.5c 45.3 ± 0.7d 
n-3:n-6 1 1.1 0.9 ± 0.0a 1.2 ± 0.0b 1.6 ± 0.0c 2.0 ± 0.0d 
1 n-3:n-6 is the ratio of ∑n-3 and ∑n-6 of n-3 and n-6 fatty acids, respectively, shown in this table. Values (mean ± 
SD, n = 3, consisting of fillets from five fish each) with different superscript letters within one row are significantly 
different (p < 0.05), values without superscript letters within one row are not significantly different (p ≥ 0.05) based 
on the statistical models described in Materials and Methods. Initial data (n = 1, consisting of five livers) was not 
statistically analyzed. 
Dietary fatty acid content linearly correlates with fatty acid content in fillet 
Linear regression analysis of the fatty acid content (in mole%) in the diet (Table 3) and the fatty 
acid content (in mole%) in fillet (Table 3-7) is shown Fig. 3-2. In terms of ALA, SDA, and DHA 
the content of these fatty acids in the diet linearly correlates with the fatty acid content in the 
fillet with R2-values in the range of 0.52-0.99. Fillet contents of ALA were always below the 
dietary content. Similar effects were found for SDA except for the diet with the lowest SDA 
content (FV). DHA had a higher content in fillet than in the diet. In contrast, EPA fillet content 
was negatively correlated with dietary EPA.  
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Fig. 3-2 Dietary fatty acid content in relation to the fillet fatty acid content. Figure shows values for 
(a) ALA, (b) SDA, (c) EPA and (d) DHA (in mole%) of rainbow trout fed the experimental diets FV, A33, 
A66 and A100. The additional line represents the line of equality. Error bars represent mean ± SD  
(n = 3). 
Dietary Ahiflower oil affects fatty acid composition of liver  
The fatty acid composition of the liver was affected by dietary Ahiflower oil (Table 3-8). Fish 
fed with the diet A100 showed a significantly (p < 0.05) lower hepatic monounsaturated fatty 
acid content compared to fish fed with the diets FV and A33. In addition, fish fed with the A66 
diet had also significantly lower levels of these fatty acids than fish fed with the control diet FV. 
In contrast, the PUFA level was significantly (p < 0.05) increased in A66 and A100 compared 
to FV due to increased content of n-3 fatty acids (ALA, SDA, EPA and DHA). Consequently, 
the n-3:n-6 ratio significantly (p < 0.05) increased from FV to A100. A33 showed no consistent 
pattern as fatty acid values were mostly in between values of FV and A66 except for ALA, 
SDA, and EPA, which were significantly higher than FV. Saturated fatty acid levels were not 
altered by the dietary treatments.  
Hepatic mRNA steady state levels  
Fatty acyl desaturase 2a (delta-6) (fads2a(d6)), fatty acyl desaturase 2b (delta-5) (fads2b(d5)) 
and cpt1a remained on constant levels regardless of the dietary treatment (Fig. 3-3). Cpt1c, in 
contrast, was downregulated in A66 and A100 and thus, differed significantly (p < 0.01) from 
FV and from A33. 
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Table 3-8. Fatty acid composition (in mole%) of liver of rainbow trout fed the 
experimental diets FV, A33, A66 and A100 for 56 days. 
Fatty acid Initial FV A33 A66  A100 
14:0 0.6 1.8 ± 0.2 1.6 ± 0.1 1.6 ± 0.1 1.5 ± 0.2 
16:0 18.6 22.5 ± 0.3 22.0 ± 1.0 22.5 ± 0.9 22.4 ± 1.2 
18:0 5.8 7.1 ± 0.4 7.3 ± 0.0 7.5 ± 0.2 7.6 ± 0.1 
Total SFA  26.0 32.0 ± 0.2 31.3 ± 1.0 31.8 ± 0.7 31.7 ± 1.2 
16:1 0.7 4.6 ± 0.4 4.4 ± 0.3 4.0 ± 0.6 3.6 ± 0.4 
18:1 19.6 22.5 ± 0.6a 19.8 ± 1.6ab 17.8 ± 1.2b 16.5 ± 1.1b 
Total MUFA  23.7 31.8 ± 1.0a 28.3 ± 1.9ab 25.4 ± 1.4bc 23.3 ± 1.3c 
n-6              
18:2n-6 7.1 8.2 ± 0.3a 6.9 ± 0.2b 6.2 ± 0.4bc 5.5 ± 0.3c 
18:3n-6 0.1 0.2 ± 0.0a 0.2 ± 0.0a 0.4 ± 0.0b 0.4 ± 0.0b 
20:4n-6 4.3 2.1 ± 0.2 2.0 ± 0.5 1.9 ± 0.0 1.7 ± 0.2 
n-3              
18:3n-3 1.6 2.1 ± 0.1a 2.5 ± 0.1b 3.2 ± 0.4bc 4.2 ± 0.4c 
18:4n-3 0.3 0.3 ± 0.0a 0.7 ± 0.0b 1.0 ± 0.0c 1.3 ± 0.1d 
20:5n-3 3.2 1.6 ± 0.1a 2.7 ± 0.3b 3.4 ± 0.1c 3.8 ± 0.3c 
22:6n-3 29.8 16.2 ± 0.4a 19.1 ± 2.0ab 19.8 ± 0.9b 20.2 ± 1.1b 
Total PUFA  50.0 35.8 ± 0.9a 39.9 ± 2.3ab 42.4 ± 1.5b 44.5 ± 2.4b 
n-3:n-6 1 3.0 1.9 ± 0.1a 2.8 ± 0.3b 3.3 ± 0.2b 3.9 ± 0.1c 
1 n-3:n-6 is the ratio of ∑n-3 and ∑n-6 of n-3 and n-6 fatty acids, respectively, shown in this table. Values (mean ± 
SD, n = 3, consisting of five livers each) with different superscript letters within one row are significantly different (p 
< 0.05), values without superscript letters within one row are not significantly different (p ≥ 0.05) based on the 
statistical models described in Materials and Methods. Initial data (n = 1, consisting of five livers) was not statistically 
analyzed.  
 
 
Fig. 3-3 Hepatic mRNA steady state levels. Rainbow trout were fed the experimental diets FV, A33, 
A66 and A100 for 56 days. Presented are boxplots of relative liver mRNA levels of (a) Carnitine palmitoyl 
transferase 1 a (cpt1a), (b) Carnitine palmitoyl transferase 1 c (cpt1c), (c) fatty acyl desaturase 2b delta-
5 (fads2b(d5)) and (d) fatty acyl desaturase 2a delta-6 (fads2a(d6)). Liver mRNA gene expression was 
determined by qRT-PCR analysis and normalized to the housekeeping gene ef1α. Boxes represent 
values between the 25th and the 75th percentile; whiskers indicate 1.5 SD; medians are indicated by 
solid lines; outliers (above/below 1.5 SD) are indicated by solid circles. At the end of the experiment, 15 
individuals per treatment were sampled in total (n = 15). Statistically significant differences between 
dietary treatments are represented by asterisks; p < 0.05 (*) < 0.01 (**) based on the statistical models 
described in Materials and Methods. 
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Discussion 
Fish of all dietary groups performed well and more than doubled their body weight over the 56-
day experimental period. Notably, fish fed with the Ahiflower oil diets had higher final body 
weights than fish fed with the FV diet. SGR and FCR in the present study were similar to those 
reported by Turchini and Francis [39] feeding fish oil- and linseed oil-based diets to rainbow 
trout. Cleveland et al. [40] substituted an SDA rich oil (Echium oil) for fish oil in rainbow trout 
with an initial body weight of about 32 g. Fish fed with Echium oil showed similar growth as fish 
fed with the fish oil diet. Furthermore, dietary Echium oil also had no effect on growth in Atlantic 
salmon parr [25], Atlantic cod [41], and arctic charr [42]. However, fish fed with the diet A100 
showed significantly higher final body weights than fish fed with the FV diet, although the 
dietary content of saturated and monounsaturated fatty acids as well as EPA and DHA were 
lowest in this diet. This is contrasting the fact that oils low in saturated and monounsaturated 
fatty acids, such as Ahiflower oil, are considered to be not that effective for energy supply than 
other oils [43]. A factor possibly contributing to the higher final body weights may be the high 
content of ALA and SDA in the A100 diet. Bell et al. [44] suggest that high dietary levels of ALA 
might have been readily oxidized in Atlantic salmon. This could have been also the case for 
ALA and SDA in the present study. Thus, rainbow trout in the present study could have 
oxidized some of the ALA and SDA to compensate the lower MUFA levels in the A100 diet. 
Furthermore, high dietary ALA and SDA levels also seem to compensate for low dietary EPA 
and DHA levels without impairing fish growth. Thus, both, ALA and SDA, potentially not only 
served as a substrate for the n-3 LC-PUFA synthesis but also as an energy source. However, 
the significant increase of final body weights of fish fed with the A100 diet is not reflected to 
the same extent in the FCR and SGR values. Maybe further investigations should monitor fish 
for a longer period to clarify these observations.  
Fish fed with the diets A66 and A100 showed increased spleen weights, and therefore, higher 
SSI values than fish fed FV and A33. A factor possibly contributing to the increased SSI values 
of fish fed A66 and A100 could be the higher PUFA contents in these diets. An increased PUFA 
content in pellets can lead to a more rapid peroxidation of fatty acids [45]. In turn, oxidized fat 
in pelleted feed increased SSI and HSI values in rainbow trout [46]. In addition to this fact, the 
spleen is involved in the immune defense [47,48]. In humans, the consumption of Ahiflower oil 
has immune modulating characteristics that are known from dietary marine oils [31]. In this 
study, a significant increase of the anti-inflammatory cytokine interleukin-10 was found in whole 
blood samples of humans consumed Ahiflower oil. Interleukin-10 is secreted inter alia by  
CD4 + T cells [49]. This type of cells can be also found in the spleen of rainbow trout [50]. It 
remains unclear whether the immune-modulating characteristics of the Ahiflower oil or the 
increased PUFA levels in the A66 and A100 diets per se might have affected the constitution 
of the spleen. Thus, a histological analysis is warranted for further studies with Ahiflower oil.  
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Inclusion of Ahiflower oil did not alter the chemical nutrient composition of whole body in 
rainbow trout. Whole body protein levels are in line with the uniform values for protein efficiency 
ratio (PER) and protein productive value (PPV) which were also not affected by dietary 
treatment. This is in accordance with a study in rainbow trout, reporting that moisture, lipid, 
and protein levels in whole body of fish were not affected by the dietary oil source [51]. Thus, 
our results indicate that Ahiflower oil can substitute up to 100% of the added oils in rainbow 
trout diets without altering the body composition and positively affecting the growth of rainbow 
trout.  
It is well documented that the dietary fatty acid composition correlates with the fatty acid 
composition in fish tissue. Feeding plant oils devoid of LC-PUFA strongly alter the fillet fatty 
acid composition and decrease EPA and DHA contents [14–17]. In the present study, only the 
main fatty acid groups - saturated, monounsaturated fatty acids and polyunsaturated fatty 
acids - of experimental diets were reflected in the fillets of our rainbow trout. However, the 
contents of individual fatty acid in tissue samples were different to their respective dietary 
contents. The decrease of the dietary EPA and DHA levels due to the Ahiflower oil inclusion 
was not reflected in the liver and the fillets of fish fed with the diets A66 and A100. In contrast, 
with Ahiflower oil, the levels of these two fatty acids increased in the liver, and so did those of 
EPA in the fillets. These findings suggest an increased endogenous biosynthesis in fish fed 
with the diets A66 and A100. Rainbow trout are able to biosynthesize n-3 LC-PUFA 
endogenously [18]. This biosynthesis can be regulated via a feedback mechanism by dietary 
LC-PUFA. A diet deficient in these fatty acids, can enhance the biosynthesis of LC-PUFA [52]. 
Therefore, it is possible that the low contents of dietary EPA and DHA in A66 and A100 
enhanced the n-3 LC-PUFA biosynthesis in fish. In addition, these findings are in line with 
results observed by Miller et al. [25], feeding Echium oil to Atlantic salmon parr. In their study, 
DHA levels in white muscle tissue were similar to those of a fish oil diet, indicating an increased 
biosynthesis of the n-3 LC-PUFA due to high dietary SDA levels. Therefore, it is possible that 
the reputed rate-limiting first delta-6-desaturase step in the biosynthesis pathway [53] could 
have been bypassed by dietary SDA in A66 and A100, thereby increasing the synthesis of 
EPA. In contrast, Cleveland et al. [40] assume that the availability of substrate might be the 
limiting factor in the n-3 LC-PUFA biosynthesis. In their study with rainbow trout, n-3 LC-PUFA 
contents in fish tissue were comparable between feeding linseed oil (rich in ALA) and Echium 
oil (rich in SDA). However, dietary content of ALA was markedly higher in the linseed oil diet 
than in the Echium oil diet. In contrast, Ahiflower oil contains higher ALA and SDA levels than 
Echium oil [28]. This, in turn, indicates that in the present study SDA as well as the high amount 
of ALA due to Ahiflower oil inclusion might have increased liver and fillet EPA of fish fed A66 
and A100. Whatever the underlying mechanisms, present data support the hypothesis that 
inclusion of Ahiflower oil enhances n-3 LC-PUFA synthesis.  
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A preferential deposition and retention of DHA seem to have occurred in fillet, regardless of 
the dietary content of this fatty acid. As a result, all fillet DHA levels were higher than the 
content in the respective diet. This phenomenon has been observed in previous studies 
feeding different oil sources to Atlantic salmon [15,54]. In comparison to other dietary n-3 fatty 
acids that were readily oxidized, DHA has been shown to be relatively resistant to β-oxidation 
[55]. Further, Bell et al. [15] suggest that selective deposition and retention of DHA might be 
associated with the specificity of the enzymes that incorporate DHA into lipids. Thus, under the 
conditions investigated, an interaction of preferential retention and/or biosynthesis of EPA and 
DHA from dietary SDA presumably occurred in rainbow trout fed Ahiflower oil.  
Studies in Atlantic salmon [55] and rainbow trout [56] indicate that enhanced LC-PUFA 
synthesis in liver only marginally affects the final fillet fatty acid composition. This is only partly 
applicable to our study, because EPA in liver and fillet was significantly increased in A66 and 
A100 compared to FV, albeit to a lower extent in the fillet than in the liver. However, DHA 
contents of A66 and A100 were significantly higher in liver but lower in fillet compared to FV. 
A possible explanation might be the duration of converting ALA and SDA, respectively, to EPA 
and DHA via the endogenous biosynthesis pathway. Bell et al. [44] fed differing levels of 
rapeseed oil as a substitute for fish oil (0-100%) to Atlantic salmon. Subsequently, all fish 
received a fish oil finishing diet. After four weeks, all groups reached similar EPA contents in 
flesh. In contrast, it took twelve weeks for the formerly 100% rapeseed oil group to reach DHA 
contents of the 0% rapeseed oil group. This corresponds to the fact that DHA is synthesized 
very slowly from ALA in rainbow trout [18]. Therefore, it could be possible that the experimental 
period of 56 days in the present study was too short for A100 fish to recover the depletion of 
fillet DHA. Thus, it remains unclear whether fish of A66 and A100 could have recovered DHA 
via increased DHA biosynthesis in liver, if the experimental period had been longer.  
Expression of genes encoding proteins involved in fatty acid biosynthesis can be affected by 
dietary fatty acids in both mammals [57,58] and rainbow trout [59]. Dietary PUFA are known 
to regulate the delta-5- and delta-6-desaturase via a feedback mechanism [52]. For example, 
high dietary LC-PUFA, namely EPA and DHA, can decrease delta-5- and delta-6-desaturase 
gene expression and thereby reducing the n-3 LC-PUFA biosynthesis and vice versa [60]. 
Similar effects were found for Echium oil having high amounts of C18-PUFA (e.g. SDA and 
18:3n-6). According to recent literature, feeding Echium oil to Atlantic salmon [27] and Lates 
calcarifer [61] resulted in liver delta-6-desaturase expression higher than fish oil and lower than 
vegetable oil (canola oil/rapeseed oil). In the present study, all dietary treatments resulted in 
similar fads2a(d6) mRNA steady state levels. However, we used a blend of both, fish and 
vegetable oils as a control group (FV). Thus, the higher content of EPA and DHA in the FV diet 
possibly led to a reduction of the fads2a(d6) mRNA expression in these fish. Simultaneously, 
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the high contents of SDA and 18:3n-6 in the A100 diet might have impaired fads2a(d6) gene 
expression, although content of EPA and DHA were lowest in this diet.  
As already mentioned, as part of the Sprecher pathway, the delta-5-desaturation of 20:4n-3 
results in EPA [62]. Miller et al. [27] described that the increased delta-5-desaturase gene 
expression due to high dietary SDA increased hepatic EPA levels in seawater Atlantic salmon. 
In the present study, we also found the highest EPA levels in liver and fillet samples of fish fed 
diets with high dietary SDA content (A66 and A100). Simultaneously, A66 and A100 had the 
lowest dietary EPA levels. Thus, we hypothesized that an increase in dietary SDA enhances 
the biosynthesis of EPA in tissues of fish fed with the diets A66 and A100. Therefore, we 
expected that the hepatic delta-5 gene expression in fish fed with these diets was significantly 
increased. Contrasting our expectations, EPA tissue levels were not supported by the hepatic 
fads2b(d5) mRNA steady state levels as there were no significant differences among dietary 
treatments. An explanation could be the influence of EPA and DHA on the gene expression. 
By the time of final sampling, liver EPA and DHA levels were significantly higher in fish fed with 
the A66 and A100 diets compared to livers of fish fed with the diet FV. A negative feedback 
loop of LC-PUFA on the expression of genes centrally involved in the biosynthesis of these 
fatty acids has been reported in zebrafish [63]. In addition, Greene and Selivonchick [64] 
assume that rainbow trout might have a physiologically optimum level of EPA. As EPA fillet 
levels were highest in fish fed with A66 and A100 by the time of sampling, they may have 
reached a physiological optimum level of this fatty acid. This factor combined with the high 
levels of EPA and DHA in the livers of the A66 and A100 fed fish might have led to a 
downregulation of the fads2b(d5) mRNA expression, resulting in similar values among dietary 
treatments.  
Carnitine palmitoyl transferase (CPT1) is centrally involved in the mitochondrial β-oxidation. 
Two of its isoforms are CPT1a and CPT1c. They are important for the uptake of long-chain 
fatty acids into mitochondria [65]. The A100 diet had the lowest monounsaturated fatty acid 
and highest ALA content of all diets. However, this was not reflected to the same extend in 
terms of the fillet fatty acid composition of fish fed with A100. Previous studies indicated that 
when certain fatty acids are provided at high dietary amounts, for example ALA in A66 and 
A100, they can be readily metabolized and catabolized by β-oxidation [44]. Thus, we expected 
that increasing levels of Ahiflower oil result in increased β-oxidation of ALA. However, mRNA 
levels of cpt1a remained largely unaffected by the dietary treatments but cpt1c was significantly 
downregulated in A66 and A100. Therefore, it remains unclear why cpt1a/c, as an indicator for 
β-oxidation, was either unaffected or decreased in response to the dietary treatment, 
respectively.  
Dietary inclusion of Ahiflower oil increases the content of ALA and SDA in fillet of rainbow trout. 
Simultaneously, the content of dietary 18:2n-6 decreases in a stepwise-manner (FV > A33 > 
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A66 > A100). This results in an increased n-3:n-6 ratio in fillet of rainbow trout, which could be 
also relevant in terms of human nutrition. Consumption of food rich in n-3 PUFA may decrease 
the risk of certain chronic diseases in humans [66,67] and it might have a protective effect on 
some forms of cancer, for example breast and prostate cancer [68,69]. Thus, present data 
support the hypothesis that the inclusion of dietary Ahiflower oil may improve the product 
quality of rainbow trout fillet for human consumption.  
In conclusion, data of the present study suggest that Ahiflower oil can be included up to 100% 
into rainbow trout diets. Further, it does not alter body composition but increases growth of 
rainbow trout. It seems that the inclusion of Ahiflower oil enhances n-3 LC-PUFA synthesis. 
Furthermore, the content of DHA in fillet of fish fed with Ahiflower oil was similar to fish fed with 
FV possibly due to a preferential retention and/or biosynthesis of this fatty acid. Increasing 
dietary SDA did not alter gene expression of fads2b(d5), fads2a(d6) and cpt1a. However, cpt1c 
was downregulated in A66 and A100. The utilization of Ahiflower oil increased the n-3:n-6 ratio 
in fillet dose-dependently toward a more favorable ratio for human nutrition. Overall, Ahiflower 
oil seems a promising candidate to substitute fish oil (and other vegetable oils) in rainbow trout 
diets. Future studies may use smaller trout and expand the duration of the experimental period 
to investigate if and to what extend DHA tissue levels are modulated by Ahiflower oil and 
whether there are any long-term effects on fish growth. Furthermore, the influence of Ahiflower 
oil inclusion into rainbow trout diets on sensory and shelf life needs to be investigated in future 
studies. 
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Abstract 
Equol and Ahiflower oil have been shown to increase either eicosapentaenoic acid (20:5n-3, 
EPA) or docosahexaenoic acid (22:6n-3, DHA) levels in tissues of rainbow trout when applied 
individually. Thus, we investigated whether the combination of an Ahiflower oil-based diet and 
equol might increase both, EPA and DHA levels, in rainbow trout. Rainbow trout (87.1 ± 0.3 g) 
were fed five diets for eight weeks. A diet based on a blend of fish and vegetable oils (FV) 
served as a reference diet. The four experimental diets contained a blend of Ahiflower oil and 
vegetable oils (AV). The AV-diets were supplemented with equol by 0.0, 0.1, 0.2 and 0.3% DM 
of the diet (AV-C, AV-EQ1, AV-EQ2, AV-EQ3). The dietary treatments did not affect growth 
performance of fish and chemical nutrient composition of whole body samples. Fish fed with 
the equol diets showed dose-dependently increased liver weights and 18:0 liver levels. The 
content of EPA showed no consistent pattern between tissues but all AV-groups were 
characterized by higher liver EPA values than FV. DHA values of AV-EQ2 and AV-EQ3 were 
similar to FV in fillet, tended to be highest in whole body and were significantly higher in liver 
compared to FV. In contrast, mRNA steady state levels of fatty acyl desaturase 2a (delta-6) 
(fads2a(d6)) were not affected by the dietary treatments. In conclusion, the combination of 
dietary Ahiflower oil and equol (0.2 and 0.3%) seem to affect the fatty acid metabolism of 
rainbow trout positively in order to increase DHA tissue levels. 
 
Keywords: Rainbow trout, Ahiflower oil, Equol, Oil Replacement, Fatty acid metabolism, long-
chain polyunsaturated fatty acids (LC-PUFA)  
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Introduction  
More than 50% of fish and aquatic plants for human consumption worldwide is supplied by 
aquaculture [1]. One of the most cultured salmonids is rainbow trout (Oncorhynchus mykiss) 
[1] and farming this carnivorous fish species was responsible for a large use of fish oil [2,3]. 
During the last decades, fish oil production remained on a stable level [4] while aquaculture 
production increased rapidly [5]. As a result, plant oils were considered the primary alternative 
to fish oil, leading to a gradual substitution of this ingredient in fish feed [2,6]. This shift in feed 
formulations had several advantages since plant oils are economically reasonable, easily 
available and devoid of harmful levels of dioxins and PCBs [7]. Further, many studies showed 
that dietary plant oils had little or no negative effect on growth and performance parameters in 
rainbow trout [8,9]. However, most plant oils exclusively contain α-linolenic acid (18:3n-3, ALA) 
as an omega-3 fatty acid (n-3) and are deficient in n-3 long-chain polyunsaturated fatty acids 
(LC-PUFA) [10]. Salmonids are able to synthesize eicosapentaenoic acid (20:5n-3, EPA) and 
docosahexaenoic acid (22:6n-3, DHA) out of the precursor fatty acid ALA endogenously [11]. 
However, the utilization of dietary plant oils results in an adverse modification of the final 
content of these health-promoting n-3 LC-PUFA in fish [9,12,13]. A study on farmed Atlantic 
salmon showed that due to this shift, humans nowadays need to consume double the amount 
of salmon to meet the recommended EPA and DHA intake levels [14]. There are currently no 
plant oils available that can be considered as equivalent alternative to fish oil in terms of the 
fatty acid composition [15].  
Ahiflower oil is derived from the plant Buglossoides arvenis and characterized by high amounts 
of stearidonic acid (SDA, 18:4n-3) [16]. Dietary SDA has been shown to be more readily 
bionconverted to n-3 LC-PUFA than ALA in humans and rainbow trout [17–19]. In our previous 
study, we showed that dietary Ahiflower oil significantly increased the content of EPA in livers 
and fillets of rainbow trout in comparison to fish fed a diet based on a fish and vegetable oil 
blend [20]. This effect was putatively due to bypassing the first step in the biosynthesis of LC-
PUFA. However, DHA fillet levels were not increased in these treatments.  
Equol is a metabolite of the phytoestrogen daidzein and synthesized by the intestinal bacterial 
metabolism in animals and humans [21,22]. Due to its similar chemical structure to estradiol it 
was shown to exert estrogenic effects in rainbow trout [23]. This could be an important 
characteristic, since genes involved in the biosynthesis of LC-PUFA such as the delta-6 
desaturase and peroxisome proliferator-activated receptor alpha (PPARα) seem to be 
responsive to and activated by estrogen, respectively [24–26]. In our previous study, equol 
significantly increased DHA levels in whole body homogenates of rainbow trout [27]. However, 
no positive effect of equol on EPA tissue levels was found in this study. 
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Thus, in presented study we investigated, whether the combination of an Ahiflower oil-based 
diet and equol supplementation might increase both, EPA and DHA levels in rainbow trout and 
involved hepatic fatty acyl desaturase 2a delta-6 (fads2a(d6)) mRNA steady state levels.  
Materials and Methods 
Animals and experimental setup 
The feeding trial was conducted at the facilities of the Gesellschaft für Marine Aquakultur mbH 
(GMA, Büsum, Germany) with monosex female rainbow trout obtained from a German fish 
farm (Forellenzucht Trostadt GbR, Germany). Fish were randomly distributed among the tanks 
of the recirculating aquaculture system (RAS, 20 m3, turnover rate 2.4 h-1, technical oxygen 
supply via oxygen cone) to acclimatize to the experimental conditions for two weeks. During 
this period, rainbow trout were fed on a commercial fish feed (AllerGold, 3 mm, AllerAqua) and 
a light/dark (14 h/10 h) cycle was adapted. Water purification system of the RAS contained 
drum filter (mesh size 20 µm), biofilter, ultraviolet (UV) disinfection and protein skimmer with 
ozone. At the start of the experiment, a total of 300 rainbow trout juveniles (87.1 ± 0.3 g initial 
body weight) were weighed individually and randomly distributed among 15 tanks of the RAS 
system. Each tank with a volume of 150 L was equally stocked with 20 fish (total initial biomass 
1741.7 ± 6.5 g). The dietary treatments were randomly distributed in triplicates and the diets 
were hand-fed once per day for eight weeks. Each tank was bulk-weighed every 14 days to 
adjust the daily feed intake (DFI) level at 1.6% of biomass. The water parameters were in range 
for rainbow trout: temperature (14.8 ± 0.5 °C), oxygen (12.0 ± 0.2 mg L-1 O2) and pH (7.5) were 
monitored continuously via probes. NH4+ (0.3 ± 0.2 mg L-1), NO2- (0.7 ± 0.3 mg L-1) (Microquant 
test kit for NH4+ and NO2-; Merck KGaA, Darmstadt, Germany) and salinity (4.2 ± 0.7 ‰) were 
measured daily. The experiment was carried out according to the national regulations for 
animal welfare (TierSchVersV) and the EU Directive 2010/63/EU for animal experiments. 
Furthermore, it was approved by the Ministry of Energy, Agriculture, the Environment, Nature 
and Digitalization (MELUND, Kiel, Germany; approved on 18 October 2017, project number 
V241-37421/2017). 
Experimental diets 
Fish were fed five diets with the same ingredient composition, differing only in their oil sources 
and the supplementation of equol. Thus, all diets were isonitrogenous and isoenergetic  
(Table 4-1). A fish and vegetable oil based diet served as a reference diet (FV). The four 
experimental diets contained a blend of Ahiflower oil and vegetable oils (AV). Three AV-diets 
were supplemented with equol by 0.1, 0.2 and 0.3% DM of the diet (AV-EQ1, AV-EQ2, AV-
EQ3) in exchange with the respective amount of the filler ingredient bentonite. AV without 
supplementation served as negative control diet (AV-C).  
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Table 4-1. Ingredients and nutrient composition (in % of dry matter (DM)) of the 
experimental diets FV, AV-C, AV-EQ1, AV-EQ2 and AV-EQ3. 
Diet FV AV-C AV-EQ1 AV-EQ2 AV-EQ3 
Ingredients [% DM]      
Fish meal a 15.0 15.0 15.0 15.0 15.0 
Blood meal b 5.0 5.0 5.0 5.0 5.0 
Feather meal c 5.5 5.5 5.5 5.5 5.5 
Pea protein isolate d 12.0 12.0 12.0 12.0 12.0 
Soy protein concentrate e 5.0 5.0 5.0 5.0 5.0 
Wheat gluten f 14.0 14.0 14.0 14.0 14.0 
Wheat starch f 22.0 22.0 22.0 22.0 22.0 
Oil sources 11.5 11.5 11.5 11.5 11.5 
Fish oil g 5.0 - - - - 
Rapeseed oil h 0.2 0.8 0.8 0.8 0.8 
Linseed oil i 4.0 - - - - 
Palm fat j 0.5 4.4 4.4 4.4 4.4 
Sunflower oil h 1.8 2.5 2.5 2.5 2.5 
Ahiflower oil k - 3.8 3.8 3.8 3.8 
Gelatin l 1.5 1.5 1.5 1.5 1.5 
Vitamin Mineral premix m 1.0 1.0 1.0 1.0 1.0 
Calcium hydrogen phosphate n 0.5 0.5 0.5 0.5 0.5 
α-Cellulose o 2.8 2.8 2.8 2.8 2.8 
Lysine p 0.7 0.7 0.7 0.7 0.7 
Methionine q 0.1 0.1 0.1 0.1 0.1 
Bentonite r 3.4 3.4 3.3 3.2 3.1 
Equol s - - 0.1 0.2 0.3 
      
Nutrient composition [% DM]      
Dry matter [in % of diet] 86.3 87.7 87.3 87.3 87.2 
Crude protein 52.0 51.5 51.0 51.0 51.8 
Crude lipid 16.1 16.1 15.8 16.0 16.0 
Crude ash 6.2 6.2 5.1 4.7 4.6 
Total COH [in % DM] t 25.7 26.1 28.1 28.3 27.6 
Gross energy [MJ/kg DM] 23.1 23.0 23.1 22.9 23.1 
a Lean fish meal “low ash”, Bioceval GmbH & Co. KG, Cuxhaven, Germany; b Daka porcine bloodmeal, Daka 
Denmark A/S, Løsning, Denmark; c GePro Goldmehl, GePro Geflügel-Protein Vertriebsgesellschaft mbH & Co. KG, 
Diepholz, Germany; d Emsland-Stärke GmbH, Emlichheim, Germany; e Euroduna Food Ingredients GmbH, 
Barmstedt, Germany; f KRÖNER STÄRKE GmbH, Ibbenbüren, Germany; g Bioceval GmbH & Co. KG, Cuxhaven, 
Germany; h Food store, Büsum, Germany; i Makana Produktion und Vertrieb GmbH, Offenbach a.d. Queich, 
Germany; j DF 100 PT-PV; EFG Elbe Fetthandel GmbH, Geesthacht, Germany; k Nature’s Crops International, 
Kensington, Canada; l Gustav Ehlert GmbH & Co. KG, Verl, Germany; m Emsland-Aller Aqua GmbH, Golßen, 
Germany; n JRS Pharma GmbH & Co. KG, Rosenberg, Germany; o Mikro-Technik GmbH & Co. KG, Bürgstadt am 
Main, Germany; p Biolys, Evonik Industries AG, Essen, Germany; q MetAmino, Evonik Industries AG, Essen, 
Germany; r Castiglioni Pes y Cía, Buenos Aires, Argentina; s Equol: Cas No: 531-95-3, Xi’an Natural Field Bio-
Technique Co., LTD, Xi’an Shaanxi, China; t Total COH = 100 – (crude protein + crude lipid + crude ash) 
The fatty acid composition of the experimental diets is shown in Table 4-2. All diets were 
formulated to meet the dietary ALA requirement (0.7-1.0% of dry diet) of rainbow trout [10]. 
Further, in contrast to the FV diet, all AV-diets were below the recommended dietary EPA and 
DHA levels for this species (0.4-0.5% of dry diet, [10]). Dietary content of amino acids was 
calculated based on the amino acid contents of single ingredients in order to meet the amino 
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acid requirements of rainbow trout [10]. Pellets (4 mm diameter, 6 mm length) were produced 
with a pelleting machine (Type 14U175, Amandus Kahl, Hamburg). 
Table 4-2. Fatty acid composition (in mole%) of the experimental diets FV, AV-C, AV-
EQ1, AV-EQ2 and AV-EQ3.  
  FV AV-C AV-EQ1 AV-EQ2 AV-EQ3 
14:0 1.2 0.7 0.7 0.7 0.7 
16:0 13.1 30.5 30.3 30.1 30.4 
18:0 3.4 3.4 3.4 3.5 3.5 
Total SFA 18.5 35.3 35.1 35.0 35.3 
16:1 1.3 0.3 0.3 0.3 0.3 
18:1 27.8 19.3 19.2 19.3 19.3 
Total MUFA 33.9 21.5 21.5 21.7 21.6 
n-6           
18:2n-6 24.9 23.1 23.1 23.1 23.1 
18:3n-6 tra 1.3 1.3 1.3 1.3 
20:4n-6 0.2 tr tr tr tr 
n-3           
18:3n-3 17.2 12.4 12.7 12.4 12.4 
18:4n-3 0.3 4.4 4.5 4.4 4.4 
20:5n-3 1.3 0.5 0.5 0.6 0.5 
22:6n-3 2.0 0.9 0.9 1.0 0.9 
Total PUFA 47.0 42.6 43.0 42.7 42.6 
ALA [% DM] b 2.6 1.9 1.9 1.9 1.9 
EPA+DHA [% DM] b 0.6 0.2 0.2 0.2 0.2 
a tr = traces (values < 0.1); b calculated from the FAME percentage data and the lipid content in the diets (in % DM), 
assuming 93% of total lipid to be fatty acids. 
Sample collection 
For the determination of growth performance parameters, all fish of a tank were bulk weighed 
at the beginning and the end of the 56 days-feeding period following 72 h of starvation. Feed 
conversion ratio (FCR), specific growth rate (SGR), protein efficiency ratio (PER) and protein 
retention efficiency (PRE) were calculated following the equations in Table 4-4. Acclimated 
residual fish were used to determine the initial status prior the start of the experiment. 
Physiological parameters are putatively sensitive and might be altered due to an extended 
starvation time. Thus, after the final bulk weighing, fish were re-fed their respective 
experimental diets for two additional days followed by the final sampling. The initial and final 
sampling were both performed following the same procedure: Prior to the sampling, fish were 
starved for 24 h, anesthetized and killed by a sharp blow on the head. Weight and length of all 
sampled fish was measured to calculate Fulton condition factor (K, Table 4-4). A pool sample 
of three fish per tank (initial: three fish) was used for the determination of the fatty acid and 
nutrient composition of whole body homogenates and stored at -20°C. Additionally, five fish 
(initial sampling: eight fish) per tank were sacrificed for pool samples of fillets and individual 
samples of spleen and liver. Pool samples of fillets were stored at -20°C. Spleen and liver 
weight was measured for calculation of spleen and hepatosomatic index (SSI and HSI). 
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Afterwards, a part of the liver was placed immediately into RNA later (Merck KGaA, Darmstadt, 
Germany) for the mRNA quantification of fads2a(d6) via quantitative real-time reverse 
transcription polymerase chain reaction (qRT-PCR). These samples were stored on ice during 
the sampling of each tank, followed by an overnight incubation at 4°C and finally stored at  
-20°C. The residual liver tissue of each tank was pool sampled and stored at  
-80°C. Prior to the analyses, whole body and fillet samples were freeze dried (alpha 1-4 LSC; 
Martin Christ Gefriertrocknungsanlagen GmbH, Osterode am Harz, Germany) and 
homogenized with a knife mill (Grindomix, Retsch, Haan, Germany). 
Chemical analysis 
The proximate nutrient analysis and the determination of the energy content of diet, fillet and 
whole body homogenate samples were realized at the laboratory of the Gesellschaft für Marine 
Aquakultur mbH in Büsum, Germany. The proximate nutrient composition included dry matter 
(DM), crude ash, crude lipid and crude protein and was performed according to the EU 
guideline (EC) 152/2009 [28]. Samples were kept in a drying oven (ED53 9010-0078; Binder 
GmbH, Tuttlingen, Germany) at 103°C until constant weight to determine DM, following a four-
hour incineration in a muffle furnace (LE 6/11/P300; Nabertherm, Lilienthal, Germany) at 
560°C for determining the crude ash content. Crude lipid content was analyzed according to 
the Soxhlet method. Samples were hydrolyzed with hydrochloric acid (HYDROTHERM HT 6; 
C. Gerhardt GmbH & Co. KG, Königswinter, Germany) and lipids were extracted using 
petroleum ether (SOXTHERM® 416, Multistat/SX PC; C. Gerhardt GmbH & Co. KG, 
Königswinter, Germany). Crude protein (N x 6.25) was determined according to the methods 
of Kjeldahl including digestion, distillation (KjelDigester K-449, Scrubber K-415, KjelFlex 360; 
BÜCHI Labortechnik GmbH, Essen, Germany) and titration (877 Titrino plus; Deutsche 
METROHM GmbH & Co. KG, Filderstadt, Germany). Bomb calorimetry (C 200; IKA®-Werke 
GmbH & Co. KG, Staufen, Germany), calibrated with benzoic acid was used to measure the 
gross energy content.   
Fatty acid composition 
Fatty acid composition of oils, diets, liver, whole body homogenate and fillet samples was 
analyzed by LUFA-ITL GmbH in Kiel, Germany, using gas chromatography (GC) (Deutsche 
Gesellschaft für Fettwissenschaft e.V. (DGF), C-VI 10a). Fatty acid methyl ester (FAME) were 
prepared following the methods of Metcalfe and Schmitz [28], using saponification with 
methanolic NaOH and transmethylation of total lipids with boron trifluoride and methanol (DGF, 
C-VI 11a). The obtained FAME samples were separated by GC via split-injection (column: CP-
Sil 88 50 m x 0.25 mm x 0.2 µm or similar) and detected using a flame ionization detector (FID) 
with helium as a carrier gas. The individual FAME were identified by comparison with certified 
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standard mixtures (18919-1AMP Supelco, F.A.M.E. Mix, Sigma-Aldrich) and FAME values 
were converted to moles. Fatty acid composition data is reported as mole% of total fatty acids. 
RNA isolation and qRT-PCR 
The RNAlater-stabilized liver samples (approximately 15 mg) were homogenized in a 
TissueLyser II (Qiagen, Hilden, Germany). Further, total RNA of these samples was isolated 
(Innuprep RNA Mini Kit, Analytik Jena, Jena, Germany) in accordance to the manufacturer’s 
protocol. NanoDrop measurements (NanoDrop2000c; ThermoScientific, Waltham, MA, USA) 
were conducted in order to determine the RNA concentration and purity (ratios A260/280 and 
A260/230). Further, qRT-PCR measurements were carried out with the SensiFast SYBR No-
ROX One-Step Kit (Bioline, London, UK) and a Rotor-Gene 6000 real-time PCR cycler 
(Corbett/Qiagen) to quantify the mRNA steady state levels of the selected target genes. A 1000 
fold-diluted RNA sample was added by 18 µl to the Master Mix. The Master Mix consisted of 
22.5 µl 2x SensiFAST-Mix, 2.48 µl DEPC treated water, 0.90 µl RNase inhibitor, 0.40 µl reverse 
transcriptase and 0.36 µl of each primer. 20 µl of this mixture was used for the analysis for 
each of the duplicates. The cycling conditions were as follows: at 49°C for 30 min, at 95°C for 
10 min, 40 cycles of 95°C for 15 s, annealing temperature of the primer pair for 30 s and 72°C 
for 30 s, followed by a melt curve analysis from 60 to 99°C of 1°C increments. Sequences and 
the respective annealing temperatures of the primers are shown in Table 3. Relative mRNA 
concentrations were calculated using a standard curve. The mRNA steady state levels of the 
fads2a(d6) gene were normalized to the expression level of the housekeeping gene elongation 
factor 1 α (ef1α). This housekeeping gene was previously suggested as a gene reference in 
salmonid fish [30]. 
Table 4-3. Primer sequences (forward and reverse) and the respective annealing 
temperatures for mRNA measurements via qRT-PCR of samples from rainbow trout 
liver. 
Gene Primer Sequence 5’→ 3’ Annealing 
Temperature (°C) 
ef1α a,* F ACAAGCCCCTYCGTCTGCC 61 
ef1α a,* R GCATCTCCACAGACTTSACCTCAG 61 
fads2a(d6) b,* F GCTGGAGARGATGCCACGGA 61 
fads2a(d6) b,* R TGCCAGCTCTCCAATCAGCA 61 
a ef1α: Elongation factor 1 α; b fads2a(d6): fatty acyl desaturase 2a (delta-6); * Geay et al. [67]. 
Statistical analysis 
The data were evaluated using the statistical software R (2017), including the packages gdata, 
gplots, nlme, piecewiseSEM and multcomp. First of all, appropriate statistical models were 
defined: (1) statistical models based on general least squares [31] if values per tank were 
considered (final body weight (FBW), FCR, SGR, PER, PRE, DFI, nutrient and fatty acid 
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composition); (2) mixed models [32,33] with tank as random factor if values per fish (HSI, SSI, 
K, fads2a(d6)) were considered. The models included an artificial pseudo-influence factor 
(Treatment), representing a mixture of the actual factors diet, concentration and additive. This 
pseudo factor was necessary because the actual influence factors are not orthogonal (see 
[34]. The data were assumed to be normally distributed by a graphical residual analysis. 
Heteroscedasticity or homoscedasticity, respectively, was taken into account. A pseudo-R2 
was calculated, based on the model [35]. Further, in order to compare the dietary treatments, 
multiple contrast tests (e.g., see [36] were conducted.  
Results 
Growth performance and nutrient composition 
All fish showed a 2.3 to 2-4-fold increase of their initial body weight within the eight weeks of 
the feeding trial. Furthermore, no  significant differences among treatments for values of FBW, 
FCR, SGR, PER, PRE, SSI, K and DFI (Table 4-4) were found. However, liver weight of fish 
fed the diets AV-EQ2 and AV-EQ3 increased, resulting in significantly higher HSI values of 
these fish compared to HSI values of fish fed the other diets.  
Table 4-4. Growth performance, feed intake, feed efficiency and biometric parameters 
of rainbow trout fed with the experimental diets FV, AV-C, AV-EQ1, AV-EQ2 and AV-EQ3 
for eight weeks. 
  FV AV-C AV-EQ1 AV-EQ2 AV-EQ3 
IBW 1 87.1 ± 0.2 86.8 ± 0.3 87.2 ± 0.3 87.2 ± 0.3 87.1 ± 0.3 
FBW 2 210.3 ± 4.0 209.9 ± 3.4 209.2 ± 1.5 203.7 ± 2.4 203.3 ± 4.8 
FCR 3 1.02 ± 0.03 1.01 ± 0.02 1.03 ± 0.01 1.06 ± 0.01 1.05 ± 0.02 
SGR 4 1.57 ± 0.03 1.58 ± 0.03 1.56 ± 0.01 1.52 ± 0.02 1.51 ± 0.04 
PER 5 2.20 ± 0.06 2.19 ± 0.04 2.18 ± 0.01 2.12 ± 0.02 2.10 ± 0.04 
PRE 6 39.1 ± 0.7 39.1 ± 1.9 39.2 ± 0.6 38.1 ± 0.9 36.9 ± 1.1 
HSI 7 1.56 ± 0.21a 1.68 ± 0.19a 1.63 ± 0.18a 1.99 ± 0.29b 2.09 ± 0.41b 
SSI 8 0.12 ± 0.03 0.15 ± 0.05 0.16 ± 0.05 0.13 ± 0.04 0.14 ± 0.05 
K 9 1.38 ± 0.13 1.36 ± 0.11 1.37 ± 0.09 1.32 ± 0.09 1.35 ± 0.09 
Values (mean ± SD, IBW, FBW, FCR, SGR, PER, PRE: n = 3; HSI, SSI: n = 3 (5 fish/tank); K: n = 3 (8 fish/tank)) 
with different superscript letters within one row are significantly different (p < 0.05), values without superscript letters 
within one row are not significantly different (p ≥ 0.05) based on the statistical models described in Material and 
methods. 
1 Average initial body weight [g].  
2 Average final body weight [g].  
3 Feed conversion ratio = feed intake [g]/weight gain [g] [10].  
4 Specific growth rate [% d-1] = [ln (final body weight) – ln (initial body weight)]/feeding day x 100 [68].  
5 Protein efficiency ratio = weight gain [g]/protein intake [g] [69].  
6 Protein retention efficiency = 100 x {[(final body protein x final body weight) – (initial body protein x initial body 
weight)]/protein intake} [10].  
7 Hepatosomatic index = 100 x (liver weight [g]/body weight [g]) [70].  
8 Spleen somatic index = 100 x (spleen weight [g]/body weight [g]) [71].  
9 Fulton condition factor = 100 x (final body weight/final body length3) [68]. 
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Furthermore, in contrast to whole body homogenates (Table 4-5), the nutrient composition of 
fillets (Table 4-6) was affected by the dietary treatments. Fillets of fish fed the diet AV-EQ1 
showed significantly higher dry matter, crude protein and gross energy contents compared to 
fillets of fish fed the reference diet FV. Dry matter and crude protein contents of AV-EQ1 fed 
fish were also higher than in fillets of AV-EQ2 fed fish, whereas crude protein levels were 
similar to AV-EQ3 fed fish. Dry matter, crude protein and gross energy contents in fillets of fish 
fed the diets AV-C did not differ significantly.     
Table 4-5. Nutrient composition of whole body homogenate (in % wet weight (WW); 
gross energy in MJ/kg WW) of rainbow trout before the experiment (Initial) and after 
being fed the experimental diets FV, AV-C, AV-EQ1, AV-EQ2 and AV-EQ3 for eight 
weeks. 
 Initial FV AV-C AV-EQ1 AV-EQ2 AV-EQ3 
Moisture 72.9 69.2 ± 0.3 70.1 ± 0.7 69.6 ± 0.0 70.8 ± 1.2 69.9 ± 0.4 
Crude ash 2.8 2.1 ± 0.0 2.2 ± 0.2 2.1 ± 0.1 2.3 ± 0.2 2.1 ± 0.1 
Crude protein 16.4 17.2 ± 0.1 17.3 ± 0.4 17.3 ± 0.1 17.3 ± 0.3 17.1 ± 0.1 
Crude lipid 7.9 11.4 ± 0.2 10.5 ± 0.6 11.0 ± 0.2 9.6 ± 1.1 10.8 ± 0.4 
Gross energy [MJ/kg] 6.9 8.6 ± 0.1 8.4 ± 0.3 8.5 ± 0.1 8.0 ± 0.5 8.4 ± 0.1 
Values (mean ± SD, n = 3) without superscript letters within one row are not significantly different (p ≥ 0.05) based 
on the statistical models described in Material and methods. Initial data (n = 1, consisting of three fish) was not 
statistically analyzed. 
Table 4-6. Nutrient composition of fillets (in % wet weight (WW); gross energy in MJ/kg 
WW) of rainbow trout before the experiment (Initial) and after being fed the experimental 
diets FV, AV-C, AV-EQ1, AV-EQ2 and AV-EQ3 for eight weeks. 
 Initial FV AV-C AV-EQ1 AV-EQ2 AV-EQ3 
Moisture 77.6 74.2 ± 0.2a 73.9 ± 0.4ab 73.7 ± 0.1b 74.2 ± 0.1a 73.7 ± 0.2ab 
Crude ash 1.4 1.3 ± 0.0 1.3 ± 0.0 1.3 ± 0.0 1.3 ± 0.0 1.3 ± 0.0 
Crude protein 18.4 19.8 ± 0.1a 20.0 ± 0.1ab 20.2 ± 0.2b 19.9 ± 0.2ab 20.4 ± 0.1b 
Crude lipid 2.6 4.6 ± 0.1 4.8 ± 0.4 4.7 ± 0.2 4.5 ± 0.1 4.4 ± 0.1 
Gross energy [MJ/kg] 5.4 6.6 ± 0.1a 6.7 ± 0.1ab 6.7 ± 0.1b 6.6 ± 0.0a 6.7 ± 0.1ab 
Values (mean ± SD, n = 3; tank pool samples of fillets of five fish/tank) without superscript letters within one row 
are not significantly different (p ≥ 0.05) based on the statistical models described in Material and methods. Initial 
data (n = 1, consisting of fillets of eight fish) was not statistically analyzed. 
Liver fatty acid composition 
Saturated fatty acids (SFA) and monounsaturated fatty acids (MUFA) of livers of rainbow trout 
were affected by the supplementation of dietary equol supplementation (Table 4-7). 14:0, 16:1, 
18:1 and total MUFA levels decreased, whereas 18:0 increased significantly with increasing 
dietary concentrations of equol. For the 18:0 this effect was shown in a stepwise manner 
(FV=AV-C>AV-EQ1>AV-EQ2>AV-EQ3). A similar pattern can be found in the n-6 fatty acid 
levels: Linoleic acid was significantly lower in livers of fish fed the diets AV-EQ2 and AV-EQ3 
compared to the control diets (FV and AV-C). In contrast, liver levels of arachidonic acid (ARA, 
20:4n-6) almost doubled from FV to AV-EQ3 fed fish. All AV-fed fish had significantly lower 
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ALA, higher SDA (p < 0.05 for AV-C fed fish) and higher EPA (p < 0.05 for AV-C and AV-EQ1 
fed fish) liver levels compared to liver levels of fish fed the reference diet FV. In case of ALA, 
the levels decreased almost in a stepwise manner with AV-EQ3 fed fish showing the lowest 
ALA content. In addition, fish fed with the diets AV-EQ2 and AV-EQ3 showed significantly 
higher DHA levels in their livers compared to levels of fish fed with the diets FV and AV-C. This 
increase further resulted in significantly higher total PUFA and sum of EPA+DHA levels in 
livers of these fish compared to livers of fish fed the FV- and AV-C-diets.  
Table 4-7. Fatty acid composition (in mole%) of livers of rainbow trout before the 
experiment (Initial) and after being fed the experimental diets FV, AV-C, AV-EQ1, AV-
EQ2 and AV-EQ3 for eight weeks.  
 Initial FV AV-C AV-EQ1 AV-EQ2 AV-EQ3 
14:0 0.6 1.8 ± 0.2a 1.8 ± 0.2ab 1.4 ± 0.1bc 1.2 ± 0.1c 1.1 ± 0.1c 
16:0 18.6 22.5 ± 0.3 23.0 ± 0.6 22.7 ± 0.3 21.2 ± 0.7 21.0 ± 1.0 
18:0 5.8 7.1 ± 0.4a 7.0 ± 0.4a 8.5 ± 0.0b 10.2 ± 0.4c 10.9 ± 0.3c 
Total SFA 23.6 29.6 ± 0.1 29.7 ± 0.7 30.2 ± 0.3 30.2 ± 0.5 30.6 ± 1.0 
16:1 0.7 4.6 ± 0.4a 4.7 ± 0.5a 4.1 ± 0.3ab 3.8 ± 0.3ab 3.3 ± 0.2b 
18:1 19.6 22.5 ± 0.6a 21.0 ± 1.1a 17.6 ± 1.2b 16.5 ± 0.7b 16.2 ± 0.6b 
Total MUFA 23.7 31.8 ± 1.0a 29.8 ± 1.7a 25.7 ± 1.3b 24.9 ± 0.9b 24.1 ± 0.6b 
n-6       
18:2n-6 7.1 8.2 ± 0.3a 8.0 ± 0.3a 7.8 ± 0.6ab 6.9 ± 0.2b 6.8 ± 0.1b 
18:3n-6 0.1 0.2 ± 0.0a 0.3 ± 0.0b 0.3 ± 0.0ab 0.3 ± 0.0ab 0.2 ± 0.0ab 
20:4n-6 4.3 2.1 ± 0.2a 2.6 ± 0.5ab 3.1 ± 0.2abc 3.4 ± 0.5bc 3.9 ± 0.2c 
n-3       
18:3n-3 1.6 2.1 ± 0.1a 1.4 ± 0.2bc 1.4 ± 0.1b 1.1 ± 0.1cd 1.1 ± 0.1d 
18:4n-3 0.3 0.3 ± 0.0a 0.5 ± 0.0b 0.5 ± 0.0b 0.4 ± 0.0ab 0.4 ± 0.0ab 
20:5n-3 3.2 1.6 ± 0.1a 2.0 ± 0.1b 2.1 ± 0.2b 2.0 ± 0.1ab 2.0 ± 0.1ab 
22:6n-3 29.8 16.2 ± 0.4a 16.7 ± 0.7a 19.4 ± 1.6ab 20.4 ± 1.0b 20.7 ± 0.2b 
Total PUFA 50.0 35.8 ± 0.9a 37.6 ± 1.8ab 41.1 ± 1.6bc 41.8 ± 1.3(b)c 42.2 ± 0.5c 
EPA+DHA 33.0 17.8 ± 0.4a 18.7 ± 0.8ab 21.5 ± 1.7bc 22.4 ± 1.0c 22.7 ± 0.2c 
Values (mean ± SD, n = 3, consisting of livers from five fish each) with different superscript letters within one row 
are significantly different (p < 0.05), values without superscript letters within one row are not significantly different 
(p ≥ 0.05) based on the statistical models described in Materials and methods. Initial data (n = 1, consisting of eight 
livers) was not statistically analyzed. 
Whole body homogenate and fillet fatty acid composition 
The fatty acid composition of whole body homogenates (Table 4-8) and fillets (Table 4-9) 
showed a similar pattern for most fatty acids. Total SFA and MUFA levels were higher and 
lower, respectively, for samples of fish fed the AV-diets. This was mainly due to an increase in 
16:0 and a simultaneous decrease of 18:1 levels in the tissue samples of AV-fed fish. The 18:0 
and 18:1 fillet levels were further increased and decreased, respectively in combination with 
high equol inclusion levels (AV-EQ2 and AV-EQ3). Furthermore, linoleic acid, 18:3n-6 and ALA 
were significantly increased and SDA significantly decreased in fillets and whole body 
homogenates of fish fed the AV-diets in comparison to samples of fish fed the diet FV. EPA 
levels in whole body homogenates were not affected by the dietary treatment. In contrast, EPA 
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levels in fillets of fish fed the AV-EQ3 diet were significantly lower than FV but significantly 
higher than fillet levels of fish fed the other AV-diets. Moreover, DHA and total PUFA levels in 
whole body homogenates were significantly affected by the supplementation of high dietary 
equol dosages. Fish fed the AV-EQ2 and AV-EQ3 diets showed significantly increased DHA 
and total PUFA levels compared to the FV fed fish. However, there was no consistent pattern 
in fillets of fish. The significantly lowest DHA level was found in the fillets of fish fed AV-EQ1. 
In comparison, DHA levels in fillets tended (p = 0.063) to be higher in AV-EQ2 and were 
significantly higher in AV-EQ3 fed fish, respectively compared to AV-EQ1 fed fish. DHA levels 
of fish fed the diet FV showed similar DHA levels as AV-EQ3 fed fish. Further, DHA fillet levels 
of fish fed the diet AV-C were in between levels of fish fed the diets AV-EQ1 and AV-EQ3. In 
contrast, significantly higher total PUFA levels were found for fish fed AV-EQ2 compared to 
fish fed the diet FV. 
Table 4-8. Fatty acid composition (in mole%) of whole body homogenate of rainbow 
trout before the experiment (Initial) and after being fed the experimental diets FV, AV-C, 
AV-EQ1, AV-EQ2 and AV-EQ3 for eight weeks.  
  Initial FV AV-C AV-EQ1 AV-EQ2 AV-EQ3 
14:0 1.7 1.8 ± 0.1a 1.4 ± 0.1bc 1.6 ± 0.0b 1.4 ± 0.1bc 1.3 ± 0.1c 
16:0 10.5 15.3 ± 0.1a 17.2 ± 0.4bc 17.7 ± 0.3b 17.0 ± 0.2c 17.5 ± 0.4bc 
18:0 2.7 3.9 ± 0.1 3.8 ± 0.1 3.8 ± 0.1 3.8 ± 0.1 4.0 ± 0.2 
Total SFA 15.6 21.7 ± 0.2a 22.8 ± 0.6ab 23.5 ± 0.3b 22.7 ± 0.3b 23.3 ± 0.5b 
16:1 2.0 4.4 ± 0.2ab 4.4 ± 0.2ab 4.9 ± 0.2b 3.6 ± 0.2a 4.1 ± 0.4a 
18:1 39.6 36.9 ± 0.9a 34.5 ± 1.0a 33.6 ± 0.2b 33.7 ± 0.9b 33.3 ± 0.2b 
Total MUFA 44.4 43.2 ± 0.8a 43.6 ± 1.0b 43.1 ± 0.3b 42.3 ± 0.8b 42.3 ± 0.6b 
n-6       
18:2n-6 15.1 16.2 ± 0.1a 16.8 ± 0.2b 16.6 ± 0.1b 17.4 ± 0.1c 17.0 ± 0.4abc 
18:3n-6 0.4 0.4 ± 0.0a 0.9 ± 0.0bc 1.0 ± 0.0b 0.9 ± 0.0bc 0.8 ± 0.0c 
20:4n-6 0.5 0.3 ± 0.1a 0.4 ± 0.1ab 0.4 ± 0.0ab 0.5 ± 0.0b 0.4 ± 0.1ab 
n-3       
18:3n-3 4.3 7.3 ± 0.3a 6.3 ± 0.1b 6.3 ± 0.1b 6.5 ± 0.3b 6.3 ± 0.2b 
18:4n-3 0.9 1.0 ± 0.1a 2.4 ± 0.1b 2.3 ± 0.1bc 2.1 ± 0.1bc 2.0 ± 0.0c 
20:5n-3 1.1 0.7 ± 0.1 0.8 ± 0.0 0.7 ± 0.0 0.8 ± 0.0 0.7 ± 0.0 
22:6n-3 5.2 2.9 ± 0.5a 3.3 ± 0.2ab 3.2 ± 0.1ab 3.8 ± 0.2b 3.7 ± 0.1(b) 
Total PUFA 29.6 30.8 ± 1.2a 32.9 ± 0.5(b) 32.7 ± 0.2ab 34.2 ± 0.5b 33.6 ± 0.6b 
EPA+DHA 6.4 3.6 ± 0.6 4.1 ± 0.2 4.0 ± 0.2 4.6 ± 0.3 4.4 ± 0.1 
Values (mean ± SD, n = 3, consisting of three fish each) with different superscript letters within one row are 
significantly different (p < 0.05), values without superscript letters within one row are not significantly different (p ≥ 
0.05) based on the statistical models described in Materials and methods. Initial data (n = 1, consisting of three fish) 
was not statistically analyzed. 
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Table 4-9. Fatty acid composition (in mole%) of fillet of rainbow trout before the 
experiment (Initial) and after being fed the experimental diets FV, AV-C, AV-EQ1, AV-
EQ2 and AV-EQ3 for eight weeks.  
  Initial FV AV-C AV-EQ1 AV-EQ2 AV-EQ3 
14:0 1.5 1.7 ± 0.1a 1.4 ± 0.0b 1.4 ± 0.0b 1.4 ± 0.1b 1.3 ± 0.0c 
16:0 11.3 15.8 ± 0.3a 17.9 ± 0.4b 18.2 ± 0.1b 18.6 ± 0.3b 18.6 ± 0.2b 
18:0 2.9 3.7 ± 0.1a 3.8 ± 0.1a 3.7 ± 0.1a 4.0 ± 0.1b 4.0 ± 0.0b 
Total SFA 16.3 21.8 ± 0.4a  23.6 ± 0.5b 23.8 ± 0.0b 24.4 ± 0.4b 24.4 ± 0.2b 
16:1 1.7 4.3 ± 0.1 4.3 ± 0.2 4.3 ± 0.1 4.1 ± 0.3 4.0 ± 0.2 
18:1 39.6 33.6 ± 0.6a 32.1 ± 0.7ab 31.1 ± 0.6bc 30.3 ± 0.2c 30.5 ± 0.1c 
Total MUFA 48.7 43.2 ± 0.8a 40.4 ± 0.9b 39.9 ± 0.8b 38.9 ± 0.1b 38.8 ± 0.2b 
n-6       
18:2n-6 14.3 15.6 ± 0.1a 16.5 ± 0.1b 16.7 ± 0.3b 16.6 ± 0.2b 16.7 ± 0.2b 
18:3n-6 0.3 0.4 ± 0.0a 0.9 ± 0.0b 0.9 ± 0.1b 0.8 ± 0.0b 0.8 ± 0.0b 
20:4n-6 0.8 0.5 ± 0.0 0.5 ± 0.1 0.5 ± 0.0 0.6 ± 0.0 0.6 ± 0.0 
n-3       
18:3n-3 4.2 7.5 ± 0.1a 6.3 ± 0.0b 6.5 ± 0.2b 6.4 ± 0.1b 6.5 ± 0.2b 
18:4n-3 0.7 1.1 ± 0.0a 2.4 ± 0.2b 2.2 ± 0.2b 2.2 ± 0.0b 2.2 ± 0.0b 
20:5n-3 1.5 1.1 ± 0.1a 0.6 ± 0.0b 0.5 ± 0.1b 0.6 ± 0.0b 0.9 ± 0.0c 
22:6n-3 10.5 5.8 ± 0.5ab 5.4 ± 0.2ab 5.3 ± 0.0b 5.7 ± 0.2(a) 5.8 ± 0.1a 
Total PUFA 34.6 34.3 ± 0.6a 35.2 ± 0.4ab 35.6 ± 0.8ab 36.0 ± 0.4b 36.0 ± 0.3(b) 
EPA+DHA 12.0 6.9 ± 0.6abc 6.0 ± 0.2bc 5.8 ± 0.1c 6.3 ± 0.1ab 6.7 ± 0.2a 
Values (mean ± SD, n = 3, consisting of fillets from five fish each) with different superscript letters within one row 
are significantly different (p < 0.05), values without superscript letters within one row are not significantly different 
(p ≥ 0.05) based on the statistical models described in Materials and methods. Initial data (n = 1, consisting of eight 
fillets) was not statistically analyzed. 
Hepatic mRNA steady state levels 
Hepatic fads2a(d6) mRNA steady state levels showed no significant differences among dietary 
treatments (Fig. 4-1). 
 
Fig. 4-1 Hepatic mRNA steady state levels. Rainbow trout were fed the experimental diets FV, AV-C, 
AV-EQ1, AV-EQ2 and AV-EQ3. Presented are boxplots of relative liver mRNA levels of fatty acyl 
desaturase 2a delta-6 (fads2a(d6)). Liver mRNA gene expression was determined by qRT-PCR analysis 
and normalized to the housekeeping gene ef1α. Boxes represent values between the 25th and the 75th 
percentile; whiskers indicate 1.5 SD; medians are indicated by solid lines; outliers (above/below 1.5 SD) 
are indicated by solid circles. At the end of the experiment, 15 individuals per treatment were sampled 
in total (n = 15). Statistical analyses was conducted based on the statistical models described in 
Materials and Methods.  
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Discussion 
Effects of dietary treatments on growth performance and nutrient composition 
All fish showed a 2.3 to 2-4-fold increase of their initial body weight within the eight weeks of 
the feeding trial without significant differences among treatments. Further, the growth 
parameters of fish in the present study can be considered as reasonable for rainbow trout at 
this size. FCR and SGR values in the present study were lower (FCR) and similar or higher 
(SGR) than values reported in experiments with rainbow trout of the same size [13,37]. The 
levels of EPA and DHA in the AV-diets in the present study were below the recommended 
dietary levels for rainbow trout [10]. However, rainbow trout are able to compensate low dietary 
EPA and DHA levels via the endogenous biosynthesis [11]. Thus, it seems that the fatty acids 
ALA and SDA of the AV-diets served as a substrate for the biosynthesis of EPA and DHA 
without impairing fish growth. This is in line with findings of our previous study using different 
inclusion levels of Ahiflower oil in rainbow trout diets [20]. Furthermore, the results of the 
present study also confirm our previous study that equol (0.1-0.3% of DM in the diet) combined 
with vegetable oil based-diets did not impair the growth of rainbow trout [27]. In contrast, other 
studies using bioactive substances such as genistein and resveratrol found reduced growth 
rates in fish [37,38]. This reduction was often related to a decrease in feed intake. A possible 
explanation could be the bitter taste of these secondary plant compounds as suggested by 
Torno et al. [39]. Equol is a metabolite of soybean originated isoflavone daidzein [40]. It has 
been described as more bitter than most of the isoflavones in soybeans [41]. In the present 
study, fish were fed on a fixed feeding ratio of 1.6% of biomass per day. Therefore, we can not 
fully exclude that equol might negatively affect feed intake and thus, growth, when included at 
higher dietary dosages and fed at higher daily feeding ratios.  
PER and PRE values as well as the nutrient composition of whole body homogenates were 
not affected by the dietary treatment. This is in accordance to the results obtained in our 
previous study [27]. Thus, it seems that neither the dietary oil composition nor the 
supplementation of equol affected these performance parameters negatively in the present 
study. However, fillets of fish fed the diet AV-EQ1 showed significantly higher dry matter, crude 
protein and gross energy contents compared to fillets of fish fed the reference diet FV. The 
slight increase in dry matter and energy content is obviously due to the increase in crude 
protein. This increase in protein was only marginal and thus, did not alter the nutrient 
composition of whole body homogenates. Contrasting our findings, equol has been shown to 
reduce the protein synthesis rates in rainbow trout myocyte cells [42]. However, fillet protein 
levels were not decreased by dietary equol in the present study. Thus, further investigations 
about the effects on equol on protein metabolism are warranted. 
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Effects on LC-PUFA tissue levels 
The replacement of the fish and vegetable oil blend (FV) with the blend of Ahiflower and 
vegetable oils (AV) altered the tissue fatty acid composition of rainbow trout in the current 
study. The AV-diets were characterized by lower EPA and DHA contents. However, DHA 
tissue levels were similar or even higher in AV-EQ2 and AV-EQ3 fed fish in comparison to 
levels of fish fed the diet FV. Further, EPA levels were increased in the livers of AV-fed fish. 
This is contrasting the findings of many studies, showing that the substitution of fish oil by 
vegetable oils decreases the EPA and DHA tissue levels in salmonids [43–45].  
Specifically, the EPA and DHA liver levels were affected by the dietary treatments. The 
increased EPA levels in livers of fish fed the AV-diets are in accordance with results of our 
previous study using Ahiflower oil in rainbow trout diets [20]. We assumed that high amounts 
of dietary SDA could bypass the initial delta-6 desaturation step from ALA to SDA and thereby 
increase the levels of EPA. Thus, the high amount of SDA in the AV-diets seems to increase 
the efficiency of the biosynthesis of EPA. As there is no further increase of EPA when equol 
was added to the diet, it possibly does not have a direct effect on EPA tissue levels. In contrast, 
DHA levels were significantly increased in the AV-EQ2 and AV-EQ3 fed fish in comparison to 
livers of fish fed the control diets FV and AV-C. According to literature, the biosynthesis of DHA 
is increased in salmonids fed plant based diets [12,46,47]. However, fish do not achieve LC-
PUFA levels of fish fed fish oil based diets [43]. As the liver DHA levels of AV-EQ2 and AV-
EQ3 fed fish in the present study even exceeded those of fish fed the diets FV and AV-C, it 
seems very likely that the efficiency of the biosynthesis was markedly increased in these fish. 
The biosynthesis of DHA requires inter alia a delta-6 desaturation from 24:5n-3 to 24:6n-3 [48]. 
The delta-6 desaturase has been shown to be responsive to estrogen and its expression was 
increased in the livers of ovariectomized rats treated with estradiol [25]. In the same study, this 
increased expression putatively increased DHA levels in plasma and liver of these animals. 
Equol exhibited an estrogenic potency in rainbow trout hepatocytes [23]. Thus, we 
hypothesized that equol would increase DHA levels in rainbow trout by increasing the 
expression of the delta-6 desaturase. In addition, phytoestrogens increased the expression of 
the gene srebp1 in rainbow trout liver [49]. Schiller Vestergren et al. [50] assumed that srebp 
mediates the expression of genes involved in the biosynthesis of DHA, such as the delta-6 
desaturase. Contrasting these assumptions, the mRNA steady state levels of fads2a(d6) were 
not affected by the dietary treatments. Fish were deprived of feed for 24 hours before the final 
sampling. Schiller Vestergren et al. [51] assume that the mRNA turnover might  promptly 
respond to dietary alterations leading to constantly fluctuating mRNA levels. In addition, the 
highest hepatic DHA levels were found in fish fed the diets AV-EQ2 and AV-EQ3. Increased 
LC-PUFA levels decreased the expression of the delta-6 desaturase in zebra fish [52]. Thus, 
a negative feedback loop of DHA could have decreased the expression of fads2a(d6) in the 
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presented study. These factors might have affected the fads2a(d6) mRNA levels, leading to 
similar values among treatments.  
However, there might be other mechanisms increasing DHA levels in fish fed the diets AV-
EQ2 and AV-EQ3. PPARα is a transcription factor centrally involved in the peroxisomal β-
oxidation [53], the synthesis step leading to DHA [54]. Kitson et al. [24] assume that estradiol 
might affect PPARα indirectly. Estrogen binds to the estrogen receptor alpha (ERα) and 
thereby may activate extracellular receptor kinase-mitogen activated protein kinase (ERK-
MAPK). Thus, the phosphorylation and activity of PPARα is enhanced, resulting in an 
increased PPARα-dependent transcription of genes involved in the synthesis of DHA. Equol 
has also been shown to bind to ERα, although it has a higher affinity for the estrogen receptor 
beta (ERβ) [55]. Thus, the action of equol on DHA levels appears to be complex and various 
mechanisms seem to be possible. To understand the underlying mechanism, further research 
is needed on this topic.  
However, the increased DHA levels in rainbow trout tissue due to the supplementation of equol 
seems to be dependent on the dietary fatty acid composition. In our previous study, we 
combined equol (0.1-0.3%) with plant oils and did not find an increase in hepatic DHA levels 
of rainbow trout [27]. Thus, the increased dietary SDA levels due to the Ahiflower oil inclusion 
might have increased the overall efficiency of the LC-PUFA biosynthesis, and combined with 
equol (0.2 and 0.3%), led to significantly higher DHA liver levels.  
The increase in DHA liver levels corresponds well to the significantly decreased ALA levels in 
livers of fish fed AV-EQ3 compared to the AV-control group. Decreased ALA levels are 
putatively associated with an increased biosynthesis of LC-PUFA, since ALA is the precursor 
fatty acid and thus, serves as a substrate for the synthesis of these fatty acids [11]. Further, 
the MUFA levels in livers of fish fed the diet AV-EQ3 were significantly decreased. Both, MUFA 
and ALA can serve as a substrate for energy production in fish [11,13,56]. It could be possible, 
that ALA was preferably used for the endogenous biosynthesis of LC-PUFA and thus, higher 
amounts of MUFA were used for energy production. 
The liver is the main tissue for the biosynthesis of EPA and DHA in fish [57]. However, DHA 
values of AV-EQ2 and AV-EQ3 fed fish were also increased in whole body homogenate 
samples in comparison to levels of fish fed the diet FV. In the fillet, DHA levels of fish fed the 
diets AV-EQ2 and AV-EQ3 were similar to levels of fish fed the diet FV. The difference in DHA 
levels between these two tissues might be explained by the fact that DHA is not only deposited 
in the liver and the fillet but also in brain, eyes and adipose tissue of rainbow trout [11]. Further, 
the synthesis of DHA in rainbow trout can be considered as rather slow [11]. Thus, by 
extending the experimental period, the DHA levels in fillets of fish might increase further and 
could possibly even exceed those of FV-fed fish. In contrast, the significantly increased EPA 
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liver levels in fish fed the AV-diets compared to fish fed the diet FV were not reflected in the 
whole body homogenate and fillet samples, indicating a higher retention of DHA in comparison 
to EPA. Low retention levels of EPA have also been found in studies with Atlantic salmon fed 
vegetable oil based diets [58,59]. A factor contributing to these results might be the different 
biological functions of these fatty acids in fish. DHA is preferably stored, as a major component, 
in the phospholipids in cell membranes [60]. In contrast, EPA is a precursor for the synthesis 
of both, DHA [48] and eicosanoids [61]. Eicosanoids of n-3 fatty acids, such as EPA, have anti-
inflammatory characteristics. In contrast, n-6 fatty acids, such as ARA, promote the formation 
of eicosanoids with the opposite effects [reviewed in [61]]. Ishak et al. [52] suggest that EPA 
might inhibit the synthesis of ARA-based eicosanoids. Thus, the dose-dependent increase of 
ARA in the liver of fish fed the equol diets might have increased the formation of EPA-based 
eicosanoids. However, EPA fillet levels could be putatively further increased by including 
higher amounts of Ahiflower oil into the diets as shown by Fickler et al. [20]. 
General effects on the liver 
Dietary equol at higher dosages (0.2 and 0.3%) exhibited putatively estrogen-like effects in the 
liver of rainbow trout in the presented study. The diets AV-EQ2 and AV-EQ3 increased the 
liver weight of fish, resulting in significantly higher HSI values in comparison to values of fish 
fed the other diets. These findings are similar to our previous study investigating the 
combination of dietary equol and plant oil-based diets in rainbow trout [27]. In addition, Siberian 
sturgeon fed a diet containing bioactive substances showed enlarged livers and hepatocytes 
[62]. Further, vitellogenin synthesis was increased in these fish. Vitellogenin synthesis has 
been found to be putatively mediated through ERβ [63]. A possible mechanism of action could 
be the binding of equol to estrogen receptors in the liver of fish. As already mentioned, equol 
preferably binds to ERβ [55]. Orally administered equol might be primarily transported to the 
liver via the entero-hepatic circulation, similar to estradiol. The liver is the tissue with the 
highest amounts of estrogen receptors in rainbow trout [64]. Thus, equol, having a structural 
similarity to the estrogen estradiol, might have exhibited an estrogenic potency and thereby 
increased vitellogenin synthesis in rainbow trout in the present study. Further, the 18:0 levels 
in livers of rainbow trout fed the equol diets increased dose-dependently. This effect has also 
been found in our previous studies with rainbow trout [27]. The enzyme elongase 6 mediates 
the elongation step from 16:0 to 18:0 [65]. This enzyme seems to be responsive to estrogen 
as it was increased in ovariectomized rats due to an estradiol application [66]. As 16:0 levels 
were decreased in AV-EQ2 and AV-EQ3 fed fish, the estrogenic potency of equol putatively 
enhanced the expression of elongase 6 and thereby increased the synthesis of 18:0 from 16:0 
in fish fed the equol diets. However, further investigations are needed to examine the potential 
long-term effects of equol in rainbow trout. 
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Conclusion 
In conclusion, the present study revealed promising results of combining Ahiflower oil and 
equol in rainbow trout diets to enhance the tissue LC-PUFA levels. Especially, the utilization 
of equol at 0.2 and 0.3% in combination with higher dietary SDA levels in the diet increased 
DHA contents in liver and whole body homogenates and thereby exceeded DHA tissue levels 
of fish fed the diet FV. Further, fish fed the diets AV-EQ2 and AV-EQ3 obtained similar DHA 
fillet levels as fillets of fish fed the diet FV. Thus, the combination of Ahiflower oil and dietary 
equol (0.2 and 0.3% of DM) might be a reasonable way to substitute dietary fish oil in rainbow 
trout diets.  
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GENERAL DISCUSSION 
This thesis aimed to enhance the levels of eicosapentaenoic acid (20:5n-3, EPA) and 
docosahexaenoic acid (22:6n-3, DHA) in rainbow trout (Oncorhynchus mykiss) which were fed 
vegetable oil-based diets in order to increase the nutritional value of these fish for human 
consumption. All approaches examined within this thesis (chapters 1-4) are based on the 
ability of rainbow trout to synthesize EPA and DHA endogenously.  
1. Physiology 
Physiologically essential highly unsaturated fatty acids like EPA and DHA have a variety of 
functions in fish. EPA and DHA are incorporated into phospholipids of the cell membrane in 
large amounts [1,2]. Specifically, DHA has a unique compact helical structure, giving this fatty 
acid a strong and flexible shape [1]. Apart from this, the characteristics of DHA are also 
important for tissues with visual and neural functions [1,3,4]. In contrast, EPA is a substrate for 
hormone-like compounds involved inter alia in the immune and inflammatory response 
(reviewed in [5,6]). Marine fish receive their high amounts of EPA and DHA via their natural 
diet: At the base of the food web, algae, mainly diatoms, produce these fatty acids, which are 
then transmitted via zooplankton to fish [6]. Freshwater fish, like rainbow trout, evolved in the 
ocean but later returned to the freshwater biosphere [6]. Thus, these fish depend on 
endogenously synthesizing long-chain polyunsaturated fatty acids (LC-PUFA) from their 
essential precursor fatty acids α-linolenic acid (18:3n-3, ALA) and linoleic acid (18:2n-6, LA). 
Due to this ability, rainbow trout rely mainly on dietary ALA and LA as substrates for the LC-
PUFA synthesis. The NRC indicates a dietary ALA requirement level of 0.7-1.0% and LA of 
1.0% of dry diet for rainbow trout, whereas for EPA and DHA only recommendations are given 
(0.4-0.5% of dry diet) [7]. Most of the diets investigated in this thesis contained EPA and DHA 
levels below the recommendations. However, there were no negative effects on growth and 
performance of fish which were fed diets containing vegetable oils in comparison to fish fed 
with the fish oil-based control diets (chapters 3 and 4). Rainbow trout which were fed the 
vegetable oil-based diets in chapters 1 and 2 also showed reasonable growth rates for fish at 
this size. Thus, rainbow trout must have synthesized sufficient EPA and DHA de novo to meet 
their physiological essential fatty acid requirements and additionally enable optimum growth 
and health as described by Tocher [8].  
The omega-3 (n-3) biosynthesis pathway described in the following is the most common [8] 
and has been confirmed for rainbow trout [9]. The studies within this thesis are based on this 
pathway. However, other options including delta-4 and delta-8 desaturations are possible. The 
delta-4 desaturation has been identified in rabbit fish and Senegalese sole [10,11], and the 
delta-8 desaturation in some marine fish species [12] as well as in rainbow trout and Atlantic 
salmon [13] (reviewed in [8]). However, all steps of the n-3 LC-PUFA biosynthesis pathway 
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take place in the endoplasmic reticulum with the final β-oxidation in the peroxisome. As 
recommended by Tocher [8], the common n-3 pathway should be divided into two separate 
pathways. The first part of the n-3 pathway comprises of the synthesis of EPA from ALA and 
requires two desaturation (delta-6 and delta-5) and one elongation step (Fig. GD-1). 
Desaturases insert a double bond in a particular position of the fatty acid [14], whereas 
elongases catalyze the extension of the fatty acid chain [15]. The second pathway, also known 
as the “Sprecher shunt” [16], includes the synthesis of DHA from EPA, involving an elongation 
of EPA to 24:5n-3 and a delta-6-desaturation followed by the final peroxisomal β-oxidation 
(chain shortening). The majority of the LC-PUFA biosynthesis takes place in the liver of 
rainbow trout and the same enzymes are operating in both pathways for the n-3 and n-6 fatty 
acids [17,18]. However, the competition between these two PUFA series has been shown to 
be only minimal in rainbow trout [19] as the enzymes involved prefer n-3 fatty acids over n-6 
fatty acids [14].  
 
Figure GD-1 Pathways of n-3 and n-6 long-chain polyunsaturated fatty acids. Both pathways share 
the same desaturases and elongases. The n-6 fatty acid linoleic acid (LA) is converted via intermediates 
to arachidonic acid (ARA). The first part of the n-3 fatty acid biosynthesis involves the synthesis of EPA 
from ALA via SDA. The second part, the conversion of EPA to DHA via intermediates is also known as 
the Sprecher shunt. Except the peroxisomal β-oxidation, all steps take place in the endoplasmic 
reticulum. Adapted from Tocher et al. [8]. 
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The promoter activities of these enzymes are regulated by transcription factors in the liver [14]. 
The transcription factors PPARα (peroxisome proliferator activated receptor alpha) and 
SREBP-1c (sterol regulatory element binding protein-1c) are centrally involved in the 
regulation of these enzymes [14]. The transcription factors and thus, the expression of genes 
involved in the biosynthesis of EPA and DHA can be regulated inter alia by nutrients (e.g. fatty 
acids) and hormones (e.g. estrogen) [14,20–23]. In the following, the relation between the final 
tissue fatty acid composition of rainbow trout and (1) the dietary fatty acid composition, (2) the 
utilization of bioactive substances and (3) the interaction of both (1) and (2), will be discussed. 
As the endogenous biosynthesis of LC-PUFA has evolved to satisfy the physiologically 
essential levels of these fatty acids in fish but does not necessarily lead to EPA and DHA levels 
high enough to meet the consumer demands [8], the approaches (1-3) will be evaluated 
regarding their potential to achieve an increased product quality of rainbow trout for human 
consumption. 
1.1 Effect of dietary fatty acid composition on tissue fatty acid composition  
It is well known that the tissue fatty acid composition resembles the dietary fatty acid 
composition in fish and that feeding vegetable oil-based diets low or devoid of EPA and DHA 
strongly influences the fillet fatty acid composition [24–26]. However, some fish can maintain 
tissue EPA and DHA contents at higher levels than derived via the diet. This is due to their 
ability to endogenously synthesize LC-PUFA. Substituting dietary fish oil with vegetable oils 
generally resulted in an increased biosynthesis of LC-PUFA in the liver [27–29]. Fish fed diets 
with gradually lower EPA and DHA levels in chapter 3 showed increased levels of these fatty 
acids in the liver, indicating an increase in the LC-PUFA biosynthesis. In accordance, livers of 
fish fed with a diet based on Ahiflower and vegetable oils had increased EPA levels in 
comparison to fish fed with a diet based on fish oil and vegetable oils (in the following termed 
as “fish oil-based diet”) (chapter 4). In salmonids, the regulation of the LC-PUFA synthesis 
can be mediated by dietary fatty acids [30]. Dietary PUFA can regulate transcription factors 
such as PPARα and SREBP-1c (reviewed in [22]). The presence of these fatty acids leads to 
a negative feedback loop on the expression of genes involved in the biosynthesis [31,32]. In 
turn, the absence of LC-PUFA can relieve this suppression and thereby increase the 
expression of genes needed to synthesize EPA and DHA. Fish which are fed vegetable oil-
based diets have been shown to increase the expression of genes involved in this biosynthesis 
pathway 2- to 3-fold (reviewed in [27,33]). For example, both the expression and the activity of 
the delta-6-desaturase were increased in salmonids fed vegetable oil-based diets in 
comparison to fish which were fed fish oil-based diets (reviewed in [34]). In this thesis, 
vegetable oil-based diets low in EPA and DHA did not lead to significantly increased hepatic 
mRNA steady state levels of the delta-6-desaturase (chapters 1, 3 and 4) and of the delta-5-
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desaturase (chapter 3). However, the activity of the desaturases was not measured. In 
addition, it cannot be excluded that fatty acids might also affect the processes in the lipid 
metabolism via alterations in fluidity and microenvironments of the membrane as suggested 
by Tocher et al. [35]. 
Nevertheless, apart from the absence of dietary LC-PUFA, providing stearidonic acid (18:4n-
3, SDA) instead of ALA could further enhance the efficiency to synthesize EPA, as the first 
delta-6-desaturation step of the biosynthesis can be bypassed. This hypothesis was 
investigated within this thesis by using a vegetable oil rich in SDA (Ahiflower oil). Figures GD-
2 and GD-3 show EPA and DHA whole body homogenate levels of rainbow trout fed diets 
based on fish oil (FVO), vegetable oil (VO) and Ahiflower oil (AVO) (dietary fatty acid 
composition described in Table GD-1). A significant effect of SDA over ALA on EPA whole 
body homogenate levels of rainbow trout was only obtained with higher dietary EPA and DHA 
levels as well as higher growth rates due to a higher daily feeding ratio (2.0% and 1.6% of 
biomass per day, respectively) (Table GD-1). Thus, it seems that the beneficial effect of SDA 
might depend on the fatty acid composition of the diet and is possibly affected by the growth 
rates of fish. Varying dietary levels of EPA and DHA and different growth rates could have also 
led to contradictory findings about the beneficial effects of the SDA-rich Echium oil over 
common vegetable oils in salmonid diets [36–38]. 
 
Fig. GD-2 EPA and DHA levels in whole body homogenates of rainbow trout fed the diets FVO-1 
(based on: fish/vegetable oils), VO-1 (vegetable oils) and AVO-1 (Ahiflower/vegetable oils) for 
eight weeks. Values (mean ± SD, n = 3, consisting of three fish each) with different superscript letters 
are significantly different (p < 0.05), values without superscript letters are not significantly different  
(p ≥ 0.05). Values were analyzed according to the statistical methods described in chapter 3 (p. 65).  
General Discussion  107 
 
 
Fig. GD-3 EPA and DHA levels in whole body homogenates of rainbow trout fed the diets FVO-2 
(based on: fish/vegetable oils), VO-2 (vegetable oils) and AVO-2 (Ahiflower/vegetable oils) for 
eight weeks. Values (mean ± SD, n = 3, consisting of three fish each) with different superscript letters 
are significantly different (p < 0.05), values without superscript letters are not significantly different  
(p ≥ 0.05). Brackets indicate a tendency towards a statistical difference (p < 0.1). Values were analyzed 
according to the statistical methods described in chapter 3 (p. 65). 
Table GD-1 Fatty acid composition (in % of FAME*) of the experimental diets FVO (based 
on fish/vegetable oils), VO (vegetable oils) and AVO (Ahiflower/vegetable oils) -1 and -
2, respectively and the specific growth rate of rainbow trout fed these diets for eight 
weeks.  
  FVO-1 VO-1 AVO-1 FVO-2 VO-2 AVO-2 
ALA  14.7 15.0 11.3 17.1 16.7 12.5 
SDA 0.7 0.2 3.9 0.3 0.1 4.4 
ΣALA+SDA 15.4 15.2 15.2 17.4 16.8 16.9 
ΣEPA+DHA 5.9 2.1 2.1 3.7 1.6 1.6 
SGRa 2.23 ± 0.03 2.15 ± 0.01 2.12 ± 0.08 1.57 ± 0.03 1.56 ± 0.01 1.58 ± 0.03 
* FAME = Fatty acid methyl ester; a Specific growth rate [% d-1] = [ln (final body weight) – ln (initial body 
weight)]/feeding day x 100. 
However, when dietary ALA and SDA levels are further increased, for example by using solely 
Ahiflower oil as a dietary oil source (chapter 3), there is a clear effect on the tissue LC-PUFA 
levels in rainbow trout. The interaction of decreased dietary EPA and DHA, and simultaneously 
increased ALA and SDA levels has improved the EPA liver and fillet levels of these fish. 
Thereby, these fish exceeded the EPA fillet levels (+25%) and reached similar DHA levels of 
fish fed with the fish oil-based control diet in chapter 3. These results are in contrast to the 
fact that the LC-PUFA synthesis generally does not compensate for the lack of dietary EPA 
and DHA leading to decreased levels of these fatty acids in fish which are fed vegetable oil-
based diets in comparison to fish which are fed diets based on fish oil [27,39]. Briefly, the 
utilization of Ahiflower oil and thus, the modification of the dietary fatty acid composition, can 
increase the LC-PUFA levels of rainbow trout. However, this increase is limited and more 
innovative approaches are needed to further increase the efficiency of the LC-PUFA synthesis. 
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1.2 Effect of isoflavones on tissue fatty acid composition 
An approach which can further stimulate the LC-PUFA biosynthesis is the utilization of 
isoflavones. Isoflavones have several possible mechanisms to affect the biosynthesis of EPA 
and DHA in rainbow trout. For example, isoflavones might increase the LC-PUFA tissue levels 
indirectly by protecting these fatty acids from oxidation. Genistein was found to develop 
antioxidant properties in endothelial cells: Genistein activated the transcription factor Nrf1 and 
thus increased the activity and expression of its target gene, the glutathione peroxidase which 
is involved in the cellular defense mechanisms of endothelial cells [40]. However, this might 
not be the only way to increase LC-PUFA tissue levels in rainbow trout. In addition to this, 
isoflavones can function, similar to PUFA, as ligands for PPARα [41,42]. PPARα can be 
activated by ligand binding, forming a heterodimer with the retinoid X receptor (RXR). This 
PPARα-RXR-complex binds to peroxisome proliferator response elements located within the 
promoters of the target genes and thereby activating their transcription [43]. In general, PPARα 
is involved in the regulation of the desaturases (delta-5 and delta-6) [14] as well as the 
peroxisomal β-oxidation (acyl CoA oxidase and D-bifunctional protein) [20,44]. All of these 
genes are necessary for the formation of DHA. This is in accordance with findings in chapters 
1 and 4 indicating that isoflavones mainly increase DHA and not EPA levels.  
In addition to ligand binding, isoflavones can affect transcription factors and genes involved in 
the biosynthesis of LC-PUFA due to their estrogenic activity. Kitson et al. [20] describes that 
the endogenous hormone estrogen likely activates PPARα via two mechanisms: Estrogen 
could bind to the estrogen receptor alpha (ERα) and thus activates the extracellular receptor 
kinase-mitogen activated protein kinase (ERK-MAPK). Thus, PPARα activity is increased via 
ERK-MAPK-mediated phosphorylation. Another possible mechanism is the enhanced ligand 
allocation for PPARα. Estrogen could increase the intracellular concentration of ligands like 
PUFA and eicosanoids, thereby activating PPARα. Isoflavones have a similar chemical 
structure as the estrogen 17β-estradiol [45] (Fig. GD-4) and thus can bind to estrogen 
receptors [46,47]. In accordance, the isoflavones genistein, daidzein and biochanin A as well 
as the isoflavone metabolite equol showed an estrogenic potency in rainbow trout [48]. In 
addition to the above mentioned mechanisms of action, isoflavones might exert estrogenic 
effects in livers of salmonid fish also by inhibiting the metabolism of estrogen and thereby 
increasing the bioavailability of estrogen as suggested by Ng et al. [49]. Although, the 
estrogenic activity of the substances used in this thesis was not measured, it seems likely that 
the isoflavone metabolite equol among all investigated substances developed estrogen-like 
effects in rainbow trout, indicated by increased liver weights (chapters 2 and 4) and increased 
18:0 fatty acid levels (chapters 1, 2 and 4).  
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Fig. GD-4 Structure of 17β-estradiol (A), the isoflavone metabolite equol (B), and the isoflavones 
genistein (C), daidzein (D), and biochanin A (E). Adapted from Setchell et al. [50] and Medjakovic et 
al. [51]. 
Ronis et al. [52] fed soy protein isolate-based diets to rats and found increased expression of 
PPARα and PPARα-regulated genes such as CPT1 (carnitine palmitoyl transferase 1). In 
contrast to these findings, genistein and equol did not affect mRNA steady state levels of 
CPT1a and c (chapter 1). Moreover, fads2a(d6) mRNA steady state levels were either not 
affected (genistein: chapter 1, equol: chapter 4) or downregulated (equol:  
chapter 1) by these substances. In addition, protein levels of Fads2a(d6) were not altered by 
genistein and equol (chapter 1). Thus, it seems that equol exerts multiple effects in rainbow 
trout that cannot be explained by one single action. 
In addition to PPARα, SREBP-1c is also an important transcription factor of genes involved in 
the biosynthesis of LC-PUFA [14]. For example, genistein inhibited the activation process of 
SREBP-1 and thus, downregulated genes regulated by SREBP-1 [53]. Li et al. [54] suggest 
that PPARα and SREBP-1c need to be activated simultaneously to increase the transcription 
of the gene encoding the delta-6-desaturase. Thus, it might be possible that isoflavones 
increase the activity of PPARα but simultaneously decrease the expression of genes mediated 
by SREBP-1c leading to a reduction of the PPARα-mediated effects on LC-PUFA levels. In 
accordance with these findings, the effects of genistein and equol on DHA were only marginal 
in whole body homogenates in chapter 1 and not existent in tissues of rainbow trout in chapter 
2. However, increased EPA and DHA liver levels due to equol application were found in 
chapter 4, indicating that the dietary fatty acid composition and thus, the dietary lipid source, 
might also play a role in the mode of action of equol.  
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1.3 Effect of different dietary fatty acid compositions in combination with isoflavones 
on the tissue fatty acid composition  
Isoflavones and their metabolites are not solely able to function as a substitute for dietary fish 
oil. The utilization of these substances as an alternative to fish oil requires the inclusion of 
vegetable oils in the diets. However, it seems that the efficacy of isoflavones to increase DHA 
in rainbow trout depends on the dietary fatty acid composition. For example, different effects 
of the bioactive compound sesamin on LC-PUFA tissue levels due to varying dietary fatty acid 
compositions have been found in Atlantic salmon and barramundi (Lates calcarifer) [55,56]. 
The dietary levels of EPA and DHA as well as ALA and SDA might, therefore, play an important 
role. The diets used in chapter 1 had higher EPA and DHA levels than those in chapter 2. In 
chapter 1, genistein and equol affected the tissue LC-PUFA levels, whereas in chapter 2 no 
effects were found, although the dietary concentration of these substances was increased. 
Obviously, higher dietary levels of EPA and DHA increase the effect of isoflavones on LC-
PUFA levels. This hypothesis seems to be confirmed as the combination of isoflavones 
(0.15%) with a diet based on fish and vegetable oils shows significantly increased DHA levels 
in the fillets (Fig. GD-5) and higher levels in the livers of rainbow trout (Fig. GD-6). In turn, it 
might be possible that diets low in EPA and DHA already fully exploit the endogenous  
LC-PUFA biosynthesis capacity and that isoflavones are not an adequate strategy to further 
increase LC-PUFA synthesis when combined with diets based on common vegetable oils.  
The efficiency of the LC-PUFA biosynthesis pathway putatively has a “funnel-like” 
characteristic, as the relative activity of desaturases and elongases decrease with increasing 
chain length of the fatty acid [57]. Thus, by increasing the ratio of the conversion of ALA/SDA 
to EPA due to dietary Ahiflower oil, there might be more substrate available for the synthesis 
of DHA. This could explain the different findings concerning the effects of equol on the LC-
PUFA biosynthesis in chapters 2 and 4, which are directly comparable as they were obtained 
within the same experiment. Equol (0.2 and 0.3%) combined with a diet based on Ahiflower oil 
significantly increased DHA levels in the livers of rainbow trout compared to rainbow trout fed 
the Ahiflower oil-based control diet in chapter 4. Contrasting these findings, equol combined 
with diets based on common vegetable oils did not affect the LC-PUFA tissue levels of rainbow 
trout. All diets had similar levels of ΣALA+SDA, but Ahiflower oil-based diets had higher levels 
of SDA and lower levels of ALA (chapter 4) compared to the diets based on common vegetable 
oils (chapter 2).  
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Fig. GD-5 EPA and DHA levels in fillets of rainbow trout fed the experimental diets for eight 
weeks. All diets were based on a blend of fish and vegetable oils. Control diet (FVO) without 
supplementation; bioactive substances were added to the diets by 0.15% of DM: BA: biochanin A; DA: 
daidzein; EQ: equol; G: genistein. Values (mean ± SD, n = 3, consisting of fillets from five fish each) 
with asterisks are significantly different (p < 0.05) from FVO, values without asterisks are not significantly 
different (p ≥ 0.05) from FVO. The “+” indicates a tendency towards a statistical difference (p < 0.1) in 
comparison to values of FVO. Values were analyzed according to the statistical methods described in 
chapter 1 (p. 21). 
 
Fig. GD-6 EPA and DHA levels liver samples of rainbow trout fed the experimental diets for eight 
weeks. All diets were based on a blend of fish and vegetable oils. Control diet (FVO) without 
supplementation; bioactive substances were added to the diets by 0.15% of DM: BA: biochanin A; DA: 
daidzein; EQ: equol; G: genistein. Values (mean ± SD, n = 3, consisting of five livers each) without 
asterisks are not significantly different from FVO (p ≥ 0.05). Values were analyzed according to the 
statistical methods described in chapter 1 (p. 21). 
Thus, higher dietary SDA levels putatively increase the synthesis rate of EPA and thereby 
provide more substrate for the synthesis of DHA. Moreover, these findings underline the 
hypothesis that the first step of the biosynthesis can be bypassed by providing dietary SDA 
instead of ALA (see Fig. GD-1, p. 103). Thus, a higher share of the key enzyme delta-6-
desaturase could be available to convert 24:5n-3 to 24:6n-3 instead of ALA to SDA. 
Additionally, equol might affect the genes centrally involved in the LC-PUFA biosynthesis via 
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the aforementioned mechanisms. In turn, equol might have increased the activity of enzymes 
involved in the biosynthesis in the experiment of chapter 2 (not measured) but did not increase 
DHA tissue levels as the substrate for the conversion was limited. Nevertheless, the liver EPA 
and DHA levels were affected to a greater extent than the fillet levels of fish fed with the 
Ahiflower oil-based diet with equol in chapter 4. This is in accordance with literature data of 
feeding vegetable oils to salmonids. These studies report that, although the LC-PUFA 
biosynthesis in the liver of fish is significantly increased, fillet LC-PUFA levels are significantly 
lower than those of fish fed with a fish-oil based diet [24–26]. However, the results of  
chapter 4 indicate that the endogenous biosynthesis is able to compensate for the lack of 
dietary DHA if a diet based on Ahiflower oil is combined with equol (0.3%). Rainbow trout fed 
this diet showed similar DHA levels to fish who were fed the fish oil-based diet. However, the 
levels of EPA were significantly lower, as EPA might have been largely converted to DHA. With 
regard to the influence of the substrate amount on the biosynthesis efficiency, it might be 
beneficial to combine equol with a diet containing high amounts of Ahiflower oil and thus ALA 
and SDA, similar to the diet in chapter 3. Thereby, both EPA and DHA could be increased in 
the fillet and might even exceed the values of fish fed with a fish oil-based control diet.  
2. Evaluation of the approaches and conclusion 
As mentioned in the introduction, a compound aquafeed has to ensure optimal physical and 
chemical quality adapted to the fish to achieve a high product quality for human nutrition. 
Further, it has to be ecologically and economically reasonable. This thesis investigated three 
approaches to substitute dietary fish oil with vegetable oils and increase the LC-PUFA levels 
in rainbow trout. As shown in table GD-2, all strategies had no negative effect on the growth 
of rainbow trout. Further, the crude protein and crude lipid content of whole body homogenates 
was not affected. In the case of vegetable oils in salmonid diets, these findings are in 
accordance with recent literature [39]. In contrast, many bioactive substances have been found 
to impair the growth of fish [56,58,59] and tend to reduce the body lipid content [60,61]. With 
regard to these findings, the substances and oils used in the experiments of this thesis seem 
to be suitable for rainbow trout feeds. However, their potential to increase EPA and DHA tissue 
levels of rainbow trout to achieve a high product quality for human nutrition is less clear.  
Among all tested substances, only genistein and equol showed an increase in DHA of 8% in 
whole body homogenates but not in fillets (chapter 1) and did not affect DHA tissue levels 
when dietary LC-PUFA levels were lower (chapter 2). Furthermore, the combination of 
Ahiflower oil and equol resulted in DHA fillet levels that were increased by 7% in comparison 
to the Ahiflower oil control group and similar to levels of fish who were fed the fish oil-based 
diet (chapter 4). However, other studies report that bioactive substances such as resveratrol 
increased DHA levels by 43-71% [59,60] and sesamin by up to 37% in tissues of rainbow trout 
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[62]. Considering the fact that isoflavones are relatively expensive (equol: 1.90 US$/g), the 
utilization of these substances in order to increase LC-PUFA levels in the fillets of fish seems 
economically questionable at this point.  
Table GD-2 Overview of main results of chapters 1-4 and additional results.  
 Isoflavones Ahiflower oil Combination 
 Chapter 1 and 2 Chapter 3 Chapter 4 
Growth No effect Increase final body 
weight (A100) 
No effect 
Nutrient composition No effect No effect No effect 
EPA and DHA levels    
Liver  No effect EPA: increase  
DHA: increase (A66, 
A100) 
EPA: increase (due to 
Ahiflower oil) 
DHA: increase (equol 
0.2, 0.3%) 
Whole body Chapter 1: 
EPA: no effect 
DHA: increase 
(genistein, equol) 
Chapter 2: no effect 
Not investigated EPA: no effect 
DHA: increase (equol 
0.2, 0.3%) 
Fillet Chapter 1 and 2: 
no effect 
Additional (FVO): 
DHA: increase  
(Fig. GD-5) 
EPA: increase (A66, 
A100) 
DHA: no effect 
EPA: Decrease 
DHA: Similar levels as 
FV-C 
Hepatic mRNA 
steady state levels 
   
fads2a(d6) Decrease (equol) No effect No effect 
fads2b(d5) Not investigated No effect Not investigated 
cpt1a No effect No effect Not investigated 
cpt1c No effect Decrease (A66, A100) Not investigated 
Fads2a(d6) protein 
level 
No effect Not investigated Not investigated 
In addition, the impact of bioactive substances on the lipid metabolism might be affected by 
manifold parameters such as the factors fish size, species and gender [56]. In this thesis, 
juvenile all-female rainbow trout were used for the experiments. In general, juvenile rainbow 
trout have a greater capacity to synthesize LC-PUFA endogenously. In addition, female 
rainbow trout contain 2 to 3 times higher amounts of estrogen receptors than male fish of this 
species [63]. Thus, the impact on the LC-PUFA biosynthesis particularly of equol, which 
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putatively developed estrogen-like effects in rainbow trout (chapters 2 and 4), might be lower 
in juvenile and male rainbow trout. Furthermore, the bioavailability of dietary isoflavones is low 
[64–66] and most of the dietary content might be excreted. Thus, further research would be 
required to investigate whether the excreted substances accumulate in recirculating 
aquaculture systems (RAS) and whether they could have an impact on the sexual 
differentiation and the gonadal development of wild fish populations when discharged via the 
effluent water.  
The aim of this thesis was to find an adequate alternative to dietary fish oil that leads to a high 
product quality for human nutrition. Thus, the utilization of Ahiflower oil in rainbow trout diets 
seems promising, as it exceeded the EPA fillet levels of fish which were fed the fish oil-based 
control diet. Further, the total n-3 levels were significantly increased in the fillets of these fish 
(chapter 3). The increase in ALA and SDA and the simultaneous decrease of linoleic acid and 
arachidonic acid increased the n-3:n-6 ratio in fillet of rainbow trout fed this diet. This could be 
also relevant in terms of human nutrition. The consumption of n-3 PUFA rich food might lower 
the risk of certain chronic diseases and could exert a protective effect on some forms of cancer 
in humans [72-75]. At the moment, the availability and cost of Ahiflower oil (36 US$/kg) is 
economically not viable for aquaculture. Therefore, an increased production would be 
necessary to lower the price. In addition, an extended experimental period might further 
increase the LC-PUFA fillet levels of fish fed with Ahiflower oil-based diets (chapter 3) and the 
combination of Ahiflower oil and equol (chapter 4). The synthesis of LC-PUFA, particularly 
DHA, can be considered as slow. It might be possible that the rainbow trout from chapters  
3 and 4 needed the entire experimental period to compensate reduced dietary DHA levels and 
additional time is needed to further increase the DHA levels.  
Beside the approach to stimulate the endogenous LC-PUFA biosynthesis in fish, there are 
other alternatives to substitute dietary fish oil. Although the use of genetically modified oilseed 
crops and microorganisms has been criticized, it might be a feasible option for the future. 
Genetically modified plant oils might constitute the most inexpensive source of LC-PUFA as it 
is estimated that the availability and the costs might be similar to those of oils currently used 
in aquafeeds [67]. Moreover, due to novel production techniques in the future, alternatives like 
single cell oils could also be produced in commercially viable amounts [68]. Another potential 
LC-PUFA source that has been used only minimal so far is krill oil. In 2014, only 0.3 million 
metric tons were caught in the Antarctic fishing areas [69], although the biomass of krill in the 
Southern Ocean is estimated to be 700 million metric tons [68]. However, krill is a main 
component at the base of the food web and thus, overfishing might adversely affect the natural 
food chain [8,70]. In addition to that, the more efficient use of by-catch and processing by-
products to produce fish oil might be an alternative [8]. By that, part of the fish oil used for 
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aquafeeds can be “recycled”. However, PCBs and dioxins could thereby be accumulated and 
the risk to transmit diseases would be increased [71].  
In conclusion, this thesis showed that the option to increase LC-PUFA fillet levels via increasing 
the endogenous biosynthesis is possible but only to a limited extent and so far, not 
economically viable. In addition, future studies should evaluate such strategies over a longer 
experimental period, ideally over a whole production cycle, as the capacity of the biosynthesis 
decreases with increasing fish size.  
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SUMMARY 
Omega-3 (n-3) fatty acids play an important role in human health. Particularly, the fatty acids 
eicosapentaenoic acid (20:5n-3, EPA) and docosahexaenoic acid (22:6n-3, DHA) are known 
for their health-benefits. For example, EPA has an anti-inflammatory potential and DHA is inter 
alia crucial for the neuronal development. Humans are able to synthesize EPA and DHA 
endogenously from the essential precursor fatty acid α-linolenic acid (18:3n-3, ALA). However, 
this biosynthesis is limited and we rely on the additional dietary uptake of the long-chain 
polyunsaturated fatty acids (LC-PUFA) EPA and DHA. Fish is the most important source of 
these fatty acids in human nutrition. The LC-PUFA content in fish depends inter alia on the 
species and the dietary fatty acid composition. In contrast to most marine fish species, many 
freshwater fish like rainbow trout (Oncorhynchus mykiss) are capable of synthesizing EPA and 
DHA endogenously. However, similar to humans, the efficiency of this synthesis is limited. In 
order to ensure a high nutritional quality of aquaculture products for human consumption, 
significant amounts of these fatty acids need to be provided via the feed. In the past, this has 
been realized mainly by including marine ingredients like fishmeal and fish oil into the diets. 
However, due to the continuous growth of the aquaculture sector and the concomitant risen 
demand for marine feed ingredients, the price of these products increased significantly. 
Consequently, vegetable oils have increasingly been used as a substitute for fish oil in 
aquafeeds for salmonids. Common vegetable oils are less expensive than fish oil and readily 
available but lack highly unsaturated n-3 fatty acids. As already mentioned, the dietary fatty 
acid composition has a great influence on the fillet fatty acid composition. Thus, by using 
dietary vegetable oils, the fillet fatty acid composition is adversely modified. Lower EPA and 
DHA levels in the diet and thus, in the fish, ultimately reduce the product quality of the fillet for 
human consumption. In order to ensure the supply of EPA and DHA for human nutrition via 
fish, the identification of alternative feed ingredients, which are equivalent to fish oil, is of the 
utmost importance. However, potential feed ingredients such as oils of primary producing 
microalgae and genetically modified plant oils containing significant amounts of EPA and DHA 
are either not available on a commercial scale yet or their utilization is controversial. The aim 
of this work was, therefore, to evaluate approaches to enhance the biosynthesis of LC-PUFA 
and thereby increase EPA and DHA levels in rainbow trout. 
The endogenous biosynthesis of LC-PUFA is complex and can be regulated by different factors 
such as dietary fatty acids and hormones. The use of dietary bioactive substances like 
isoflavones and their metabolite equol seems to be an appropriate tool to stimulate the 
endogenous LC-PUFA biosynthesis in rainbow trout. Isoflavones occur naturally in plants like 
soy (Glycine max) and red clover (Trifolium pratense) and have characteristics that could affect 
the biosynthesis via different mechanisms. For example, they have a structural similarity to the 
hormone estrogen and are further potential ligands for transcription factors of the biosynthesis 
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(e.g. PPARα). Therefore, they may be able to increase the expression of genes encoding 
proteins centrally involved in the biosynthesis of LC-PUFA. So far, little is known about the 
potential and mode of action of these substances on the lipid metabolism in fish in vivo.  
Thus, the experiment in chapter 1 investigated four different isoflavones to identify those which 
stimulate the LC-PUFA biosynthesis in rainbow trout. For this experiment, juvenile rainbow 
trout were fed five diets based on a blend of vegetable oils for eight weeks. Four of these diets 
were supplemented with 0.15% of dry matter of the isoflavones biochanin A, daidzein, 
genistein and an isoflavone metabolite equol, respectively. A diet without the supplementation 
served as a control diet. Among all tested substances, only fish which were fed the diets 
containing equol and genistein showed increased DHA levels in whole body homogenates. In 
contrast, fillet and liver EPA and DHA levels were not modified by the dietary treatments. Equol 
might have enhanced the biosynthesis of DHA via estrogen-like mechanisms of action. A fact, 
which supports this hypothesis, is the increase of the fatty acid 18:0 (stearic acid) in the livers 
of these fish. An increase of this fatty acid has been associated with increasing estrogen levels 
in rats. In contrast, genistein could have increased DHA levels in whole body homogenates 
due to its antioxidative characteristics or via binding to transcription factors. For a better 
understanding of the mechanisms of action of these substances, potential effects on the 
hepatic lipid metabolism were investigated. The hepatic mRNA steady state levels and the 
protein content of the delta-6-desaturase, a key-enzyme of the LC-PUFA biosynthesis, were 
of particular interest. However, the increase in DHA levels was not supported by the hepatic 
mRNA steady state levels of the delta-6-desaturase as equol showed decreased levels. In 
addition, the substances did not affect the protein content of this enzyme. Furthermore, the 
effects on growth and nutrient composition of fish are important aspects to evaluate the 
potential of these substances as feed ingredients. These two factors were also not affected by 
the diets. Thus, these substances can be included at concentrations of 0.15% of dry matter 
into diets for rainbow trout without impairment of performance parameters. Taken together, 
equol and genistein seem to enhance the DHA levels in whole body homogenates of rainbow 
trout, however only to a moderate extent.  
Several studies reported that bioactive substances can develop dose-dependent effects in the 
organism. Thus, different dietary concentrations could increase the stimulation of the LC-PUFA 
biosynthesis. For that, chapter 2 investigated whether there is a dose-response of dietary 
equol and genistein on the LC-PUFA tissue levels in rainbow trout. In this experiment, juvenile 
rainbow trout were used and fed with a total of seven diets over a period of eight weeks. A 
vegetable oil-based diet served as a control diet and was supplemented with equol and 
genistein, respectively at 0.1%, 0.2% and 0.3% of dry matter. An example for a dose-response 
could be the growth impairment of fish due to increasing dietary concentrations of bioactive 
substances. This effect has been observed in some studies with rainbow trout and Atlantic 
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salmon. In the current study, however, no effects of higher concentrations of the respective 
substance on the growth of fish were found. However, these results were obtained in fish fed 
on a fixed daily feeding ratio of 1.6% of biomass and might be different if feed intake was 
higher. Similar to chapter 1, rainbow trout fed the equol diets in chapter 2 showed increased 
liver levels of stearic acid. Additionally, the liver weights of these fish were increased. This 
indicates an estrogen-like effect of equol in the liver and thus, underlines the assumptions of 
chapter 1. However, there were no effects of the substances on liver, fillet and whole body 
homogenate LC-PUFA levels. The diets in chapter 1 had higher levels of EPA and DHA than 
those used in chapter 2. Thus, it might be possible that diets low in LC-PUFA already fully 
exploit the endogenous LC-PUFA biosynthesis capacity of rainbow trout and isoflavones are 
not able to further stimulate the biosynthesis. In conclusion, based on the generated results of 
chapter 1 and 2, the utilization of equol and genistein in diets based on common vegetable 
oils in order to increase the LC-PUFA fillet levels of rainbow trout seems only possible to a 
limited extent.  
However, there are also other possibilities to stimulate the biosynthesis in rainbow trout. For 
example, dietary fatty acids can regulate the expression of genes involved in the biosynthesis. 
Due to a negative feedback mechanism, the absence of LC-PUFA can increase the expression 
of these genes and thus, stimulate the synthesis of EPA and DHA in fish. In addition, an 
increased substrate availability of the precursor fatty acids might further increase the overall 
efficiency of the biosynthesis. Studies in humans, dogs and mice indicate that stearidonic acid 
(18:4n-3, SDA) is a superior substrate for the synthesis of EPA than ALA, because the first 
step of the biosynthesis, the delta-6-desaturation of ALA to SDA, can be bypassed.  
Thus, chapter 3 focused on the question whether higher dietary ALA and SDA levels increase 
the efficiency of the EPA and DHA biosynthesis in rainbow trout. For that, an oil of the plant 
Buglossoides arvensis (Ahiflower oil) was used. Contrasting commercial plant oils, this oil 
contains high amounts of SDA but is also rich in ALA. In the experiment described in  
chapter 3, juvenile rainbow trout received four diets over a period of eight weeks. A diet based 
on a blend of fish and vegetable oils served as a control diet. The oils of this diet were 
substituted with Ahiflower oil at levels of 33%, 66% and 100%. The higher levels of ALA and 
SDA in the 66% and 100% Ahiflower oil diets resulted in a significant increase of EPA levels 
in the fillets of fish compared to levels of fish which were fed the control diet. This is particularly 
relevant because the Ahiflower diets had significantly lower EPA levels than the control diet. 
This result suggests that a higher substrate availability of precursor fatty acids (ALA and SDA) 
can increase the efficiency of LC-PUFA synthesis. The biosynthesis of EPA requires a delta-
5-desaturation step. For example, Atlantic salmon fed with high dietary SDA levels showed an 
increased mRNA expression of the delta-5-desaturase. However, the hepatic mRNA steady 
state levels of the delta-5-desaturase of rainbow trout in this experiment showed no significant 
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differences among dietary treatments. Furthermore, it seems that high dietary levels of ALA 
and SDA could compensate for low dietary EPA and DHA levels because the levels of DHA in 
the fish fillets were not significantly different. In addition, rainbow trout fed the highest dietary 
Ahiflower oil contents had the significantly highest body weights. These results highlight the 
potential of Ahiflower oil as a potential candidate to substitute fish oil in rainbow trout diets. 
In chapter 1, equol increased DHA in whole body homogenates, whereas in chapter 3 
Ahiflower oil increased EPA levels in fillets of rainbow trout. However, the aim of the thesis 
was to increase both EPA and DHA in fillets of rainbow trout. Thus, the experiment in  
chapter 4 aimed to investigate the interactions of dietary equol and Ahiflower oil to improve 
the fillet quality of rainbow trout. For this experiment, a diet based on a blend of fish and 
vegetable oils was used as a control diet. In addition, there were four diets based on a blend 
of Ahiflower oil and vegetable oils. Three of these diets were supplemented with equol in 
amounts of 0.1%, 0.2% and 0.3% of the dry matter of the diet. Similar to chapter 2, no effects 
on growth and nutrient composition of whole body homogenates of juvenile rainbow trout were 
observed. In contrast, fish fed with Ahiflower-equol diets showed increased liver weights and 
higher levels of stearic acid in the liver. This, again, underlines the assumption that equol could 
develop estrogen-like effects in the liver of rainbow trout. The initial hypothesis that equol could 
also increase the expression of the target genes of biosynthesis via estrogen-like mechanisms 
of action, however, could not be proven. Similar to chapter 1, there were no significant 
differences in hepatic mRNA steady state levels of the delta-6-desaturase among treatments. 
Thus, the increase of DHA levels in the liver of fish fed with the Ahiflower-equol diets cannot 
be explained by an increased gene expression of delta-6-desaturase. Another possibility could 
be that equol enhances the activity of this desaturase and a transcription factor centrally 
involved in the biosynthesis, respectively, by binding to estrogen receptors. However, it seems 
that equol combined with Ahiflower oil particularly affects the fatty acid composition of the liver. 
Thus, this combination significantly increased the LC-PUFA levels in this tissue. By 
comparison, the fillets of fish which were fed diets containing 0.2% and 0.3% equol 
supplementation, however, had lower EPA levels than fish which were fed the fish oil-based 
control diet, but both sets had similar DHA levels. Nevertheless, DHA synthesis can be 
considered as relatively slow and it may require additional time to exceed the DHA levels of 
the fish fed with the fish oil-based control diet. The fact that equol showed an effect on the LC-
PUFA levels in chapter 4 but not in chapter 2, could be due to the dietary SDA content, which 
could probably have contributed to an increased efficiency of the biosynthesis. 
In conclusion, this thesis showed that the endogenous biosynthesis of LC-PUFA in rainbow 
trout can be regulated by dietary fatty acids and the isoflavone metabolite equol. However, the 
approach to increase the LC-PUFA fillet levels via the stimulation of the endogenous 
biosynthesis in order to increase the product quality for human consumption is limited. Further, 
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it seems that the efficiency of equol and genistein depends on the dietary fatty acid 
composition. These substances do not have any beneficial effect if dietary EPA and DHA levels 
are low and simultaneously only ALA but not SDA is provided via the diet. Future studies 
should investigate the use of Ahiflower oil and equol to increase the LC-PUFA biosynthesis 
over a longer experimental period, ideally over an entire production cycle, to evaluate the full 
potential of these ingredients.     
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ZUSAMMENFASSUNG 
Omega-3 (n-3) Fettsäuren sind von großer Bedeutung für die menschliche Gesundheit. 
Insbesondere die Fettsäuren Eicosapentaensäure (EPA, 20:5n-3) und Docosahexaensäure 
(DHA, 22:6n-3) sind für ihre potentiell gesundheitsfördernden Effekte bekannt. Während EPA 
entzündungshemmend wirken kann, ist DHA unter anderem für die neuronale Entwicklung von 
entscheidender Bedeutung. Der menschliche Organismus ist in der Lage, EPA und DHA aus 
der essentiellen Vorläufer-Fettsäure α-Linolensäure (ALA, 18:3n-3) endogen zu 
synthetisieren. Diese Biosynthese findet jedoch nur in begrenztem Maße statt. Deshalb ist der 
Mensch auf die zusätzliche Aufnahme der langkettigen mehrfach ungesättigten Fettsäuren 
(LC-PUFA, long-chain polyunsaturated fatty acids) EPA und DHA über die Nahrung 
angewiesen. Dabei ist Fisch die bedeutsamste Quelle dieser Fettsäuren in der 
Humanernährung. Der LC-PUFA-Gehalt in Fischen hängt unter anderem stark von der 
jeweiligen Fischart und der Zusammensetzung der Fettsäuren in der Nahrung ab. Im 
Gegensatz zu den meisten Seewasserfischen können viele Süßwasserfische wie die 
Regenbogenforelle (Oncorhynchus mykiss), EPA und DHA endogen synthetisieren. Ähnlich 
wie beim Menschen ist die Effizienz dieser Synthese jedoch begrenzt. Um eine hohe 
Produktqualität von Aquakulturerzeugnissen für den menschlichen Verzehr zu gewährleisten, 
müssen folglich erhebliche Mengen dieser Fettsäuren über das Fischfutter bereitgestellt 
werden. In der Vergangenheit wurde dies vor allem über den Einsatz von marinen Rohstoffen 
wie Fischmehl und Fischöl in der Fischernährung umgesetzt. Durch das kontinuierliche 
Wachstum des Aquakultursektors und dem damit einhergehenden zunehmenden Bedarf an 
marinen Rohstoffen, stieg der Preis für diese Produkte deutlich an. Deshalb wurden vermehrt 
pflanzliche Öle als Substitut für Fischöl in Futtermitteln für Salmoniden eingesetzt. Pflanzenöle 
sind günstiger als Fischöl und besser verfügbar, beinhalten jedoch außer ALA keine 
längerkettigen n-3 Fettsäuren. Wie bereits erwähnt hat die Fettsäurezusammensetzung des 
Futtermittels einen beträchtlichen Einfluss auf die Fettsäurezusammensetzung des Fischfilets. 
Durch die Verwendung von Pflanzenölen im Futtermittel wird somit die 
Fettsäurezusammensetzung des Filets nachteilig modifiziert. Durch die geringeren EPA- und 
DHA-Gehalte sowohl im Futter als auch dann im Fisch wird letztlich die Produktqualität des 
Filets für den menschlichen Verzehr reduziert. Um die Bereitstellung an EPA und DHA über 
das Lebensmittel Fisch für die Humanernährung gewährleisten zu können, ist die Identifikation 
alternative Rohstoffe, die ein Äquivalent zu Fischöl darstellen, von immenser Bedeutung. 
Potentielle Futtermittelrohstoffe wie Öle von primärproduzierenden Mikroalgen und 
gentechnisch veränderte Pflanzenöle, die EPA und DHA in nennenswerten Mengen enthalten, 
sind allerdings entweder noch nicht kommerziell erhältlich oder in ihrer Verwendung umstritten. 
Ziel der vorliegenden Arbeit war es deshalb, Möglichkeiten zur Steigerung der Synthese von 
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LC-PUFA zu evaluieren, um die Gehalte an EPA und DHA in der Regenbogenforelle zu 
erhöhen.  
Die endogene Biosynthese von LC-PUFA ist komplex und kann durch verschiedene Faktoren 
wie beispielsweise Nahrungsfettsäuren und Hormone reguliert werden. Die Verwendung von 
bioaktiven Substanzen, wie Isoflavone und der Isoflavon-Metabolit Equol, scheint ein 
geeignetes Mittel zur Stimulierung der endogenen LC-PUFA-Biosynthese in der 
Regenbogenforelle zu sein. Isoflavone kommen natürlicherweise in Pflanzen wie Soja (Glycine 
max) und Rotklee (Trifolium pratense) vor und besitzen Eigenschaften, die die Biosynthese 
über verschiedene Mechanismen beeinflussen können. Zum Beispiel haben sie eine 
strukturelle Ähnlichkeit mit dem Hormon Östrogen und sind außerdem potentielle Liganden für 
Transkriptionsfaktoren der Biosynthese (z.B. PPARα). Dadurch könnten sie möglicherweise 
die Expression von den Genen erhöhen, die zentral an der LC-PUFA Biosynthese beteiligt 
sind. Bislang ist allerdings wenig über das Potential und die Wirkweise dieser Substanzen auf 
den Lipidmetabolismus in Fischen bekannt. 
Daher wurden in Kapitel 1 vier verschiedene Isoflavone hinsichtlich ihres Potentials, die LC-
PUFA-Biosynthese in Regenbogenforellen zu stimulieren, untersucht. Für dieses Experiment 
wurden fünf Diäten basierend auf einer Mischung aus Pflanzenölen konzipiert und über einen 
Zeitraum von acht Wochen an juvenile Regenbogenforellen verfüttert. Vier dieser Diäten 
wurden mit 0,15% der Isoflavone Biochanin A, Daidzein, Genistein bzw. Equol supplementiert. 
Die fünfte Diät, ohne Zusatz, diente als Kontrolldiät. Von allen getesteten Substanzen zeigten 
nur Fische, die mit Equol und Genistein gefüttert wurden, erhöhte DHA-Werte im 
Ganzkörperhomogenat. Im Gegensatz dazu wurden die EPA- und DHA-Gehalte im Filet und 
in der Leber nicht durch die Futtermittel beeinflusst. Equol könnte die Biosynthese von DHA 
über östrogen-ähnliche Wirkmechanismen gesteigert haben. Ein Fakt, der diese These stützt, 
ist die Erhöhung der Fettsäure 18:0 (Stearinsäure) in der Leber dieser Fische. Ein Anstieg 
dieser Fettsäure wurde mit steigenden Östrogenspiegeln bei Ratten in Verbindung gebracht. 
Im Gegensatz dazu könnte Genistein den DHA-Gehalt im Ganzkörperhomogenat aufgrund 
der antioxidativen Eigenschaften oder mittels Bindung an Transkriptionsfaktoren erhöht 
haben. Zum besseren Verständnis der potentiellen Wirkmechanismen dieser Stoffe, wurden 
mögliche Auswirkungen auf den Lipidstoffwechsel der Leber untersucht. Von besonderem 
Interesse waren hierbei die hepatische mRNA-Level und der Proteingehalt der Delta-6-
Desaturase, einem Schlüsselenzym der LC-PUFA-Biosynthese. Der Anstieg des DHA-
Gehalts wurde jedoch nicht durch die Ergebnisse der Genexpressionsanalyse gestützt, da die 
Fische, die mit der Equol-Diät gefüttert wurden sogar verringerte mRNA-Level aufwiesen. 
Außerdem konnte kein Einfluss der Substanzen auf die Proteinmenge dieses Enzyms 
nachgewiesen werden. Ein weiterer Aspekt, der wichtig für den potentiellen Einsatz als 
Futtermittelrohstoff ist, ist die Wirkung der Substanzen auf das Wachstum und die 
128  Zusammenfassung 
Nährstoffzusammensetzung der Fische. Diese beiden Faktoren wurden ebenfalls nicht durch 
die Diäten beeinflusst. Somit können diese Substanzen in Konzentrationen von 0,15% der 
Trockensubstanz in der Diät für Regenbogenforellen verwendet werden, ohne die 
Leistungsparameter zu beeinträchtigen. Equol und Genistein können die DHA-Gehalte im 
Ganzkörperhomogenat von Regenbogenforellen erhöhen, jedoch nur in einem geringen 
Ausmaß. 
Studien mit bioaktiven Substanzen deuten darauf hin, dass diese Stoffe im Organismus 
dosisabhängige Wirkungen entfalten können. Daher könnten unterschiedliche diätetische 
Konzentrationen zu einer verstärkten Stimulation der LC-PUFA-Biosynthese in 
Regenbogenforellen führen. Deshalb wurde in Kapitel 2 untersucht, ob es eine Dosis-
Wirkungs-Beziehung von Equol und Genistein auf die LC-PUFA-Gehalte im Gewebe von 
Regenbogenforellen gibt. In diesem Experiment wurden juvenilen Regenbogenforellen 
verwendet und mit insgesamt sieben Diäten über eine Dauer von acht Wochen gefüttert. Eine 
auf Pflanzenöl basierende Diät diente als Kontrolldiät und wurde mit Equol bzw. Genistein in 
einer Menge von 0,1, 0,2 und 0,3% der Trockensubstanz der Diät ergänzt. Ein Beispiel für 
einen Dosis-Wirkungs-Zusammenhang wäre die Beeinträchtigung des Wachstums mit 
zunehmender Konzentration der bioaktiven Substanz im Futtermittel. Dieser Effekt wurde in 
einigen Studien mit Regenbogenforellen und dem Atlantischen Lachs beobachtet. In der 
aktuellen Studie wurden jedoch keine Auswirkungen einer höheren Konzentration des 
jeweiligen Stoffs auf das Wachstum der Fische gefunden. Dieser Befund ist allerdings auf das 
tägliche Fütterungsniveau von 1.6% der Biomasse der Fische beschränkt und schließt nicht 
aus, dass es bei einer höheren Futteraufnahme zu einer Beeinträchtigung des 
Fischwachstums kommen kann. Ähnlich zu den Ergebnissen aus Kapitel 1 wiesen 
Regenbogenforellen, die mit Equol gefüttert wurden, in der Studie in Kapitel 2 höhere 
Stearinsäuregehalte in der Leber auf. Zusätzlich waren bei diesen Fischen die Lebergewichte 
erhöht. Dies deutet auf eine östrogen-ähnliche Wirkung von Equol in der Leber hin und 
unterstreicht somit die Annahme aus Kapitel 1. Im Gegensatz dazu gab es keine 
Auswirkungen der Substanzen auf die LC-PUFA-Gehalte in der Leber, im Filet und im 
Ganzkörperhomogenat der Fische. Die Diäten in Kapitel 1 hatten höhere EPA- und DHA-
Gehalte im Vergleich zu den in Kapitel 2 verwendeten Diäten. Daher könnte es möglich sein, 
dass geringe LC-PUFA Gehalte im Futtermittel die endogene LC-PUFA-Biosynthesekapazität 
der Fische bereits voll ausschöpfen und eine weitere Stimulation mittels Isoflavonen nicht 
möglich ist. Auf Grund der nicht vorhandenen bis geringen Wirkung erscheint die Verwendung 
von Equol und Genistein in Diäten auf der Basis kommerziell eingesetzter Pflanzenöle zur 
Erhöhung der LC-PUFA-Gehalte im Filet von Regenbogenforellen scheint nur in begrenztem 
Umfang möglich. 
Zusammenfassung  129 
 
Es gibt jedoch auch andere Möglichkeiten, die Biosynthese in Regenbogenforellen zu 
stimulieren. Zum Beispiel können Fettsäuren, die über die Nahrung aufgenommen wurden, die 
Expression von Genen, die maßgeblich an der Biosynthese beteiligt sind, regulieren. Über 
einen negativen Feedback-Mechanismus kann die Abwesenheit von LC-PUFA die 
Genexpression eben dieser Gene erhöhen und somit die Synthese von EPA und DHA im Fisch 
stimulieren. Darüber hinaus könnte eine Steigerung der Substratmenge der Vorläufer-
Fettsäuren die Gesamteffizienz der Biosynthese weiter erhöhen. Studien mit Menschen, 
Hunden und Mäusen zeigen, dass Stearidonsäure (SDA, 18:4n-3) für die Synthese von EPA 
ein höherwertigeres Substrat als ALA sein kann, da der erste Schritt der Biosynthese – die 
Delta-6-Desaturierung von ALA zu SDA – übersprungen werden kann.  
Daher sollte in Kapitel 3 untersucht werden, ob höhere ALA- und SDA-Gehalte im Futtermittel 
die Effizienz der endogenen EPA- und DHA-Biosynthese bei Regenbogenforellen steigern 
können. Dafür wurde ein Öl der Pflanze Buglossoides arvensis (Ahiflower Öl) verwendet. Im 
Gegensatz zu herkömmlichen Pflanzenölen enthält dieses Öl hohe Mengen an SDA, ist aber 
ebenfalls reich an ALA. Im Experiment, das in Kapitel 3 beschrieben wird, erhielten juvenile 
Regenbogenforellen über einen Zeitraum von acht Wochen vier Futtermittel. Als Kontrolle 
diente eine Diät, die auf einer Mischung aus Fischöl und pflanzlichen Ölen basierte. Dieses 
Ölgemisch wurde zu 33, 66 und 100% durch Ahiflower Öl ersetzt. Die höheren Gehalte an ALA 
und SDA in den Futtermitteln mit 66 und 100% Ahiflower Öl-Anteil führten zu einem 
signifikanten Anstieg des EPA-Gehalts im Forellenfilet im Vergleich zu den Fischen, die mit 
der Kontrolldiät gefüttert wurden. Dies ist besonders relevant, da die Ahiflower-Diäten deutlich 
geringere EPA-Gehalte als die Kontrolldiät aufwiesen. Dieses Ergebnis deutet darauf hin, dass 
eine größere Substratmenge an Vorläufer-Fettsäuren (ALA und SDA) tatsächlich die Effizienz 
der LC-PUFA Synthese steigern kann. Für die Biosynthese von EPA wird ein Delta-5-
Desaturaseschritt benötigt. So wiesen Lachse, die mit hohen SDA-Gehalten im Futtermittel 
gefüttert wurden, eine gesteigerte mRNA-Expression der Delta-5-Desaturase auf. Die mRNA-
Level der Delta-5-Desaturase der Fische dieses Versuchs zeigten jedoch keine signifikanten 
Unterschiede zwischen den verschiedenen Futtergruppen. Da sich außerdem die DHA-
Gehalte der Fischfilets nicht signifikant voneinander unterschieden, scheint es, als könnten 
hohe Gehalte an ALA und SDA die geringen EPA und DHA Gehalte in der Diät kompensieren. 
Darüber hinaus wiesen die Forellen, die mit den höchsten Konzentrationen an Ahiflower Öl 
gefüttert wurden, die signifikant höchsten Körperendgewichte auf. Dieses Ergebnis 
unterstreicht das Potential des Ahiflower Öls als Alternative zum Einsatz von Fischöl in 
Futtermitteln für Regenbogenforellen. 
In Kapitel 1 erhöhte Equol den DHA-Gehalt im Ganzkörperhomogenat, wohingegen Ahiflower 
Öl in Kapitel 3 die EPA-Gehalte im Filet von Regenbogenforellen erhöhte. Ziel dieser Arbeit 
war es jedoch, sowohl EPA als auch DHA im Filet der Regenbogenforelle zu steigern. Daher 
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lag der Fokus des Experiments in Kapitel 4 darauf, eine mögliche Wechselwirkungen von 
Equol mit Ahiflower Öl zu untersuchen, um die Filetqualität von Regenbogenforellen zu 
verbessern. Für diesen Versuch wurde ein Futtermittel basierend auf einem Gemisch aus 
Fischöl und pflanzlichen Ölen als Kontrolldiät verwendet. Zusätzlich gab es vier Diäten, 
basierend auf einer Mischung aus Ahiflower Öl und pflanzlichen Ölen. Drei dieser Diäten 
wurden mit Equol in Mengen von 0,1, 0,2 und 0,3% der Trockensubstanz der Diät ergänzt. 
Ähnlich zu Kapitel 2 wurden keine Auswirkungen der Equol-Zulage auf das Wachstum von 
Fischen und die Nährstoffzusammensetzung der Ganzkörperhomogenate der juvenilen 
Regenbogenforellen festgestellt. Im Gegensatz dazu zeigten Fische, die mit Ahiflower-Equol-
Diäten gefüttert wurden, ein erhöhtes Lebergewicht und höhere Gehalte an Stearinsäure in 
der Leber auf. Dies unterstreicht erneut die Vermutung, dass Equol in der Leber von 
Regenbogenforellen eine östrogen-ähnliche Wirkung erzeugen könnte. Die 
Anfangshypothese, dass Equol ebenfalls über östrogen-ähnliche Wirkmechanismen die 
Expression der Zielgene der Biosynthese steigern könnte, konnte dagegen nicht belegt 
werden. Auch in diesem Versuch gab es keine signifikanten Unterschiede zwischen den 
mRNA-Leveln der Delta-6-Desaturase in den Lebern von Fischen der verschiedenen 
Futtergruppen. Demnach kann der DHA-Anstieg in der Leber der mit Ahiflower-Equol 
gefütterten Fische nicht über eine erhöhte Genexpression der Delta-6-Desaturase erklärt 
werden. Eine weitere Möglichkeit wäre, dass Equol die Aktivität dieser Desaturase oder eines 
Transkriptionsfaktors, der zentral an der Biosynthese beteiligt ist, erhöht, indem es an 
Östrogenrezeptoren bindet. Es scheint aber, als erziele Equol in Zusammenhang mit Ahiflower 
Öl vor allem in der Leber maßgebliche Effekte auf das Fettsäuremuster. So steigerte diese 
Kombination die LC-PUFA-Gehalte signifikant in diesem Gewebe. Im Vergleich dazu wies das 
Filet der Fische, denen Diäten mit 0,2 und 0,3% Equol Supplementierung gefüttert wurden, 
allerdings geringere EPA-Gehalte und ähnliche DHA-Gehalte auf, wie diejenigen Fische, die 
die Fischöl-Kontrolldiät erhielten. Indessen ist die DHA-Synthese relativ langsam und es 
könnte sein, dass zusätzliche Zeit erforderlich ist, um die DHA-Gehalte der Fische, die mit der 
Kontrolldiät auf Fischölbasis gefüttert wurden, zu überschreiten. Dass Equol in dieser Studie 
im Gegensatz zur Studie in Kapitel 2 einen Effekt auf die LC-PUFA-Synthese zeigt, könnte 
am diätetischen SDA-Gehalt liegen, der vermutlich zu einer gesteigerten Effizienz der 
Biosynthese beigetragen haben könnte.  
Zusammenfassend zeigt diese Arbeit, dass die endogene Biosynthese von LC-PUFA in 
Regenbogenforellen durch Fettsäuren in der Nahrung und den Isoflavon-Metaboliten Equol 
reguliert werden kann. Der Ansatz, die LC-PUFA-Gehalte im Filet durch Stimulierung der 
endogenen Biosynthese zu steigern, um die Produktqualität für den menschlichen Verzehr zu 
erhöhen, ist jedoch nur in begrenztem Umfang möglich. Ferner scheint es, dass die 
Wirksamkeit von Equol und Genistein von der Fettsäurezusammensetzung des Futtermittels 
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abhängt. Diese Substanzen haben keine Wirkung auf die LC-PUFA-Gehalte in der Forelle, 
wenn im Futtermittel die EPA- und DHA-Konzentrationen gering sind und gleichzeitig nur ALA, 
aber kein SDA, im Futtermittel vorhanden ist. Zukünftige Studien sollten den Einsatz von 
Ahiflower Öl und Equol zur Steigerung der LC-PUFA-Biosynthese über einen längeren 
Versuchszeitraum, idealerweise über einen gesamten Produktionszyklus, untersuchen, um 
das gesamte Potential dieser Rohstoffe zu bewerten. 
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Nutrient composition 
Used in chapter 1-4 
The proximate nutrient analysis was conducted for samples of experimental diets, fillets and 
whole body homogenates. It was performed at the laboratory of the Gesellschaft für Marine 
Aquakultur according to EU guideline (EC) 152/2009 [1]. The analysis included the 
determination of dry matter (DM), crude protein, crude lipid and crude ash.  
Prior to the analysis, fillet and whole body homogenate samples were freeze dried (alpha 1-4 
LSC; Martin Christ Gefriertrocknungsanlagen GmbH, Osterode am Harz, Germany) until the 
weight was constant. Subsequently, these samples were homogenized with a knife mill 
(Grindomix, Retsch, Haan, Germany). All samples were analyzed in duplicate. For the 
determination of dry matter and crude ash, samples (2g) were dried at 103°C in a drying oven 
(ED53 9010-0078; Binder GmbH, Tuttlingen, Germany) until constant mass. After the samples 
were weighed to determine dry matter, same samples were incinerated for 4 h at 560°C in a 
muffle furnace (LE 6/11/P300; Nabertherm, Lilienthal, Germany) to determine crude ash. 
Crude protein content was analyzed according to the methods of Kjeldahl. The samples (0.5g) 
were prepared via digestion (KjelDigester K-449 and Scrubber K-415; BÜCHI Labortechnik 
GmbH, Essen, Germany) with sulphuric acid and distillation (KjelFlex 360; BÜCHI 
Labortechnik GmbH) with sodium hydroxide and boric acid following titration (877 Titrino plus; 
Deutsche METROHM GmbH & Co. KG, Filderstadt, Germany) using a nitrogen to protein 
coefficient of 6.25. Crude lipid content was determined according to the Soxhlet method. 
Samples (2g) were hydrolyzed with hydrochloric acid (HYDROTHERM HT 6; C. Gerhardt 
GmbH & Co. KG, Königswinter, Germany) and dried prior to the extraction with petroleum 
ether (SOXTHERM 416, Multistat/SX PC; C. Gerhardt GmbH & Co. KG, Königswinter, 
Germany). The gross energy content (MJ/kg) was determined by bomb calorimetry (C 200; 
IKA-Werke GmbH & Co. KG, Staufen, Germany) using 0.5g per sample for each analysis. 
Prior to the measurement, the device was calibrated with benzoic acid.  The content of total 
carbohydrates was calculated as follows: Total carbohydrates = 100 – (crude protein + crude 
lipid + crude ash).  
Fatty acid composition 
Used in chapter 1-4 
Fatty acid composition of oils, diets, liver, whole body homogenate and fillet samples was 
analyzed by LUFA-ITL GmbH in Kiel, Germany. The analyses were conducted using gas 
chromatography (GC) (Deutsche Gesellschaft für Fettwissenschaft e.V. (DGF), C-VI 10a).  
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Samples (1g) were prepared using saponification with methanolic NaOH and transmethylation 
of total lipids with boron trifluoride and methanol (DGF, C-VI 11a). The obtained fatty acid 
methyl ester (FAME) samples were separated by GC via split-injection (column: CP-Sil 88 50 
m x 0.25 mm x 0.2 µm or similar) with an injection amount of 0.5 μl and a split ratio of 12.5:1. 
In addition, FAME were detected using a flame ionization detector (FID) with helium as a carrier 
gas. The individual FAME were identified by comparison with certified standard mixtures 
(18919-1AMP Supelco, F.A.M.E. Mix, Sigma-Aldrich) similar to the chromatogram shown in 
Fig A-1. Finally, the fatty acid composition was calculated as percent of FAME relative to total 
FAME. If required by the journal (Lipids, manuscripts of chapter 3 and 4), FAME values were 
converted to moles and the fatty acid composition data is reported as mole% of total fatty acids. 
 
Fig. A-1 Represantive GC chromatogram of fatty acid methyl ester (FAME) from a standard 
mixture for fish samples. Each peak represents a specific FAME and the peak area is correlated to 
the total amount of FAME.  
RNA isolation and qRT-PCR 
Used in chapter 1, 3 and 4 
Prior to total RNA isolation, approximately 15 mg of RNA later stabilized liver tissue of rainbow 
trout was homogenized in a TissueLyser II (Qiagen, Hilden, Germany). Total RNA was 
extracted from liver samples using the Innuprep RNA Mini Kit (Analytik Jena, Jena, Germany) 
according to the manufacturer’s protocol. RNA concentration and purity were determined by 
measuring the absorbance at ratios of A260/280 and 260/230 via NanoDrop measurements 
(NanoDrop2000c; ThermoScientific, Waltham, MA, USA). For the following analysis, each 
sample was diluted with DEPC treated water to result in a RNA concentration of 100 ng/μl. 
Hepatic mRNA steady state levels of selected target genes were quantified via quantitative 
real-time reverse transcription polymerase chain reaction (qRT-PCR) measurements using the 
SensiFast SYBR No-ROX One-Step Kit (Bioline, London, UK) and a Rotor-Gene 6000 real-
time PCR cycler (Corbett/Qiagen). Eighteen microliters of a 1000-fold-diluted RNA sample 
were added to 27 µl Master Mix. The 27 µl Master Mix consisted of 2.48 µl DEPC treated water, 
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0.40 µl reverse transcriptase, 0.90 µl RNase inhibitor, 22.5 µl 2x SensiFAST-Mix and 0.36 µl 
of each primer. The analysis was conducted in duplicate using 20 µl of this mixture each. The 
cycling conditions were as follows: at 49 °C for 30 min, at 95 °C for 10 min, 40 cycles of 95 °C 
for 15 s, annealing temperature of the primer pair for 30 s and 72 °C for 30 s, followed by a 
melt curve analysis from 60 to 99 °C of 1 °C increments. Primer sequences and the respective 
annealing temperatures are listed in the respective chapters separately. A standard curve was 
used to calculate relative mRNA concentrations. The mRNA steady state levels of genes 
encoding proteins related to lipid metabolism were normalized to the expression level of the 
housekeeping gene elongation factor 1 alpha (ef1α). Ef1α was previously used and suggested 
as a gene reference in salmonids [2]. 
Enzyme-Linked Immunosorbent Assay (ELISA)  
Used in chapter 1 
The protein levels of Fads2a(d6) were determined using a Fish Fatty Acid Desaturase 2 ELISA 
Kit (MBS066226, MyBiosource Inc., San Diego, CA, USA; purchased from Biozol, Eching, 
Germany) according to the manufacturer’s protocol. Rainbow trout liver samples diluted in 
phosphate buffered saline in a TissueLyser II (Qiagen, Hilden, Germany). After the 
centrifugation, standards and diluted samples were applied to the Microelisa 96-well plate. 
Samples were incubated and treated with horseradish peroxidase (HRP) conjugate reagent. 
Wells were sealed following a 60-minute incubation at 37°C in a microplacte rader. 
Subsequently, wells were washed multiple times. Color intensity was determined at 450 nm 
using a Labsystems iEMS MF multiplate reader (MTX Lab Systems, Bradenton, FL, USA 
purchased from Thermo Fisher Scientific, Darmstadt, Germany). The Fads2a(d6) protein 
concentration in the liver samples of rainbow trout was calculated via standard curve. Values 
were normalized to the total protein concentration determined by bicinchoninic acid (BCA) 
measurements. For these measurements, a Pierce BCA Protein Assay Kit was used according 
to the manufacturer’s protocol. 
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